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Research towards the development of medicines that treat genetic diseases, 
cancer, or viral infections has gained increasing interest over the last decades. Also, 
progress in the field of genome sequencing and bioinformatics provided information 
about the genetic origin of many conditions. This knowledge expanded the group of 
diseases potentially treatable by gene therapy, thereby increasing the interest in this 
type of treatment even more. In the meantime, it became clear that technology enabling 
the controlled delivery of nucleic acids would be needed to succeed in the introduction 
of a therapeutic gene into a mammalian cell. 
Both physical and chemical methods have been explored to increase the 
delivery efficiency of nucleic acids in cells. Physical methods involve the application of 
an external “physical” trigger to deliver nucleic acids across the cell membrane into the 
cell’s cytoplasm. Examples of this approach are microinjection, electroporation, 
sonoporation, photoporation, and biolistic gene delivery (so-called gene gun). A 
prerequisite for these physical delivery methods to work is that the target tissue should 
be confined and that it’s accessible by the physical trigger. Chemical delivery methods, 
on the other hand, have the potential to more easily reach different types of tissues by 
means of passive or active targeting strategies. Chemical delivery methods typically 
involve the use of nanomaterials that act as carriers for the therapeutic nucleic acids. 
Their main task is to protect the nucleic acids and transport them across biological 
barriers to the target cells. Since these nanocarriers typically need to be injected 
intravenously, the blood compartment already constitutes a first major barrier. First of 
all, blood contains nucleases as well as immune cells that can respectively degrade 
nucleic acids or eliminate exogenous materials. Secondly, contact with blood proteins 
may lead to nanocarrier aggregation, dissociation of the nucleic acid – nanocarrier 
complex and loss of targeting functionality. Thirdly, the nanocarriers should be able to 
extravasate through the endothelial wall toward the target tissue. If all of that is 
successful, the nanocarriers typically have to cross the extracellular space and reach 
the target cells. Also on the level of the cell substantial barriers exist, including the 
plasma membrane, endosomal sequestration following nanoparticle endocytosis, and 
the nuclear envelope in the case of DNA-based gene therapy. Drug delivery scientists 
are working hard to design nanomaterials capable of overcoming all of these bio-
barriers and bring gene therapy closer to reality. 
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Synthetic or non-viral vectors that complex nucleic acids are designed to have 
low immunogenicity and low cytotoxicity. Furthermore, they are easy to manufacture 
and allow for a broad range of possible chemical modifications. The efficiency of non-
viral gene delivery remains, however, relatively low especially when compared to viral 
vectors. Therefore, fundamental research aimed at obtaining a better understanding of 
the different extra- and intracellular barriers is necessary to enable further rational 
optimization of nanocarrier design. 
One of the biological barriers that is expected to be responsible for a decrease 
in efficiency of the nanocarriers in both the extra- and intracellular environment is the 
degradation of nucleic acids. Nevertheless, only a limited amount of research groups 
focus on where and how fast plasmid DNA (pDNA) is degraded, especially in living 
cells. Lechardeur et al. (1999)1 used fluorescence in situ hybridization (FISH) to 
visualize degradation after fixation, dual fluorescent labeling was used to visualize 
degradation in living cells, 2 and atomic force microscopy (AFM) was used to study 
degradation of pDNA in buffers. 3 This shows that fluorescence microscopy has already 
proven to be a powerful technique to investigate the interaction of drug delivery 
nanocarriers with the relevant biological barriers. Especially on the intracellular level it 
offers detailed insight in the cellular processing of nanocarriers. 
The general aim of this thesis was to use advanced fluorescence microscopy 
methods to study degradation of nucleic acids, which we believe is an important 
intracellular barrier encountered during the cellular processing of nanocarriers. 
Fluorescence correlation spectroscopy (FCS) and single particle tracking (SPT) were 
the advanced microscopy techniques that were used. Both of these techniques give 
information on the diffusion coefficient (and thus size) and concentration of the 
fluorescent molecules of interest. 
To detect the nucleic acids with these fluorescence-based techniques, evidently 
they need to be labeled with a fluorescent tag. The design of microscopy experiments, 
however, often lacks attention to the labeling method. Using the right labeling method 
to label the carrier or the cargo at the right labeling density is crucial. It is generally 
accepted that high densities of fluorescent labels alter the intracellular behavior of the 
labeled molecules. It was, however, not studied how and at which points, interference 
of the fluorescent labels was significant. For this reason, the first goal of this work was 
to study the effect the random covalent labeling strategy, that is most often used to 
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attach fluorophores to pDNA, has on the intracellular processing and the transfection 
efficiency after lipid-mediated transfection. When a labeling density with minimal 
interference was found, our second goal was to evaluate two advanced microscopy 
techniques (FCS and SPT) to follow pDNA degradation in a biological environment. 
Next, we wanted to investigate if less common alternatives for the fluorescent labeling 
of nucleic acids showed the same effect on transfection efficiency and could be used 
for measurements with advanced microscopy techniques. Our final goal was to 
evaluate a new type of non-viral carrier, based on polycationic amphiphilic β 
cyclodextrins (paCDs), for the delivery of pDNA or mRNA. 
The first Chapter gives a detailed overview of the different methods that are 
available for fluorescence labeling of nucleic acids. Additional to the background and 
mechanism of each labeling method, a guide for choosing the optimal labeling strategy 
for intracellular gene trafficking studies is presented. Next, in Chapter 2 the theoretical 
background of FCS and SPT is given and the methodology that is used in the rest of 
the thesis is explained in detail. 
Chapter 3 focuses on one of the labeling methods of Chapter 1, namely random 
covalent labeling, and the effect it has on the intracellular trafficking of pDNA that is 
delivered with a lipid-based carrier. The results showed that the fluorescent labeling 
influences the transfection capability of the pDNA, even at relatively low labeling 
densities. This shows that care should be taken when studying the intracellular 
trafficking of exogenous fluorescent DNA. It also obviates the need for further studies 
on which intracellular processes are potentially affected by the addition of fluorescent 
labels. Chapter 4 describes the evaluation of two advanced microscopy techniques to 
measure molecular concentration of fluorescently labeled pDNA in biological fluids. We 
focused on the measurement of pDNA concentration since degradation by enzymes in 
the extracellular environment, as well as in the cell, leads to a significant loss of pDNA 
during nucleic acid delivery. Since the regularly used methods at this moment (e.g., 
agarose gel electrophoresis or quantitative polymerase chain reaction (qPCR)) cannot 
cope with, for example, the presence of proteins in biologic fluids, purification steps 
are necessary. For this reason, microscopy measurements directly in the biological 
fluid would be less labor intensive and faster. The two techniques, FCS and SPT, were 
evaluated in their ability to measure the concentration of intact pDNA in buffer, in 
complex mixtures with degraded pDNA, and over time during enzymatic degradation 
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by the endonuclease DNase I. By increasing the complexity of the medium, it became 
clear that SPT with concentration analysis was the best technique and that it could 
show that intracellular degradation after lipofection causes the loss of a significant 
amount of pDNA even after 8 hours. In Chapter 5 different possible nucleic acid 
labeling methods were explored as alternatives to the most commonly used random 
covalent labeling method. Cyanine dimeric nucleic acid stain TOTO-3, labeling via 
peptide nucleic acid (PNA) hybridization, methyltransferase (MTase)-mediated 
enzymatic labeling, and one non fluorescent method were tested with regard to ease-
of-use, transfection efficiency, and compatibility with confocal laser scanning 
microscopy (CLSM), FCS, and SPT. 
Newly synthesized carriers are often evaluated using techniques often used in 
our research group. This expertise was consulted by the research group of Prof. J.M. 
García Fernández. Chapter 6 describes the characterization and evaluation of three 
non-viral nucleic acid carriers consisting of polycationic amphiphilic β cyclodextrins 
(paCDs) which vary in their polycationic chain. In serum-free medium, the tested 
paCDs performed almost as well as Lipofectamine 2000 in the transfection of HeLa 
cells with pDNA and mRNA. However, when serum-containing culture medium is used, 
the transfection efficiency dropped significantly. We found that uptake of the 
complexes was affected when the experiments were performed in serum-containing 
cell culture medium, as well as in the presence of cholesterol. Although further 
research is needed, it is an indication that CDs need the interaction with cholesterol in 
the cell membrane to successfully transfect cells and that blocking this mechanism (by 
the formation of a protein corona in serum, or by saturating the CDs with an excess of 
free cholesterol) before reaching the cells should be avoided. 
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ABSTRACT 
Live-cell imaging has provided the life sciences with insights into the cell 
biology and dynamics. Fluorescent labeling of target molecules proves to be 
indispensable in this regard. In this chapter, we focus on the current fluorescent 
labeling strategies for nucleic acids, and in particular mRNA (mRNA) and plasmid 
DNA (pDNA), which are of interest to a broad range of scientific fields. By giving a 
background of the available techniques and an evaluation of the pros and cons, we 
try to supply scientists with all the information needed to come to an informed choice 
of nucleic acid labeling strategy aimed at their particular needs. 
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INTRODUCTION 
Ever since Robert Hooke and Anton van Leeuwenhoek used a single lens to 
visualize and describe simple biological samples in the 17th century, scientists relied 
on advances in technology to reveal more of Nature’s details. Image quality was 
improved in the following two centuries by optimizing lens combinations and progress 
in glass production, but resolution, contrast, noise, optical aberrations, sensitivity, and 
specificity were still major problems. Progression toward modern microscopy 
commenced when halfway through the 19th century, fluorescence was described by 
Stokes 1 and Von Lommel, creating the awareness that substances could be 
identified by measuring their specific fluorescence spectrum. Hence, one of the most 
important principles of fluorescence microscopy was born. Around the same time, 
Ernst Abbe published his theoretical analysis of the role of diffraction in optical 
microscopy. 2 It was however only at the start of the 20th century that a prototype of a 
bright field fluorescence microscope was built at the Carl Zeiss factory. Continuous 
instrumentation development and fluorescent probe design was conducted over the 
next 50 years, and with the invention of the beam splitting plate (dichroic mirror), 3 the 
basis of the fluorescence microscope as we know it today was formed. 4, 5 
The use of fluorophores to color specific substances of interest, has become 
indispensable in biology. While some molecules have intrinsic fluorescence 
properties, most biological substances have to be made visible by “labeling” them 
with specific fluorophores. Once labeled, some molecules can be used as a probe to 
identify cellular structures, such as for example the use of labeled antibodies to 
detect protein location. Alternatively, the labeled molecules themselves are the 
subject of investigation and their intracellular distribution and the biological processes 
in which they are involved are directly monitored. The choice for a certain fluorophore 
and an appropriate labeling strategy will greatly depend on the biological process one 
wishes to study. Ideally, the fluorophores specifically label the molecule of interest 
without nonspecific binding to other intracellular structures. Also, the fluorophores 
should have a high brightness and limited photobleaching to allow for imaging of 
biological processes during a suitable time frame. Finally, the fluorophores should 
show no or only limited interference with the process one wishes to study, to avoid 
labeling-induced artifacts. There is a wide variety of fluorophores available with 
output wavelengths in the blue, green, yellow, orange, red, far-red, or near-infrared 
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region of the emission spectrum. Obviously, the choice of suitable output 
wavelengths is strongly dictated by the optics of the available fluorescence 
microscopes. Also, the labeling strategy itself and the biological application (e.g., live-
cell imaging versus fixed samples) will further determine the availability of compatible 
fluorophores. In Table 1, an overview of common fluorescent molecule families is 
presented with available functionalities and photophysical properties. 
One of the biological processes that is of interest in the field of non-viral 
nucleic acid delivery, is the hurdles nucleic acids face on their extracellular and 
intracellular journey. For decades, researchers have fluorescently labeled nucleic 
acids with a variety of labeling strategies to gain insight in the fate of these nucleic 
acids. While labeling short interference RNA (siRNA) or antisense oligonucleotides is 
primarily done during chemical synthesis by the manufacturer, several strategies 
exist for the labeling of larger polynucleotides, such as plasmid DNA (pDNA) and 
messenger RNA (mRNA), in a research lab. These polynucleotides are of interest for 
any biological application in which the expression of proteins is beneficial. The main 
obstacle to the wide-spread use of these pDNA and mRNA based therapies is the 
low efficiencies obtained with the current transfection methods. Negatively charged 
nucleic acids are mostly complexed with positively charged carriers to enhance 
cellular uptake of the complexes which are formed. Designing new delivery vehicles 
is crucial for the future success of these treatments. Live-cell imaging will undeniably 
play an important role in unraveling the different steps of the transfection pathway. 6 
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Table 1 Overview of fluorescent molecule classes often used in nucleic acid labeling. 
Fluorescent 
molecule 
class 
 Functionalities Photophysical properties Supplier 
λAbs. 
(nm) 
λEm. 
(nm) 
Quantum 
yield 
Remarks 
Cyanine (Cy) 
dyes 
Cy3 SE, CA, strep, 
mal, azide, 
alkyne, NH2, 
UTP, CTP, GTP, 
ATP, pCp, 
dUTP, dCTP 
550 570 0.15 Broad range of applications, less 
bright than Alexa Fluor 546 
Invitrogen, Jena 
Bioscience, GE 
Healthcare Life 
Sciences, 
Lumiprobe, … 
Cy5 649 670 0.27 Broad range of applications, less 
bright than Alexa Fluor 647 
Cyanine 
dimers 
YOYO-1 
N/A 
491 509 0.38a, 0.25b 
7
 
Photocleavage of NA and bleaching 
reported8 
Molecular Probes 
TOTO-3 642 660 0.06 Bleaches fast (20-30s)9 
Ethidium 
bromide 
 N/A 285 605 0.20 Especially used for gel staining, but 
suspected mutagenicity 
Invitrogen, Sigma-
Aldrich, Bio-Rad, … 
Alexa Fluor 
Alexa Fluor 488 SE, CA, strep, 
mal, azide, 
alkyne, UTP, 
dUTP 
495 519 0.92 Fluorescence output unmatched by 
any other spectrally similar dye 
Molecular Probes 
 
Alexa Fluor 546 556 573 0.79 Cy3 and TM-Rhodamine substitute 
Alexa Fluor 594 SE, CA, strep, 
mal, azide, 
alkyne, dUTP 
590 617 0.66 Bright and photostable 
Alexa Fluor 647 SE, CA, strep, 
mal, azide, 
alkyne, ATP, 
dUTP, dCTP 
650 668 0.33 brighter substitute for Cy5 
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ATTO dyes 
ATTO 488 SE, CA, strep, 
mal, azide, 
alkyne, NH2, 
biotin, UTP, 
ATP, dUTP, 
dCTP 
501 523 0.80 Very high photostability ATTO-TEC, Sigma-
Aldrich, Jena 
Bioscience 
ATTO 647N 644 669 0.65 Cy5 substitute, high thermal and 
photostability, exceptionally high 
stability towards atmospheric ozone 
Fluorescein 
FITC 
(isothiocyanate) 
SE, mal, azide, 
alkyne, UTP, 
CTP, ATP, 
dUTP, dCTP, 
dGTP, dATP 
494 518 0.86 
(0.1 N 
NaOH) 
pH sensitive, prone to photobleaching Thermo Scientific, 
Sigma-Aldrich, Jena 
Bioscience, … 
5-FAM 
(carboxylic 
acid) 
SE, azide, 
alkyne, strep, 
NH2, dUTP, 
dCTP 
494 518 0.90 SE form more stable bond with 
amines compared to FITC-SE 
Molecular Probes, 
Sigma-Aldrich, Jena 
Bioscience, 
Lumiprobe, … 
TM-
Rhodamine 
TRITC 
(isothiocyanate) 
SE, strep, mal, 
azide, dUTP, 
dCTP 
555 580 0.10 Prone to aggregation Thermo Scientific, 
Sigma-Aldrich, … 
5-TAMRA 
(carboxylic 
acid) 
SE, strep, mal, 
azide, alkyne, 
NH2, dUTP, 
dCTP 
555 580 0.10 More stable than TRITC Molecular Probes, 
Sigma-Aldrich, 
AnaSpec. 
CX-
Rhodamine 
5-ROX 
SE, mal, azide, 
alkyne 
576 591 0.70 (PO4 
buffer, pH 
9) 
Unstable compared to other 
rhodamines 
Molecular Probes, 
Sigma-Aldrich, Jena 
Bioscience, 
AnaSpec. 
Fluorescent 
proteins 
EGFP N/A 488 509 0.60 Most used, brighter variants available, 
no problems with photostability 
Thermo Scientific, 
Sigma-Aldrich, 
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BioVision 
mCherry N/A 587 610 0.22 Superior photostability when 
compared to other red proteins 
BioVision, Abcam 
Quantum 
dots 
CdSe-ZnS CA, strep, mal, 
azide, alkyne 
(cyclooctyne), 
NH2, biotin 
  0.20-0.50c Bright, photostable, broad excitation, 
tunable narrow emission, but 
concerns about cell toxicity 
Molecular Probes, 
Sigma-Aldrich, 
Mesolight 
Lanthanide 
chelate 
Eu(III)-chelates SE, CA, strep, 
mal, azide, 
alkyne, NH2, 
biotin 
376 616 
~1 (2H2O 10) 
Narrow emission peaks, long 
fluorescence lifetimes, high 
photostability but often needs a 
chromophore to transfer absorbed 
excitation energy to the lanthanide 11 
PerkinElmer,  
Tb(III)-chelates 340 545 Invitrogen, 
PerkinElmer 
Transient 
metal 
complexes 
Pt(II), Ir(III), 
Ru(II), 
Re(I)based 
SE, CA, strep, 
mal, azide, 
alkyne, NH2, 
biotin, dUTP 
   Long fluorescence lifetimes interesting 
for FLIM, tunable excitation/emission, 
high photostability, good quantum 
yield 
Sigma-Aldrich 
SE: Succinimidyl ester, CA: carboxylic acid, strep: streptavidin, mal: maleimide, NH2: amine, FLIM: Fluorescence-Lifetime Imaging 
Microscopy . a: double strand DNA, b: single strand DNA, c: dependent on shell thickness12 
CHAPTER 1 | FLUORESCENT LABELING OF PLASMID DNA AND MRNA: GAINS AND LOSSES OF 
CURRENT LABELING STRATEGIES 
PAGE | 30 
This chapter focusses on methods to add fluorescent labels to 
polynucleotides, with the idea to image these in a biological environment. Labeling 
strategies which are compatible with live-cell imaging are of particular interest. Both 
methods that label polynucleotides prior to delivering these to living cells, as well as 
“in situ” labeling methods will be discussed. Polynucleotides have a well-defined 
primary and secondary structure, which enables yet another classification of 
fluorophore interaction which is based on their sequence specificity. Fluorophores 
that exhibit no sequence specificity interact with polynucleotides in a random fashion 
and are spread all over the polynucleotide chain. Sequence-specific polynucleotide 
labeling, on the other hand, only occurs at a predefined primary sequence, enabling 
control over the exact location of the labels on the target polynucleotide. In this 
chapter, the current available labeling strategies for DNA-based and RNA-based 
polynucleotides are classified based on their ability to label the nucleic acids in a 
random or sequence-specific way, with a special focus on the pros and cons of each 
labeling method that is being discussed. 
AT RANDOM ATTACHMENT OF FLUOROPHORES TO 
POLYNUCLEOTIDES 
In general, at random attachment requires little to no knowledge of the exact 
primary sequence of the polynucleotide that needs to be labeled. Not surprisingly, it 
is being used by the oldest, easiest, and most commonly used labeling methods 
around. Random labeling of polynucleotides can occur based on noncovalent or 
covalent interactions of the fluorophores with the polynucleotides backbone. 
Additionally, the random incorporation of fluorescent nucleotides during 
polynucleotide synthesis will be discussed. 
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Figure 1 Overview of at random labeling methods. (A) Different modes of intercalation. (B) 
Schematic overview of random covalent attachment. (C) Different techniques used to 
incorporate modified nucleotides into DNA and RNA. dNTP: deoxynucleotide triphosphate. 
NTP: nucleotide triphosphate. *: Linker molecule structures can be found in Slattum (2003)13 
(Mirus kit), Daniel et al. (1998)14 (FastTag) and van Gijlswijk et al. (2001)15 (Universal Linkage 
System) 
Noncovalent Nucleic-Acid Binding Dyes 
Two modes of random noncovalent interactions with nucleic acids are 
considered, namely groove binding and insertion of a fluorescent tag between base 
pairs, which is called intercalation (see Figure 1 A). The family of molecules with 
nucleic acid-binding properties is fairly large and diverse and binding mechanisms 
are often not (yet) defined 16, but it is believed most of them exhibit only one of the 
two binding modes (e.g., YOYO-1 17); the combination of both has also been reported 
for PicoGreen. 18 
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Groove binding dyes, as the name indicates, interact with the major or minor 
groove of a helix structure. In nucleic acids, these grooves are found in the α-helix of 
double stranded DNA. Reactions in the major groove of DNA are more common for 
molecules reacting directly with the bases like, for example, the covalent labeling 
methods which will be discussed later, and proteins. 19 Minor-groove binding dyes 
are widely used and interact with the DNA in a noncovalent manner. These 
interactions are based on the shape of the minor groove, which should be 
accommodating for the dye (see Figure 1 A). A good match will maximize the stability 
of the van der Waals contacts between target and dye. Next to these contacts, 
hydrogen bonds and electrostatic stabilizing interactions between the base pairs in 
the groove floor and the dye are the main contributors to a stable minor-groove 
binding. Additionally the increase in entropy due to the expulsion of bound water 
molecules from the minor groove will contribute slightly to the stability. 20 The effect 
these interactions have on the DNA morphology will differ from dye to dye, but in 
general an elongation of the total length and persistence length and DNA topology 
could be observed when using the minor-groove binding dye DAPI. 21 
Intercalation, on the other hand, is generally defined as the reversible insertion 
of molecules between layered structures. In polynucleotides, these layered structures 
consist of the stacked base pairs which form the secondary structure of DNA and 
RNA. Intercalating dyes are often cationic molecules with planar aromatic rings that 
insert between the base pairs of the helix-structure. During intercalation, π-stack 
interactions (intercalated moiety), hydrogen-bonding, van der Waals interactions, 
hydrophobic interactions, and steric hindrance effects all play a role. 22 Most of these 
will exhibit a strong fluorescence enhancement upon binding. Intercalators can be 
found either as a monomer (intercalator) or combined in a dimer (bis-intercalation) for 
stronger binding and higher brightness (see Figure 1 A). Next to this advantage, 
monomers and dimers will also exhibit a different affinity for a given polynucleotide, 
such as single stranded vs double stranded DNA or RNA, since intercalation is 
dependent on the secondary and tertiary structure of the nucleic acid. A good 
example is the monomer TOPRO-3 which does not stain RNA, while its dimer TOTO-
3 does stain RNA. 9 
Like groove binding, the insertion of one (or two) dyes between the stacked 
bases will induce unwinding and lengthening of the nucleic acid helix structure and 
may subsequently disturb polynucleotide function. Hence, some intercalating dyes 
FLUORESCENT LABELING OF PLASMID DNA AND MRNA: GAINS AND LOSSES OF CURRENT 
LABELING STRATEGIES | CHAPTER 1 
PAGE | 33 
are potentially mutagenic by interfering with replication, transcription, and DNA repair 
processes. The best known example is ethidium bromide, which is used for staining 
of agarose gels and subsequent nucleic acid quantitation. Ethidium bromide is more 
and more being replaced by less toxic alternatives. Cyanine stains (like the TOTO 
and TOPRO family of dyes 23)(see Table 1), for example, seem safer but often need 
cell permeabilization or other membrane disruptive techniques for cell staining. Martin 
et al. (2005)9 therefore compared several intercalating labeling methods for their use 
in staining the nuclei during live-cell imaging (so-called counterstaining). The dyes 
were scored on cell permeability, live/fixed cell use, RNA staining, and bleaching 
behavior. They came to the conclusion that the minor-groove binding dyes Hoechst 
33258 and DRAQ5 are the most suitable stains for live-cell imaging, wherein the 
latter dye is reported to have more favorable optical properties. In the search for 
brighter fluorophores that exhibit better resistance against photobleaching, different 
metal complexes with intercalating or groove binding properties were considered. 
Among the elements from the lanthanide group, europium (Eu) (III) and terbium (Tb) 
(III) are two ions which possess interesting photophysical properties with a large 
Stokes’ shift, long emission lifetimes, interesting for fluorescence-lifetime imaging, 
and high resistance to photobleaching (see Table 1). 24 When these ions are 
complexed in a ligand structure, some complexes, like the conjugation of a 
naphthalene diimide derivative moiety with two luminescent chelates of tetradentate 
β-diketone-Ru3+, were used to specifically intercalate in double stranded DNA. 25 
Similar properties can be found in the transition metal complexes with Pt(II) or d6 
metal ion complexes (Ir(III), Ru(II), and Re(I) complexes)(see Table 1). 11, 26 Square 
planar Pt(II) terpyridyl complexes were first reported to be DNA intercalators in the 
1970s. 27 More recently “Ru(II) bisimine complexes” were verified and used as DNA 
binders. 28 It should be noted that different isomeric forms of the same complex might 
result in different affinities. ∆-[Ru(phen)3]2+ is, for example, a DNA intercalating 
complex while the Λ isomer prefers minor-groove binding. 11 Alternatively when one 
lanthanide complex and two platinum complexes are conjugated in a so-called 
heterometallic hairpin structure, bis-intercalation is seen. 29 
Next to the use of intercalating dyes for counterstaining of nuclei or staining of 
dead cells (e.g., propidium iodide), 30 for which they have been known for decades, 
intercalating dyes are good candidates for super resolution imaging of DNA 31. The 
photochemical properties of the minor-groove binding dye Picogreen makes it 
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possible for direct stochastic optical reconstruction microscopy (dSTORM) to give 
insight into the dynamics of DNA organization after direct DNA labeling. 32 
Using intercalating dyes is probably the easiest method, since it solely 
requires mixing a dye with the target polynucleotide. Intercalating dyes are often used 
in quality control, nucleic acid quantification (e.g., quantitative polymerase chain 
reaction (PCR)) and as counterstain for the visualization of (live-) cell processes. Due 
to their interactions with the structure of the polynucleotides, 19, 21, 33, 34 influence on 
protein-nucleic acid interaction, 35 and low brightness, they are however not used 
extensively for labeling polynucleotides with the intention of following their 
intracellular fate in living cells. 
Random Covalent Attachment of Fluorophores and Haptens 
To prevent possible redistribution of intercalating dyes to non-target nucleic 
acids, covalently attaching fluorophores to the target nucleic acid is an interesting 
option. The irreversible binding of an organic dye or hapten to the nucleic acid will 
secure a stable and bright fluorescent signal. Haptens are defined as small 
molecules that can be detected by specific antibodies. After binding to nucleic acids, 
they allow subsequent immunodetection or affinity-base purification. When biotin is 
used as hapten, any streptavidin or avidin coupled molecule can be coupled to the 
biotinylated nucleic acids through the strong and specific (strept)avidin-biotin 
interaction. 
One of the most frequently encountered examples of covalent modification of 
exogenous polynucleotides is the use of the commercially available Label-IT Nucleic 
Acid Labeling Kit (Mirus bio LLC, Madison, WI, U.S.A.). Slattum (2003)13 
demonstrated that reagents with an aromatic nitrogen mustard reactive center 
covalently alkylate nucleotides, primarily at the N7 of (deoxy)guanine residues (see 
Figure 1 B). The available Label-IT reagents enable the direct coupling of 
fluorophores to the DNA structure (e.g., Cy3, Cy5, fluorescein, CX-rhodamine, and 
TM-rhodamine; see Table 1), or the coupling of haptens like biotin that offer the 
possibility to couple any streptavidin or avidin conjugated molecule in a subsequent 
labeling reaction. It has been described that the transfection efficiency of pDNA 
labeled with the Label-IT kit is decreased when compared to unlabeled plasmids in a 
labeling density dependent manner. 13, 36 For pDNA transfections using liposomal 
carriers, endosomal escape, DNA dissociation from the carrier, and transcription 
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were reported to be affected, probably due to the hydrophobicity and steric hindrance 
of the fluorescent labels. 36 Also, Gasiorowski and Dean (2005)37 reported that 
nuclear retention of pDNA was affected by this labeling strategy. The labeling density 
of the nucleic acids can be controlled by titrating the amount of label-IT reagent for a 
given amount of nucleic acids. Ideally, the lowest labeling density that is still 
detectable by the instrumentation used should be preferred. Despite these caveats, 
this labeling method is useful for, among other things, intracellular tracking of 
polynucleotides to elucidate cellular mechanisms. Rhodamine labeled pDNA was for 
example imaged during cytoplasmic transport over the tubulin network after 
transfection. 38 The labeling of pDNA with Cy3 and Cy5, on the other hand was used 
to elucidate the cellular internalization mechanisms after transfection with 
polyethylenimine (PEI). 39 Similarly, Cy5 pDNA was used to image the internalization 
pathway of bioreducible polymeric nonviral vectors. 40 Furthermore, nonviral nucleic 
acid carriers like for example cyclic arginylglycylaspartic acid (RGD) peptide-
conjugated polyplex micelles, 41 RGD-tagged and non-RGD-tagged PEGylated 
liposomes, 42 and oligopeptide polyplexes, 43 were tracked and evaluated using 
labeled polynucleotides. Although most reports make use of fluorescently labeled 
pDNA, it should be noted also that the fluorescent labeling of mRNA is feasible with 
the label-IT reagents. 
An alternative commercial nucleic acid labeling kit is available from Vector 
laboratories (Burlingame, CA, U.S.A.). 14 The FastTag Basic Nucleic Acid Labeling 
Kit is based on aryl-azide chemistry in which the universal disulfide containing 
FastTag reagent, when exposed to heat or light, becomes activated and attaches 
onto the nucleic acids without base specificity. In a second step, the disulfide is being 
reduced after which any sulfhydryl reactive moiety can be coupled. The FastTag 
system can react with any single- or double-stranded DNA, RNA, or oligonucleotide. 
For double-stranded nucleic acids, however, light-induced coupling is preferred over 
heat to avoid denaturation of the double-stranded nucleic acids structure. A wide 
variety of fluorescent tags and haptens can be added by using this method, mostly 
using maleimide-derivatives as sulfhydryl reactive moiety (see Table 1). The method 
is used for the same type of experiments as described for the Label-IT nucleic acid 
labeling kit, but their broad range of fluorophores, including far-red dyes, makes it 
possible to extend to in vivo applications. A series of poly(glutamic acid)-based 
peptide coatings were, for example, targeted to the liver, spleen, spine, sternum, and 
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femur. DNA accumulation in these tissues was confirmed by Alexa Fluor 680 – 
pDNA. 44 This versatility was also employed to make biotinylated plasmids for in vivo 
transfection with Lac-PEI. Intracellular location was afterward visualized in 
cryosections by adding streptavidin conjugated dyes. 45 
An older labeling kit is the ULYSIS Nucleic Acid Labeling Kit (Molecular 
Probes, OR., U.S.A.). Alexa Fluor fluorophores are linked to the bases of DNA, RNA, 
oligos, and peptide nucleic acids (PNA) through the Universal Linkage System 
platinum-based chemistry. This system consists of a square planar platinum 
complex, stabilized by a chelating diamine. One of the two remaining coordination 
sites of this complex is occupied by a fluorophore, the second one will bind to the N7 
position of (deoxy)guanine. 15 This technique has been used to observe that the rate 
limiting step in pDNA-PEI transfections is the transfer from the lysosomal 
compartment to the nucleus. 46 Other carriers like mannosylated dendrimer/α-
cyclodextrin conjugates were evaluated 47 to study how, and via which pathway, the 
DNA of a pathogen (Cryptococcus neoformans) stimulates dendritic cells Alexa Fluor 
647 was attached using the ULYSIS kit. 48 
In summary, the covalent attachment of haptens and fluorophores offers a lot 
of benefits when random labeling of exogenous nucleic acids is desired. The different 
commercially available kits are readily available and easy to use and have already 
been extensively used for imaging polynucleotides, especially pDNA in living cells. A 
possible interaction with the system under study, however, should always be kept in 
mind, as each added fluorophore adds hydrophobicity and steric hindrance to the 
nucleic acids, when compared to their nonlabeled analogs. Also, the often cationic 
fluorophores lower the overall negative charge of the polynucleotides, which might 
interfere with the intracellular migration behavior of nucleic acids, complexation with 
and dissociation from a cationic carrier. 
Incorporation of Modified Nucleotides  
Apart from the labeling strategies mentioned above, another popular 
commercially available option is the in vitro incorporation of modified nucleotides into 
the polynucleotide backbone. The term “modified” stands for a nucleotide that differs 
from the naturally occurring nucleotides through the addition of a functional moiety. At 
first, the nucleotides with radioactive atoms (32P, 33P, 14C, 3H, 35S) were used, but 
nowadays radioactive labels are often replaced by different types of coupling 
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moieties, fluorescent labels (see Table 1), or haptens (see Table 2). Since the 
addition or replacement of nucleotides is a phenomenon that occurs constantly in 
living cells, all these methods are based on naturally occurring enzymatic reactions. 
In general, DNA or RNA synthesis is catalyzed respectively by DNA or RNA 
polymerases that read a DNA template in the 3’ to 5’ direction. The newly 
synthesized DNA or RNA molecules are then elongated in the 5’ to 3’ direction by the 
coupling of complementary nucleotides at the 3’ end. While nucleotide triphosphates 
(NTPs) are used in RNA molecules, DNA exists of deoxynucleotide triphosphates 
(dNTPs). In living cells, RNA polymerases are responsible for the transcription of 
mRNA from the genomic DNA. For labeling purposes, RNA polymerases (T7, SP6, 
and T3) manage the incorporation of modified NTPs into RNA by in vitro transcribing 
so-called complementary RNA from a provided DNA template. The addition of 
modified nucleotides in the reaction mixture will therefore result in labeled RNA (see 
Figure 1 C). 49-51 DNA polymerases are adaptations from the cellular enzymes that 
take care of DNA replication in every living cell. Also here, modified dNTPs can be 
incorporated during synthesis of the new DNA strand complementary to the template 
strand (see Figure 1 C). In other words, both RNA and DNA polymerases act in a 
template-dependent manner and incorporate modified (deoxy)nucleotides at random 
over the complete length of the polynucleotide chains. 
There is also the possibility to incorporate modified nucleotides in a template-
independent manner by using “nick translation”. During nick translation, which is 
based on the cellular DNA repair mechanism, DNA is “nicked” by a DNA 
endonuclease creating single strand gaps in the nucleotide sequence. A DNA ligase, 
like DNA polymerase I, will start to repair the polynucleotide starting from this gap by 
addition of dNTPs supplied in the reaction mixture. Commercially available kits will 
mostly make use of DNase I as endonuclease which nicks at random, while other 
sequence specific endonucleases can be bought separately. These endonucleases 
are derived from existing restriction enzymes, but modified to cut only one strand. 
When modified nucleotides are used, DNA fragments become fluorescently labeled 
(see Figure 1 C). 52, 53 By controlling the ratio of modified over nonmodified 
nucleotides in the reaction mixture, the labeling density of the resulting 
polynucleotides can be changed. Both methods described above incorporate 
modified nucleotides all over the polynucleotide chains, thereby achieving internal 
labeling of pDNA and mRNA. It is therefore to be expected that modified nucleotides 
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will also be present in the coding region of the pDNA or mRNA molecules. For some 
applications, this has to be avoided, in which case it is better to add modified 
nucleotides only to the 3’ or 5’ end of the polynucleotides. 
The addition of nucleotides to the 3’ terminus of an existing polynucleotide can 
occur in a template-independent way by the use of terminal deoxynucleotidyl 
transferase (TdT). TdT has the strongest affinity for single-stranded DNA or the 3’ 
overhang of double-stranded DNA and is used frequently for adding modified dNTPs 
to PCR primers or restriction enzyme generated 3’ overhangs (see Figure 1 C). 54, 55 
An example is the 3’ EndTag DNA end labeling kit from Vectorlabs, which couples 
SH-GTP to the 3’ end of DNA molecules. The SH-GTP can subsequently be modified 
with thiol-reactive molecules such as for example maleimide-coupled dyes. T4 RNA 
ligase is another enzyme that is able to add modified NTPs to the 3’ terminus in a 
template-independent manner, but only for RNA (see Figure 1 C). It should be noted 
that a DNA or RNA primer which contains a modified nucleotide at the 3’ end 
(generated using TdT for example) can be used by DNA or RNA polymerases to be 
further elongated. Hence, internally labeled polynucleotides can also be formed in 
this way. 5’ EndTag nucleic acid labeling kits are another available option from 
Vectorlabs, using T4 polynucleotide kinase to transfer a thio-phosphate from ATPγS 
to the 5’ end of DNA, RNA, or oligonucleotides. Again, any thiol-reactive molecule 
can be coupled to the 5’ end of these polynucleotides. DNA or RNA primers 
containing a modified nucleotide at the 5’ end can also be used by DNA or RNA 
polymerases to create longer 5’ end labeled polynucleotides (see Figure 1 C). 
Another interesting enzyme for end-labeling is the DNA polymerase I Klenow 
Fragment, which lacks 5’ to 3’ exonuclease activity, but retained its 3’ to 5’ 
exonuclease activity and 5’ to 3’ polymerase activity. The 5’ to 3’ polymerase activity 
can be used to fill in 5’ overhangs (created for example by restriction enzymes) with 
dNTPs, leading to labeled fragments when modified nucleotides are used. 
As already indicated above, nucleotides can be modified in a broad range of 
ways (see Table 1). In general, however, they can be classified as (i) containing a 
fluorophore, (ii) containing a hapten such as biotin or digoxigenin, (iii) being alkyne- 
or azide-modified for click-chemistry based labeling or (iv) being amine-modified for 
coupling to NHS-activated molecules (see Table 1). Available fluorescent nucleotides 
are mostly UTP and CTP and their deoxy-analogues dUTP and dCTP. Alexa Fluor 
488 and Alexa Fluor 594-dUTP were used during amplification of linear DNA 
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fragments which were microinjected in the cytoplasm and nucleus of living cells. 
Their location and migration was followed using live-cell fluorescence microscopy. 56 
Biotinylated nucleotides have been proven useful to conjugate streptavidin-quantum 
dots to pDNA for live-cell imaging. Biotinylated nucleotides were added in three 
different ways: nick translation, TdT addition, and by end-filling by the DNA 
polymerase I Klenow Fragment. 57 The addition of “clickable” nucleotides has been 
documented as well. Copper-catalyzed click chemistry refers to coupling of an azide-
containing molecule A with an alkyne-containing molecule B to form an A-B 
conjugate. Alkyne- and azide-modified nucleotides can be combined with a wide 
variety of respectively azide- and alkyne-modified dyes (see Table 1). It should be 
noted that copper ions damage DNA, resulting in, for example, strand breaks. 
Therefore, copper(I)-stabilizing ligands should be used, or alternatively, copper-free 
click reactions involving the coupling of dibenzocyclooctyne (DBCO)-containing 
molecules to azide-containing molecules could be considered. Attaching fluorophores 
to nucleotides, added by TdT, has been shown to be feasible via copper-catalyzed 
azide-alkyne cycloaddition, strain-promoted azide-alkyne cycloaddition, Staudinger 
ligation, or Diels-Alder reaction with inverse electron demand. 58 Additionally, amine-
modified (d)UTP, (d)CTP, and (d)ATP are available, enabling the coupling of NHS-
activated fluorophores to, respectively, DNA (dNTPs) and RNA (NTPs) (see Table 1). 
In summary, the addition of modified nucleotides is a versatile way of adding 
radioactive labels, fluorescent labels, or functional moieties to a polynucleotide. The 
availability of commercial kits also makes them accessible to a broad audience 
although a well-equipped biotechnology lab and accompanying lab experience is a 
prerequisite. 
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LABELING METHODS FOR SEQUENCE-SPECIFIC ATTACHMENT OF 
FLUOROPHORES TO POLYNUCLEOTIDES 
 
Figure 2 Overview of sequence-specific labeling methods. (A) General principle of MTase 
directed fluorescent labeling. (B) Schematic of linear hybridization probe interactions and bis-
triplex forming oligonucleotides. *: antiparallel interaction following Watson-Crick base pairing. 
°: antiparallel interaction following reverse Hoogsteen base pairing. °°: parallel interaction 
following Hoogsteen base pairing. (C) Principle of molecular beacons. (D) Principle of binary 
probes. (E) Principle of nucleic-acid binding small molecules based on a structure described 
by Nickols et al. (2007)59. (F) Mechanism of GFP-tagged nucleic acid-binding proteins and the 
lacO/LacI principle. SAM = S-Adenosyl-L-methionine. SAH = S-Adenosyl-L-homocysteine. NA: 
Nucleic Acid. TFO: Triplex forming oligonucleotide. R and R’: functional moieties. 
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Sequence-specific labeling techniques comprise every method that labels 
polynucleotides at a predefined primary sequence. The primary sequence of 
polynucleotides is determined by the particular way in which each of only 4 possible 
nucleotides is ordered. Targeting specific sequences is beneficial to obtain site-
specific labeling, without (much) off-target binding. From a labeling point-of-view this 
opens up a plethora of opportunities with regard to selectivity, choice of labeling 
density, and label location. The first technique that is described is remarkably similar 
to the random covalent attachment methods. The sequence-specificity lies in the fact 
that an enzymatic reaction is used, instead of the chemical reactions as shown 
above, adding functional groups only to those sequences that are recognized by the 
respective enzymes. 
Enzymatic Labeling at a Specific Target Sequence 
In enzymatic labeling, a functional group (or fluorophore) is added to nucleic 
acids due to an enzyme-mediated reaction between the nucleic acid and a dedicated 
cofactor. This direct modification of the chemistry of the nucleobase by the enzyme 
distinguishes this method from those that use enzymes to incorporate modified 
nucleotides as mentioned above. 
The enzymes used in the so-called sequence‐specific methyltransferase‐
induced labeling (SMILing) method are DNA methyltransferases (MTases). 60 The 
cytosine-specific DNA MTase from Haemophilus haemolyticus, M.HhaI, for example, 
recognizes the double-strand DNA sequence 5’-GCGC-3’ and subsequently 
catalyzes a covalent bond formation between the activated methyl group from a 
specifically designed cofactor (e.g., S-adenosyl-L-methionine) to the exocyclic amino 
group of cytosine (see Figure 2 A). The choice of MTase will determine the 
recognition sequence at which functional groups are attached. At the moment, most 
recognition sequences exist of 4 to 6 base pairs in which nucleophilic attack will 
occur on adenine, guanine or cytosine. The cofactor is, however, equally important, 
as it determines the functional group which is added in the enzymatic reaction. 
Synthesis of new cofactors determines the range of molecules that can be attached 
to the activated group. 61 Originally this method was used to add methyl groups, but 
linear alkyl, alkenyl, and alkynyl functionalization was developed, opening up more 
possibilities. 60, 62, 63 In the meantime a similar approach was developed for RNA. 64, 65 
Based on these techniques the mTAG method was developed, making it possible to 
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incorporate a primary amine group which can be used for chemoligation reactions 
with all amine-reactive probes (e.g., NHS coupled-dyes; see Table 1 for examples) 
onto DNA or RNA. 66 For an in depth overview of the progress in this field the review 
by Gillingham and Shahid (2015)67 is recommended. 
This enzymatic labeling approach is interesting because it enables labeling 
polynucleotides internally in a sequence-specific manner. Especially for RNA, which 
is mostly fluorescently labeled using 3’ or 5’ end labeling, this might be an interesting 
opportunity. Labeling density can be easily controlled by designing polynucleotides 
that contain a fixed number of recognition sequences. Labeling position, on its turn, 
can be tuned by incorporating recognition sequences side-by-side, for example, 
flanking the encoding region of the polynucleotide of interest. Also, by combining 
different enzymes with their own recognition sequence and specific cofactor, dual-
labeling of polynucleotides on predefined sites is possible. Despite these interesting 
features, only a limited amount of studies have employed enzymatic labeling for live-
cell imaging applications. Schmidt et al. (2008)68 evaluated the transfection of 
enzymatically labeled pDNA with a nonviral carrier. Imaging was, however, 
performed in fixed cells. Due to the absence of a commercial supplier, follow-up 
publications in living cells are still lacking. Nevertheless, research is still ongoing to 
further optimize this labeling method. 69 Neely et al. (2010)70, for example, adapted 
this technique to create a DNA fluorocode, making use of the sequence specificity. 
Fluorophores are added at different locations depending on the location of the 
recognition sequence which will differ depending on the target nucleic acid. The 
specific pattern of fluorophores on the target can then be used as a barcode for fast 
nanometer scale DNA sequence information. 70, 71 Along this line of thought 
enzymatic labeling is also used for rapid bacteriophage strain typing. 72 
In summary, enzymatic labeling is a promising covalent labeling technique 
which adds sequence specificity when compared to the random methods. The 
translation to a broad audience will, however, benefit from the development of a 
straight-forward labeling kit, ruling out the need for a thorough understanding of the 
enzymatic reaction before it can be employed. 
Nucleic Acid-Based Hybridization Probes 
The next method that will be discussed makes use of oligonucleotides which 
recognize and bind to their nucleic acid target based on sequence complementarity. 
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Therefore, knowing the exact sequence of the target polynucleotide is key. Sequence 
complementarity can manifest itself in two types of interactions: antiparallel and 
parallel to a nucleic acid strand. Antiparallel interactions follow Watson-Crick or 
reverse Hoogsteen base pairing, while parallel interaction makes use of Hoogsteen 
base pairing. For single strand DNA and RNA, the complementary oligonucleotides 
will prefer to follow an antiparallel interaction following Watson-Crick base pairing. 
For double stranded DNA, antiparallel interactions following Watson-Crick base 
pairing is also the most common interaction, but it requires the displacement of one 
strand to form a new oligo-DNA duplex (see Figure 2 B). Oligonucleotides that 
interact in an antiparallel manner following reverse Hoogsteen base pairing, as well 
as oligonucleotides interacting in a parallel manner, mainly bind into the major groove 
of the double helix, creating a triple helix structure at the binding site (see Figure 2 
B). 73 These oligonucleotides regardless of their orientation are called triplex forming 
oligonucleotides. 
Linear Oligonucleotide Probes 
Already in the late 1970s, it was proposed that antisense oligonucleotides 
could have a potential in a therapeutic environment. 74 In this method, short DNA or 
RNA oligonucleotides are designed to bind antiparallel to complementary mRNA 
sequences inducing downregulation of this specific mRNA. When a fluorescent label 
is attached to these oligos, this binding could be visualized. A well-known example 
where the principle of nucleic acid-binding oligonucleotide probes is used is in the 
cytogenic technique fluorescence in situ hybridization (FISH) where the location of a 
target DNA or RNA sequence is visualized in fixed and permeabilized cells. 75 This is 
achieved by the addition of fluorescently labeled oligonucleotide probes, which bind 
to their complementary sequence and can be visualized by fluorescence microscopy. 
76, 77
  
This approach was also applied in live cells, but low stability and poor cellular 
uptake of these DNA and RNA oligonucleotide probes led to the development of 
modified oligonucleotides. 78 A combination of backbone and sugar moiety 
modifications proved to be the most interesting, since binding affinity is less affected 
compared to modifying the bases themselves. 79 Peptide (or polyamide) nucleic acid 
(PNA) 80, 81, locked nucleic acid (LNA) 82 and 2’-O-methyl and 2’-O-aminoethyl 
chemistry based nucleic acids 83, 84 are some examples of modified oligonucleotides 
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used to create a strong and sequence-specific binding to complementary sequences 
(see Figure 3). 
 
Figure 3 Structures of DNA, RNA, and the backbone-modified oligonucleotides. 
Probably the best known modified oligonucleotides are PNAs, where the 
backbone consists of N-(2-aminoethyl)-glycine units linked by amide bonds. The 
purine (A, G) and pyrimidine (C, T) bases are attached to the backbone through 
methylene carbonyl linkages (see Figure 3). 85 This neutral backbone structure leads 
to a PNA/DNA or PNA/RNA interaction which is stronger than just the DNA/DNA or 
RNA/RNA interaction. Furthermore, this interaction is also more sequence-specific. 
Interactions can be either the preferred, antiparallel method, which requires strand 
displacement and follows Watson-Crick base pairing, or parallel pairing which creates 
a triple helix. The combination of both can be found in bis-PNA (2 PNA) which is 
therefore a triple helix forming oligonucleotide (PNA-DNA-PNA) (see Figure 2 B). A 
bis-PNA – DNA triplex was the first PNA complex described and it is probably the 
most interesting with regard to labeling. 80 It consists of a Watson-Crick PNA strand 
coupled with flexible ethylene glycol type linkers to the Hoogsteen PNA strand (see 
Figure 2 B). Often, the Hoogsteen strand is optimized by replacing cytosine with 
pseudoisocytosine, eliminating the need for a low pH during hybridization. 86 The 
versatile use of PNAs has been excellently reviewed by Nielsen and Egholm 
(1999)85. 
LNA bases are far more identical to DNA (or RNA) bases compared to the 
modifications seen in PNA bases. The only change from a DNA (or RNA) base is the 
introduction of an additional 2’-C, 4’-C-oxymethylene linkage that effects 
conformational fixation of the furanose ring in a C3’-endo conformation (see Figure 
3). 87, 88 Oligonucleotides consisting of only LNA bases, however, have no double 
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helix binding capacity. 89, 90 LNA-containing oligonucleotides on the other hand 
undergo Watson-Crick base pairing resulting in thermostable, 3’-exonucleolytic 
stable, and sequence-specific double helix interactions with DNA and RNA. 82, 87, 91 
Bis-LNA was also developed more recently to bind to supercoiled DNA in a fashion 
similar to bis-PNA (see Figure 2 B). 92 
2’ O-methyl and 2’ O-aminoethyl modified RNAs differ only very slightly from 
regular RNA in that they respectively have a methyl group and a short amino alkyl 
group attached to the 2’ position of the ribose (see Figure 3) which allows, in the case 
of the aminoethyl group, a specific charge-charge contact of this protonated amino 
group with a proximal phosphate group of the DNA duplex. This interaction strongly 
enhances the binding affinity of this oligonucleotide toward double-stranded DNA. 83 
Although originally designed to interfere with the nucleic acid metabolism, 
similar to antisense oligonucleotides, 93 modified oligonucleotides can be used as a 
sequence-specific labeling strategy due to their specificity and strong nucleic acid-
binding capacity. In general, fluorophores are attached via a linker to the 3’ or/and 5’ 
terminus of the oligonucleotide, 94 although fluorophore attachment is reported at all 
locations of the PNA strand through the use of fluorescently modified nucleotides 
during synthesis. 95 Other modified oligos can likely be internally labeled in a similar 
fashion. Early on the potential of PNAs in particular, was seen for detecting single 
base pair mutations by PNA-directed PCR, facilitating the amplification of mutants 
due to binding to the native templates and subsequently blocking PCR amplification. 
96
 PNA strands employing a quencher and fluorescent reporter are also used to 
perform quantitative PCR (commercially available under the name of PANA qPCR, 
Panagene, Daejeon, Korea). Their high specificity makes them ideal candidates for 
multiplexing. As already mentioned, also for FISH, modified oligonucleotides are the 
ideal candidates. 97, 98 
When we look at live-cell imaging, modified oligonucleotides have been used 
in very interesting applications. Molenaar et al. (2003)99, for example, were the first to 
visualize the spatial localization and dynamics of telomeres in living human 
osteosarcoma cells, using fluorescently labeled PNA delivered to the cells using 
glass bead loading. 100 The same research group microinjected 2’ O-methyl 
oligoribonucleotide-RNA probes and used photobleaching techniques to investigate 
the mobility of poly(A)+ RNA throughout the nucleus. 101 These applications show the 
potential of modified oligos for intracellular labeling of endogenous nucleic acids in 
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living cells. However, a major drawback is the background generated by the unbound 
oligonucleotides. Labeling of exogenously synthesized nucleic acid is also a 
possibility which does not encounter this problem since a purification step is included 
before exposure to the cell. Zelphati et al. (1999)102, for example, followed the 
nuclear uptake of Rhodamine PNA-labeled nucleic acids and correlated Rhodamine-
positive nuclei with green fluorescent protein (GFP) expressing cells. The PNA-based 
technique for labeling pDNA was also compared with random covalently labeled 
pDNA with regard to their post-mitotic nuclear retention. It was seen that random 
covalently labeled pDNA was not retained within the nucleus of the daughter cells 
after cell division, whereas PNA-labeled pDNA acted as if it were unlabeled pDNA. 37 
It was also established via atomic force microscopy and transfection experiments that 
pDNA labeled with quantum dots via PNAs was still functional. 103 Dual color labeling 
of one plasmid was later used in combination with confocal time-lapse imaging and 
intracellular trafficking by the same research group to study the intracellular DNA 
distribution and degradation after lipofection. 104 For the evaluation of nonviral 
carriers, PNA labeling is also a good candidate as was shown by testing the effect 
cell-surface glycosaminoglycans have on the transfection efficiency of mixtures of 
low-molecular-weight PEI and cationic lipids. 105 
It should be noted that the GeneGrip PNAs and plasmids with corresponding 
PNA labeling sites (Gene Therapy Systems, U.S.A., now Genlantis, U.S.A.) are no 
longer commercially available. Obviously it is still possible to design and order 
vectors and PNAs with the appropriate sequences for site-specific labeling of pDNA. 
As with any oligonucleotide, however, a careful control of the annealing efficiency 
and the purification of unbound oligos is necessary to obtain high quality and purified 
fluorescent nucleic acids. 
Related to the direct labeling, as described until now, the concept of 
complementary sequence recognition by oligonucleotides is also recently used in 
live-cell RNA expression profiling. So-called Nanoflares (AuraSense, Skokie, IL, 
U.S.A.) are spherical nanoparticles with a gold core to which oligos complementary to 
the target RNA are attached. Via a second small oligonucleotide, a dye is bound on 
the complementary oligo closely to the gold nanoparticle whereafter it is quenched. 
When the Nanoflare enters the cell after receptor-mediated endocytosis, cytoplasmic 
target RNA can bind to the complementary oligo, effectively releasing the small oligo 
with the dye. This release induces unquenching whereafter this signal can be 
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visualized via live-cell fluorescence microscopy, making it possible to quantify RNA 
synthesis. 106, 107 Building further on this concept, Briley et al. (2015)108 designed the 
so-called sticky flares. Instead of releasing the dye in the cytoplasm, the dye is 
attached to the target RNA via a long complementary oligo. This oligonucleotide is 
originally bound to one of the strands attached to the gold nanoparticle. When 
encountering the target RNA in the cytoplasm, the labeled oligonucleotide will have a 
higher affinity for the target RNA than for the one bound to the nanoparticle, thus 
effectively labeling the RNA in situ. 
Molecular Beacons 
“Molecular beacon” (MB) is a collective term for all probes that recognize and 
bind to a particular cellular target, enabling visualization. In this chapter, the 
molecular beacons are an extension on the concept of oligonucleotide probes which 
are mentioned above. While the “traditional” oligonucleotide probes make use of one 
fluorescent label, MBs employ two (or more) labels, which are attached at the 
opposite ends and make use of the fluorescence resonance energy transfer (FRET) 
principle, a quencher/dye principle or a combination of both (see Table 2 for 
examples) to ensure that the labels remain in a dark state until they bind to the target 
hereby guaranteeing a low background signal from unbound probes, which is 
necessary for live-cell microscopy. The FRET principle makes use of two fluorescent 
molecules that, when they are in close proximity (tens of nanometers), can transfer 
energy in a nonradiative way from one (the donor) to the other (the acceptor). To this 
end, the oligonucleotide is designed in a stem-loop structure which brings both 
functionalities in close proximity when no target sequence is encountered. Upon 
binding, the probe’s stem-loop structure is stretched and respectively the donor dye 
(in FRET MBs) or quenched dye will become visible (see Figure 2 C). 109, 110 The 
concrete implementation of this general principle is variable due to the use of 
different fluorophores, quencher/dye pairs, oligonucleotide conformations, and 
number of oligonucleotides used (multiplexing), etc., but all are based on the same 
concept. 
According to Santangelo (2010)111, a good MB for tracking intracellular RNA 
should have four characteristics, namely: (i) the importance of delivery to the right 
cellular compartment, (ii) affinity for the target RNA without disturbing the 
functionality, (iii) sequence sensitivity and last but not least, (iv) a beacon should be 
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visible throughout biogenesis, transport, translation, and degradation pathways. 
These characteristics also pinpoint the four bottlenecks of this labeling method. For 
labeling intracellular targets, MBs need to be delivered to the cell since they are not 
taken up spontaneously. The techniques used to deliver MBs, like microinjection, 
passive uptake, cationic transfection, or reversible cell membrane permeabilization, 
suffer from low efficiency and a high toxicity to the cells. Also, the stability of the dyes 
used and the MB over time is important, since most cellular applications need to 
image the target over a longer period of time without the loss of signal. Despite these 
challenges, MBs easily found their way in live-cell imaging, but are also used in 
quantitative PCR. The exonuclease activity of DNA polymerases will cleave the MBs 
and disconnect the donor/quencher from the acceptor dye/dye, whereupon a 
fluorescent signal can be detected and correlated to an increase in amplified DNA. 
109, 112
 In live-cell imaging, MBs are popular for tracking intracellular RNA, 113-115 
tracking DNA, 116 and to study protein-DNA interactions. 117, 118 
Similar to MBs, a different type of RNA oligos undergo a conformational 
change, when they bind to their target sequence. These RNA oligonucleotides, 
targeting specific RNA sequences (called RNA aptamers), can be integrated and 
expressed in a stable or transient manner in cells. The induced conformational 
change upon binding makes them accessible to small fluorescent protein-like 
molecules, which allow in situ labeling of the target RNA. 119 The design and 
synthesis of the small dye is crucial for brightness and specificity since it should only 
be activated by one specific RNA aptamer. Paige et al. (2011)120 coined the term 
“Spinach” for their RNA aptamer that in combination with their fluorophore resembled 
the spectral properties of GFP the most, allowing the localization and tracking of RNA 
in living cells. Improvements in brightness and specificity on this system have been 
developed (e.g., Spinach2, 121 RNA mango 122) and more are under development. 
Binary Probes 
One of the alternative approaches that combines the structural properties of 
linear oligos and a light-up principle of MBs is the use of binary probes. In general, 
this approach makes use of two oligonucleotides which are complementary to 
adjacent sequences of the target nucleic acid, and each has a different molecule that 
needs to be joined together to emit fluorescence on their ends (see Figure 2 D). As a 
standard, this is a fluorescence acceptor and a fluorescence donor which are each 
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situated at the ends of a oligonucleotide. Only in the presence of the target will the 
acceptor dye receive the energy with a significant emission. 123 This method has 
been applied routinely in real-time LightCycler PCR Technology. 124, 125 
Although this method in theory offers improvements on the high signal 
background signal of linear oligo probes by employing a light-up principle and offers 
less chance of nonspecific binding by using two independent oligos, some drawbacks 
should be noted. First of all, the complexity of the design of the probes is even higher 
than for single linear oligos or MBs. 126 Second, the signal of the acceptor fluorophore 
might suffer from the noise of the cellular autofluorescence. Additionally, the donor 
and acceptor fluorophores should be chosen in order to avoid overlap between the 
spectra of emission of the donor and the acceptor, which would generate false 
positives. Finally, the hybridization of two separate oligos is from a kinetic and a 
thermodynamic point of view less favorable. 123 Kolpashchikov (2010)126 as well as 
Guo et al. (2012)123 made overviews of the different approaches that were developed 
within the concept of binary probes to tackle these issues. The most interesting 
developments are the use of a ruthenium complex as a fluorescence donor (see 
Table 1) together with an organic fluorescence acceptor, 127 the creation of a 
lanthanide chelate (see Table 1), 128, 129 and quenched autoligation 130-132 which was 
used for live-cell imaging of bacterial strains 133 or to visualize mRNA in living cells. 
134
 
In summary, oligonucleotide hybridization strategies, as listed above, are a 
great way of labeling extracellular administered polynucleotides, like those for gene 
replacement therapy, and intracellular endogenous polynucleotides. Their 
mechanism however requires a well thought-through design of probes as well as 
target, ensuring stable and specific labeling of the target sequence with no, to limited, 
disturbance of its function. To obtain sufficient signal to follow single nucleic acid 
molecules, for example, not one but an array of recognition sequences is needed. 135 
In combination with the initial cost and optimization needed, these methods might not 
be for every cell biologist who ventures into live-cell imaging, but will remain in 
specialized laboratories. 
Nucleic Acid-Binding Small Molecules 
In contrast to the oligonucleotides described above, which are making use of 
(modified) nucleic acid bases, synthetic small molecules are making use of 
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polyamides to bind to DNA in a sequence-specific manner. This approach was 
pioneered by the Dervan group at CalTech who described in detail how the invention 
of these type of hairpin pyrrole-imidazole polyamides was conceived. 136 Starting 
from the structure of naturally occurring antibiotics netropsin and actinomycin, which 
were known to be A/T tract selective DNA minor-groove binders, synthetic hairpin 
polyamides were developed which showed minor-groove binding and a high 
sequence specificity (see Figure 2 E). Originally, this approach was aimed at creating 
synthetic molecules for therapeutic gene expression regulation. However, 
conjugations of these polyamides to fluorescent dyes were developed and shown to 
be effective in binding double stranded DNA 137 and in intracellular localization, 138 
due to their uptake in living cells. 139 Vaijayanthi et al. (2012)140 assembled practical 
information about dye-polyamide conjugates and summarized the progress in this 
field based on the fluorescent dye used. Most notably was the increase of biological 
information obtained due to the overlap of the biological activity of the polyamides in 
gene expression regulation and the monitoring of the fluorescent signal in real time. 
140
 The sequence specificity made them ideal candidates for following DNA repeats in 
genomes of eukaryotic cells. 141, 142 Furthermore, FRET was observed when 
combining two polyamide conjugates with either Cy3 or Cy5, opening the door to the 
study of DNA-protein interactions by the gain or loss of the FRET signal. 143 
In summary, conjugates of hairpin pyrrole-imidazole polyamides and 
fluorophores have found applications as sequence-specific nuclear stains. Due to 
their gene regulatory properties in which interest was shown as a therapeutic, 144 
these minor-groove binders can aid in the study of the mechanism of these 
therapeutics. The chemical synthesis, design and cost might be a hurdle to the 
application by a broader cell biology community and remains for specialized 
laboratories. 
Nucleic Acid-Binding Proteins 
Most labeling techniques discussed so far, with the exception of the molecular 
beacons, the binary probes, and polyamide conjugates, are employed to label 
exogenous DNA and RNA prior to delivering them to the target cells. In situ labeling 
of polynucleotides is however an interesting option in those cases in which only 
nucleic acids that are present in the cytoplasm or nucleus of the cells should be 
detected. The main principle of in situ labeling is that the target cells express 
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(fluorescently tagged) proteins that bind specifically to DNA or RNA sequences. An 
advantage of this method is that the polynucleotides are not modified during the early 
steps of the transfection pathway, ruling out potential label-induced artifacts until 
cytoplasmic or nuclear entry. This implies that information on the steps in the 
transfection pathway before endosomal escape is lacking when using in situ labeling 
of nucleic acids. 
In the informative review by Tyagi (2009)113, an overview is presented of the 
methods that are available to track intracellular RNA. The nucleic acid binding 
methods: MS2 system, 145 Bg1 system, 146 the λN system, 147 poly(A)-binding 
proteins, 148 and PUMILIO1 149, are all systems that share the same basic principle. 
113, 150
 A fluorescent protein (most often GFP; see Table 1) is fused to an RNA-
binding protein which has a strong affinity for a certain RNA motif or sequence, which 
is mostly incorporated in the target RNA sequence as a stem-loop structure. This 
binding of the GFP-tagged protein makes it possible to visualize RNA molecules 
intracellularly and can be used for endogenous mRNA tracking (see Figure 2 F) (e.g., 
ref. 151), as well as for exogenously delivered RNA. Especially in the field of RNA 
viruses, these techniques have proven to be valuable. 146, 152 
A similar approach is available for DNA. A well-known example is the Lac 
operon/Lac repressor (lacO/LacI) system in which the LacI-GFP protein binds to the 
lacO sequence (see Figure 2 F). 153 Annibale and Gratton (2015)154 used the 
lacO/LacI-GFP approach to visualize DNA, while the MS2 system was used to 
visualize the transcriptional kinetics of the produced mRNA. Apart from using GFP-
fusion proteins, two methods are commercially available that attach a protein tag to 
the target sequence of a nucleic acid. When a fluorescently labeled ligand is added, it 
binds the protein tag resulting in a fluorescently labeled protein. Both the SNAP tag 
method 155 by New England Biolabs (cited by 798 papers (Google Scholar, 
September 2015)) and the HaloTag technology 156 by Promega (cited by 472 papers 
(Google Scholar, September 2015)) make use of this principle. These methods have 
the advantage of a broad range of cell-permeable organic fluorophores that can be 
utilized in comparison with the fusion of, traditionally less bright, fluorescent proteins 
to the DNA-binding protein of interest. Nevertheless, the option of directly fusing a 
fluorescent protein to the DNA-binding protein might be preferred in cases where, for 
example, unwanted binding events in the nucleus are observed when using the 
commercially available methods. 157 This was also a concern when Shimizu et al. 
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(2005)56 microinjected DNA into the cytoplasm and nucleus of cells. That is why, next 
to the use of modified nucleotides to detect the short DNA fragments, they worked 
with lacO arrays to visualize their long DNA fragments. 
Apart from the lacO/LacI system, other naturally occurring transcription factors 
like zinc-finger nucleases, CRISPR/Cas-based methods, and transcription activator-
like effectors (TALEs) are used. This last type can be designed to recognize very 
specific DNA sequences, which makes them great tools for labeling. 158, 159 Their 
specificity made it, for example, possible to track major satellite DNA throughout the 
cell cycle. 160 The use of these rather complex techniques is up to this point not 
routinely utilized in live-cell imaging. 
In summary, nucleic acid-binding proteins are an interesting option in the 
range of labeling techniques available to researchers (see Table 2), but are certainly 
not the most straightforward. The availability of commercial options relieves this 
partly, but the need for a stable or transient expression of the fluorescent protein-
tagged proteins poses an extra hurdle which lowers efficiency. Furthermore, the need 
for a well-designed target also complicates the experimental design. 
LIGHTING UP THE INTRACELLULAR DELIVERY PATH OF PDNA AND 
MRNA POLYNUCLEOTIDES 
The choice of an optimal labeling strategy to visualize nucleic acids in living 
cells will greatly depend on the specific research questions. The labeling of native 
DNA and RNA in the context of analyzing gene expression profiles, elucidating 
primary and secondary structure, and following epigenetic modifications and 
visualizing interactions with other cell components has been nicely reviewed by 
Boutorine et al. (2013)161. Here, we aim to overview the labeling choices which are 
available for fluorescent labeling of pDNA and mRNA, in the context of following their 
intracellular uptake, endosomal escape, mobility, stability, and distribution in living 
cells. 
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Table 2 Advantages and disadvantages of the different labeling methods. 
labeling 
method 
pros cons ideal for: available functional groups 
 
key 
ref. 
Intercalating 
dyes 
+ Easy to use kits 
available 
+ Fast 
- Off-target interactions 
- Negative effects on NA conformation 
Counterstaining  
Possibilities all over the visual spectrum 
(e.g. YOYO-1, TOTO-3) 
 
19
, 
22
, 
9
 
+ Large scale reactions 
+ Light-up principle 
- Low efficiency dyes Quantification of 
cellular uptake 
Covalent 
attachment 
+ Easy to use kits 
available 
+ Fast 
- Negative effects on transfection at 
high labeling density 
 
 
Polynucleotide 
tracking 
 
Random 
labeling 
 
Label-IT: DIG, biotin, DNP, Cy3, fluorescein, Cy5, 
TM-Rhodamine, CX-Rhodamine 
FastTag: thiol-reactive reagents 
ULYSIS: Alexa Fluor 488-546-594-647  
13
, 
36
, 
14
, 
15
 
+ Large scale reactions 
+ Strong covalent 
attachment 
Modified 
nucleotides 
+ Kits available 
+ Broad range of 
possible methods 
+ End labeling possible 
- Prior knowledge of labeling 
mechanism 
- Labor intensive 
- Expensive modified nucleotides 
 
 
End labeling 
 
Random 
labeling 
 
NHS ester + primary amine 
Maleimide + thiol 
Azide + Alkyne 
Biotin + streptavidin 
Intrinsically fluorescent labeled nucleotides 
(see Table 1) 
 
50
, 
52
, 
55
 
Enzymatic 
labeling 
+ Sequence-specific (4 
to 6 bp recognition 
sequence) 
+ Easy to use 
+ Strong covalent 
attachment 
+ Fast 
- No individual components for reaction 
commercially available 
- Extensive knowledge of chemistry of 
co-factors necessary 
- Small scale reaction 
- Expensive enzymes and co-factors 
 
Polynucleotide 
tracking 
 
All NHS ester-dyes and haptens 
(e.g. NHS ester-Alexa Fluor 488, NHS ester-Alexa 
Fluor 647, NHS ester-biotin ) 
 
66
, 
68
  
Linear 
oligos 
+ Highly sequence-
specific 
+ Strong attachment 
+ Fast 
+ Large-scale reactions 
+ Low cost per reaction 
+ Multiplexing possible 
- No kit available (anymore) 
- Needs sequence information of target 
- Needs knowledge of oligo design 
- Optimization needed 
- High initial price of nucleotides 
 
Polynucleotide 
tracking 
 
Same options as for modified nucleotides 
(see Table 1) 
 
79
, 
81
, 
85
 
MBs + Highly sequence-
specific 
- No kit available 
- Intracellular delivery needed 
 
Intracellular 
 
Virtually all commercial organic quencher-dye pairs 
 
109
, 
111
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+ Strong attachment 
+ In situ labeling 
possible 
+ Light-up principle 
+ Versatile 
- Sequence information on target 
needed 
- Custom oligo design 
- Optimization needed 
- High initial price of (modified) probe 
detection of 
specific 
polynucleotides 
available 
(e.g. TAMRA – 5’-FAM, Quasar 670 – Cy 5) 
Binary 
probes 
+ Highly sequence-
specific 
+ Strong attachment 
+ In situ labeling  
+ Light-up principle 
+ Versatile 
+ Reduction of 
background 
- No kit available 
- Intracellular delivery needed 
- Sequence information on target 
needed 
- Custom design for two adjacent 
oligos 
- Optimization needed 
- High initial price of (modified) probe 
 
Intracellular 
detection of 
specific 
polynucleotides 
 
Virtually all commercial quencher-dye pairs 
available 
(e.g. TAMRA – 5’-FAM, Quasar 670 - Cy5,  
Ru(II) – Cy5) 
 
 
123, 126
 
NA-binding 
small 
molecules 
+ Sequence-specific 
+ In situ labeling 
possible 
+ Spontaneous uptake 
by cells 
+ Versatile 
- No kit available 
- Sequence information on target 
needed 
- Not all sequences can be targeted 
- Extensive knowledge of polyamide 
conjugate chemistry necessary 
- Expensive 
 
Intracellular 
detection of 
specific 
polynucleotides 
 
Same options as for modified nucleotides 
(see Table 1) 
 
NA-binding 
proteins 
+ Kits available 
+ Sequence-specific 
+ In situ labeling 
+ Cell compartment 
specific labeling possible 
 
- Extensive knowledge of FP-tagged 
proteins needed 
- Adaption of target with recognition 
sequences to facilitate binding of 
proteins 
- Stable or transient expression of FP-
tagged protein in cell needed 
- Labor intensive 
- Expensive 
- Optical properties of FP  
 
 
Intracellular 
detection of 
specific 
polynucleotides 
in specific cell 
compartment 
 
All available fluorescent proteins. Mostly (E)GFP 
 
113
, 
150
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Polynucleotides such as pDNA and mRNA are prominently negative due to the 
anionic charge at the phosphate group of each nucleotide in the polymer sequence. 
Polynucleotides can be directly delivered into the cytoplasm or nucleus of the cells by 
microinjection or electroporation. They are however most frequently complexed with 
positively charged carriers to enable cellular uptake of the (net positive) complexes 
that are formed. These complexes are taken up by endocytosis, after which they 
should escape the endosomal compartment to prevent lysosomal degradation. 
Finally, the complexes should release their cargo into the cytoplasm (mRNA) or 
nucleus (pDNA) of the cells. 162, 163 
The different steps of the intracellular delivery path contribute to the overall 
observation that polynucleotide delivery is rather inefficient, especially when nonviral 
nucleic acid delivery is concerned. Therefore, each step of the intracellular trafficking 
has been the subject of intensive investigation over the past years. Hereby, 
fluorescence microscopy remains the most widely applied tool to gather information, 
going from more common wide field or confocal fluorescence microscopy setups to 
more advanced instrumentation such as spinning disk microscopy, single particle 
tracking, fluorescence correlation spectroscopy and super resolution microscopy. 164-
167
 
The choice of labeling technique needs to be incorporated early in 
experimental design, at the same time the microscopy method, cell line, transfection 
method, and type of polynucleotide (mRNA or pDNA) are chosen. Several aspects 
have to be considered when choosing a labeling strategy for mRNA and pDNA, such 
as the need for single versus dual color labeling, random versus sequence-specific 
labeling, labeling of the polynucleotides during in vitro synthesis, or intracellular (in 
situ) labeling. The ease and cost of the labeling procedure is also a factor to 
consider. 
When complexing fluorescently labeled polynucleotides with nonlabeled 
carriers, for example, single-colored complexes are formed. These single-colored 
complexes can be used to follow, for example, intracellular uptake and endosomal 
escape, as well as the intracellular location of the (fluorescent) nucleic acids. Also, 
the colocalization of (e.g. red) complexes with GFP-tagged (green) endosomal 
vesicles could be performed. 40, 165 One should always keep in mind, however, that 
the fate of the nonlabeled complexation partner cannot be followed in this 
experimental setup. Moreover, certain carriers such as PEI have the tendency to 
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quench fluorescence upon complexation. In that case, fluorescence will only return 
once the polynucleotides have dissociated from their carrier. This principle was 
elegantly explored to develop an endosomal escape assay based on the 
(de)quenching of small oligonucleotide fragments. 168 By simultaneously labeling 
different types of endosomal vesicles, the specific type of endosomes from which 
complexes are preferentially released has been recently identified. 169 Apart from 
single color-labeling, both the carrier and nucleic acids can be labeled with spectrally 
separated fluorophores to obtain dual-colored complexes. 170 In this way, both parts 
of the delivery complex can be tracked before and after dissociation of the nucleic 
acids from the carriers. Dual-labeling of the polynucleotides themselves is also an 
interesting option to monitor their stability in the intracellular environment, as 
discussed below. 
The choice between random and sequence-specific labeling of 
polynucleotides will largely depend on the biological application under investigation. 
Random labeling frequently results in more fluorophores per polynucleotide, 
generating brighter polynucleotides and complexes (until quenching occurs) suited 
for use with basic fluorescence microscopes. The two fast and easy options for 
random labeling are intercalation and covalent attachment of probes. After 
endosomal escape, however, intercalating dyes hold the risk of redistribution to 
endogenous nucleic acids in the cytoplasm or nucleus of the cells. Random covalent 
attachment of fluorophores to polynucleotides, on the other hand, has been proven to 
interfere with the endosomal escape and transcription/translation properties of the 
labeled polynucleotides themselves. Therefore, both labeling methods are best 
suited to follow the first two steps (cellular uptake and identification of endosomal 
vesicles) of the transfection pathway. 
Whenever the random presence of dyes on the polynucleotide backbone holds 
a risk of disturbing the natural function of the polynucleotides, sequence-specific 
labeling can be preferred. Both for mRNA and pDNA, target sequences can be 
chosen outside the coding region. While linear oligos, MBs and binary probes can in 
theory make use of the natural primary sequence of the polynucleotides, plasmids for 
sequence-specific labeling are mostly designed to contain a known number of target 
repeats to ensure sufficient and specific binding. Alternatively, recognition site arrays 
for enzymatic labeling can be incorporated at the location of choice. An elegant 
application of sequence-specific labeling of polynucleotides is the spatially separated 
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double labeling. 104 This allows the coding region to be flanked with, for example, a 
green and a red fluorophore, which can be of interest to monitor the stability of 
polynucleotides. Indeed, as long as the polynucleotides remain intact, the green and 
red color will colocalize. As soon as backbone degradation occurs the colocalization 
is expected to disappear. Despite many possible experimental designs, the 
disadvantage of the sequence-specific labeling methods remains the need to custom 
order and design your polynucleotide of interest. This requires the preparation, 
isolation, and quality control of cloned pDNA vectors, which might be a challenge for 
researchers with a limited biotechnology background. It should be noted that, for 
mRNA stability testing, 5’ and 3’ end labeling of the synthesized mRNA can also be 
considered, overcoming the need to incorporate recognition sequences into the 
template DNA used to prepare mRNA. 
The labeling of polynucleotides during synthesis is an option that is of interest 
when fluorescently labeled mRNA molecules are desired. Indeed, the in vitro 
synthesis of mRNA is a routine method to prepare mRNA from a DNA template. 
Nonmodified NTPs are frequently replaced by modified nonfluorescent NTPs in the 
reaction mixture to yield more stable and less immunogenic mRNA. 171 The addition 
of labeled NTPs to prepare fluorescent mRNA is thus a slight and easy adaptation of 
the normal protocols. Also, fluorescent cap analogues are available for 5’ end 
labeling. 172 3’ End labeling, on the other hand, would require fluorophore addition to 
the mRNA poly-A tail. 
A final consideration to be made is the added value of using an in situ labeling 
method. For the detection of endogenously synthesized polynucleotides, in situ 
labeling is obviously the only suitable method to ensure intracellular detection. In situ 
labeling of exogenously delivered polynucleotides could also be an interesting option 
to visualize the polynucleotides only after reaching the cytoplasm or nucleus of the 
cells. This would allow detection of endosomal escape events of initially nonlabeled 
polynucleotides, ensuring that the labeling strategy cannot interfere with the escape 
process. The three possible methods for in situ labeling are the use of molecular 
beacons, nucleic acid-binding small molecules, or the nucleic acid binding proteins. 
Molecular beacons have the advantage of employing a light-up principle, thereby 
limiting any fluorescent background signal. The use of organic dyes also increases 
their brightness and photostability, compared to fluorescent proteins. A substantial 
disadvantage of these molecular beacons is the need for a delivery method since 
CHAPTER 1 | FLUORESCENT LABELING OF PLASMID DNA AND MRNA: GAINS AND LOSSES OF 
CURRENT LABELING STRATEGIES 
PAGE | 58 
they are essentially (modified) oligonucleotides, which will not spontaneously reach 
the cytoplasm of cells. Mechanical methods like microinjection, electroporation, and 
bioballistics as well as chemical methods like toxin-mediated cell membrane 
permeabilization, liposomes, and polyplexes are possible strategies. 173-175 The 
nucleic-acid binding small molecules have the advantage of MBs in their use of 
organic dyes while being spontaneously taken up by cells. The need for an in depth 
knowledge of the polyamide conjugate chemistry, cost, and the limitations in 
sequences that can be specifically recognized limits their application by a broader 
audience. For in situ labeling with nucleic acid-binding proteins, the fact that one 
molecule of coding DNA/mRNA leads to multiple functional proteins is an advantage 
when compared to the large amount of MBs and polyamide conjugates that need to 
be present for a good reporter signal. To accomplish this, however, the target cells 
need a transient or stable expression of nucleic-acid binding proteins, which might be 
experimentally challenging. Furthermore, extra toxicity or cell stress that might 
influence the intracellular path of the polynucleotides under investigation might be 
induced. 
It should be noted that apart from coupling fluorophores and haptens to 
polynucleotides, the label-free detection of polynucleotides is also gaining attention. 
The biggest advantage is that the use of bulky fluorophores or haptens is avoided, by 
employing the molecule’s own chemical fingerprint for visualization. Interestingly, 
label-free detection can occur over a long time, since photobleaching, which is an 
important bottleneck in live-cell imaging, is no issue anymore. Raman scattering is 
one of those promising techniques that might be used to visualize nucleic acids. 176 
Alkyne-bearing nucleotides were, for example, used to visualize DNA and RNA 
synthesis in vivo by stimulated Raman spectroscopy. 177 This principle might be 
extended to a priori labeling, making this an interesting option for the future. 
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CONCLUSION 
In this chapter, we aimed for an overview of different labeling strategies for 
adding fluorophores or haptens to polynucleotides such as pDNA and mRNA. Also, 
some considerations on how to evaluate the compatibility of a certain labeling 
technique for tracking polynucleotides in the context of nonviral gene delivery were 
made. It is clear that more than one labeling strategy might be suited for a given 
application. Then, ease of operation, cost, and compatibility of the possible 
fluorophores with the research instrumentation will be valuable extra concerns to 
determine the preferred labeling option. Obviously, one should always carefully 
evaluate if the labeling method and labeling density of choice is not interfering with 
the process under investigation, relative to a nonlabeled control. It is expected that 
the continuous development of advanced microscopy methods will further shape the 
future of polynucleotide labeling strategies. One exciting new application, for 
example, is the label-free detection of molecules, which is being explored in a broad 
range of fields. Undeniably, live cell imaging will continue to play an important role in 
unraveling intracellular mysteries, creating a step-by-step insight in (and possible 
optimization of) the polynucleotide delivery pathways. 
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INTRODUCTION 
Next to the use of fluorescence microscopy to visualize the behavior of 
fluorescently labeled molecules or particles in a biological environment, studying the 
dynamic properties of these labeled particles has gained importance for many research 
areas. In the context of this thesis, especially the mobility studies of molecules 
associated with gene delivery capabilities, like non-viral carriers or nucleic acids, is of 
interest. These mobility studies have provided information on the capability of non-viral 
gene carriers to move, for example, through sputum 1 and vitreous, 2 but also surface 
modifications of non-viral carriers to protect the therapeutic molecules against 
enzymatic degradation were evaluated. 3 
A collection of advanced fluorescence microscopy methods have been 
developed over the years to study the mobility of particles at extremely low 
concentrations. Fluorescence correlation spectroscopy (FCS) and single particle 
tracking (SPT) are the relevant techniques for this thesis, but also fluorescence 
recovery after photobleaching is a technique that can be used to this end. 
FCS is a fluorescence microscopy-based technique that was developed in the 
1970’s as a special case of relaxation analysis to measure diffusion and chemical 
dynamics of DNA-drug intercalation via the temporal autocorrelation of fluctuations in 
fluorescence emission. 4, 5 The fluctuations are caused by the entrance and the exit of 
fluorescent molecules in and out of the observational volume. The technique was 
refined by reducing the observational volume and concentration of the molecules of 
interest, while increasing the sensitivity to detect fluorescence. By the combination of 
FCS with confocal detection, the current form of the technique was established. 6 Rigler 
and Elson (2012)7 bundled an extensive overview describing the technique and most 
interesting applications. In our lab, the technique was used to study the complexation 
and dissociation of antisense oligonucleotides and short interference RNA (siRNA) 
from non-viral complexes and the in vitro and in vivo stability of these nucleic acids. 8-
11
 
SPT on the other hand is a fluorescence microscopy-based method that obtains 
spatio-temporal information on individual moving fluorescent molecules or particles. To 
this end, movies are recorded inside a solution with a low concentration of the particles 
of interest. The movement of the particles during the movie is then used to calculate 
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the distribution of the diffusion coefficients of the particles and a number 
concentration.12-15 Zagato et al. (2014)16 provided an interesting overview of how single 
particle tracking (SPT) has been used in the field of drug delivery. In our lab, this 
method has been used to study the mobility of carriers within environments that form 
a barrier for the delivery of non-viral vectors, like sputum and the vitreous. 1, 2 
In this chapter, FCS and SPT are described with regards to their principle, 
instrumentation, and particular analysis methods that were used throughout this thesis. 
This should enable a better understanding of all the terms and analysis methods that 
are being used in the following chapters of this thesis. 
FLUORESCENCE CORRELATION SPECTROSCOPY 
Fluorescence correlation spectroscopy is a fluorescence microscopy-based 
method that, rather than making use of the fluorescence emission intensity, makes use 
of spontaneous fluorescence intensity fluctuations to analyze low concentrated 
biomolecules by high-resolution spatial and temporal analysis. These fluctuations stem 
primarily from the movement of fluorescently labeled particles in and out of the 
detection volume, (Figure 1 A) but also conformational changes and chemical or 
photophysical reactions (e.g., blinking, photobleaching, …) induce fluorescence 
intensity fluctuations. The fluorescence intensities (()) are recorded over time and 
displayed in so-called time traces (Figure 1 B). Based on these traces an 
autocorrelation curve (() is calculated, (Figure 1 C) which can be fitted by a 
mathematical model (vide infra). From these calculations, most importantly for this 
thesis, local concentrations and diffusion coefficients can be retrieved. 4, 17 To achieve 
this, the fluorescence intensity is measured in a confocal observation volume (~1 fl) in 
a solution with a nanomolar concentration of fluorescently labeled molecules, to assure 
that every fluorescent molecule contributes significantly to the fluorescent signal. 
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Figure 1 (A) Schematic representation of the detection volume with fluorescently labeled 
particles moving in and out of the focus. ,
	and  are respectively the radial and the axial 
radius of the focal volume. Plots of the (B) fluorescence intensity time trace and (C) 
autocorrelation curve.  
Instrumentation 
A FCS setup to simultaneously detect fluorescence fluctuations of two colors 
needs at least four important components, namely: laser excitation, a high numerical 
aperture (NAp) objective, emission filters, and single molecule sensitive detectors. 
These requirements allow the integration of this setup with a standard confocal 
microscope. In Figure 2, the setup at our facility is schematically represented. The 
Compact FLIM and FCS Upgrade Kit for LSMs (PicoQuant, Berlin, Germany) is, in our 
case, added to a Nikon EZC1-si setup (Nikon Instruments Europe B.V., Brussels, 
Belgium). In practice this means that from a laser box with solid state lasers of 488 nm 
and 636 nm, laser light is sent through an excitation pinhole toward a dichroic mirror, 
which directs this excitation light to a 60x water immersion (WI) objective (Nikon Plan 
Apo VC 60x WI DIC N2, NAp 1.2). This objective focuses the excitation beam into a 
sample which is contained in a glass bottom 96 well plate (Greiner Bio-One, Vilvoorde, 
Belgium) and simultaneously collects the fluorescence emission. This emission light 
passes through the dichroic mirror and excitation pinhole after which the light is 
focused on the τ-single photon avalanche diode (τ-SPAD) detectors. The PicoQuant 
detector box consists of a 50/50 beam splitter guiding the emission light via a 520/35 
nm bandpass filter or a 690/70 nm bandpass filter towards two detectors which detect 
photons to address them respectively to the green channel or the red channel. The 
electronic signal from the detectors is finally sent to the Time-Correlated Single Photon 
Counting (TCSPC) module to assign arrival times to the fluorescence intensities. This 
data is synced with the SymphoTime software (FCS package) to perform the analysis. 
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Figure 2 Setup of a (dual) color FCS instrument. For single color FCS, the emission light is guided 
to only one detector. SPAD = Single Photon Avalanche Diode, TCSPC = Time-Resolved Single 
Photon Counter. Dashed line: excitation light, dashed and dotted line: emission light 
Autocorrelation Analysis 
As mentioned above, fluorescence intensity fluctuations can be quantified by 
temporally autocorrelating the intensity signal (()). This measure of self-similarity of 
the time signal can then further be used to extract time constants of underlying physical 
processes. 4 For the theoretical derivation to be correct, a couple of assumptions about 
the data acquisition should be made. The laser power, effective volume and 
temperature are assumed to be constant during the measurement and the dynamic 
processes observed are caused by free diffusion. 
During the recording process the fluorescence intensity from the fluorescent 
molecules inside the detection volume is recorded photon by photon. The fluctuations 
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of the fluorescence signal ( are defined as the deviation of this signal to the 
average signal 〈(〉 over the time frame of the measurement. 
 
Eq. 1 
 
 
The correlation function is then obtained by calculating the self-similarity of fluctuations 
after lag time . The normalized autocorrelation curve is then calculated by: 
Eq. 2 
 
This function is plotted in function of  to give rise to a graph depicting the experimental 
autocorrelation curve (cf. Figure 1 C). 
Since the goal of the FCS experiments in this thesis is to extract information on 
concentration () and the diffusion time (), the experimental autocorrelation curve 
needs to be fitted with a mathematical model. The SymphoTime fitting software 
requires some parameters, describing the effective volume and the ratio of the axial 
over the lateral radius of the detection volume 		and	, to be able to retrieve 
meaningful values for  and . The structural parameter κ (defined in Eq. 3) was 
calibrated and is fixed at 6 for the red channel and 9 for the green channel for all the 
fits. 	 of the detection volume (see Figure 1 A and Figure 2) is experimentally 
obtained by measuring a rhodamine green solution with a known diffusion coefficient 
and solving the equations in Eq. 3 based on the obtained correlation curve. 
( = 〈( × ( + 〉〈(〉  
( = ( − 〈(〉 
〈(〉 = 1 (!
"
#
 
$ = %&,'

4  
 = )* + 	%&,'	%, 
 = 	 %,%&,' 
Eq. 3 
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The model that is used throughout this thesis to fit the autocorrelation curves, is 
the predefined triplet-state model from the SymphoTime software. This model adjusts 
the general model for free diffusion to compensate for triplet blinking, which arises from 
the transition of fluorophores to the first excited triplet state. The number of species 
can be adjusted by varying the - in Eq. 4. 
Eq. 4 
 
with: 
T = % fluorophores in triplet state 
- = number of species 
∑ /01023  = 3〈4〉 
" = triplet state time 
0 = diffusion time for species 5 
 = see Eq. 3 
In this thesis, most of the time, a two species fit was used to analyze the 
autocorrelation curves of the pDNA solutions. Next to the structural parameters  
and κ, the dynamic	parameters 73, 3, 7, , T, and " can be provided by the 
user. By fixing one of the two diffusion times, while leaving the other dynamic 
parameters free, the presence of fast species, like free dye, labeled hybridization 
probes, or degraded DNA fragments with a pre-defined diffusion time, can be taken 
into account (illustrated in Figure 3). This leads to a better fit of the data which returns 
better values for the parameters of the slow species. 
( = 81 −  + 9:; <<=>?@/0 A1 + 0B
;3 A1 + 0κB
;3/1
023
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Figure 3 FCS analysis window in the SymphoTime software (A) for calibration and (B) for a 
sample with supercoiled pDNA. The sample in (A) is free dye with a known D of 400 µm²/s. The 
E value is fixed at 6 and the FGHH is calculated and fixed. The obtained ID can then be used as a 
measure for the fast component in (B). In (B) the correlation curve of supercoiled pDNA is fitted 
with the two species triplet-state model. FGHH, E, and IDJ are fixed based on (A). A diffusion 
coefficient is then calculated from the fit for the second species. 
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Peak Number Analysis 
Alternatively to autocorrelation analysis, the total number of peaks, present in 
the time trace, was also used as a measure for the concentration of pDNA (see Chapter 
3). This is possible due to the observation that in the low concentration solutions that 
are used for these experiments, a large, slow moving fluorescently labeled pDNA 
molecule gives rise to a high intensity value when it passes through the detection 
volume, (Figure 4 A) while small, fast moving DNA fragments generate only small 
fluctuations around the average fluorescence intensity when passing through the 
detection volume (Figure 4 B). These so-called high intensity peaks are quantified in 
the “burst size histogram” window of the SymphoTime software. This analysis counts 
a peak when the fluorescence intensity increases to a value higher than the threshold 
and returns back to a lower value. To obtain a number of peaks, a threshold is 
determined and fixed, based on the baseline of the fast moving fragments (see 
Supplementary data of Chapter 3 and 4 for a practical example). The threshold is 
chosen to be above the maximum fluorescence intensity seen in these samples, since 
no large pDNA should be present (see Figure 4 B). This baseline is then fixed for all 
other samples (see Figure 4 A) and a number of peaks is calculated in the software for 
every time trace. 
 
Figure 4 Schematic representation of a fluorescence intensity peak rising from (A) fluorescently 
labeled pDNA and (B) a degraded DNA fragment migrating through the detection volume. Blue 
line indicates the threshold which is chosen based on the maximum value on the right. 
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SINGLE PARTICLE TRACKING 
Single particle tracking (SPT) is the second fluorescence microscopy-based 
method that was used throughout this thesis. It enables the study of the movement of 
individual fluorescently labeled particles or molecules in time and in space with 
nanometer precision. 13 This is achieved by a multiple step process as depicted in 
Figure 5. First, images are recorded in solutions with a concentration that is low enough 
to avoid the presence of more than one particle per diffraction-limited spot. For a high 
NA objective, this means that there should be a distance of at least 500 nm between 
each particle. 12 Then, trajectories are calculated based on image processing of the 
recorded movies. Finally, these trajectories are analyzed in a quantitative manner to 
obtain information on the mobility and concentration of the particles in solution. The 
instrumentation used in this thesis and the analysis methods will now further be 
discussed in more details in the following paragraphs. 
 
Figure 5 Schematic overview of a typical workflow when performing SPT for sizing and 
concentration analysis on the swept-field confocal (SFC) microscope. MEM: Maximum Entropy 
Method which is used to refine the obtained distribution of diffusion coefficients. 
Instrumentation 
The equipment that is typically used to record movies of moving fluorescent 
particles for SPT is an epi-fluorescence microscope which is adjusted to allow widefield 
laser illumination and detection with a fast and sensitive charge-coupled device (CCD) 
camera. In this thesis however, a swept-field confocal (SFC) microscope (Nikon 
LiveScan attached to a Nikon Eclipse Ti-E inverted microscope (Nikon Instruments 
Europe B.V., Brussels, Belgium)) is used to record the movies. The SFC microscope 
setup makes use of a four line solid-state laser box of which either the 488 nm laser or 
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the 640 nm were used in this thesis depending on the type of fluorescent label. From 
there on, the laser light is sent to the SFC scan head (Figure 6 A), which guides the 
light via a pinhole array/slit aperture (Figure 6 B) and a scanning galvanometer mirror 
toward the sample. This pinhole array/slit aperture allows for pinhole imaging at a high-
resolution or high-speed slit imaging. In this work, the microscope was always used in 
slit mode (50 µm slit), which uses a single slit for sweeping the sample and allows for 
high-speed imaging at a lower excitation power. This, however, leads to a slightly 
diminished spatial resolution and optical sectioning, when compared to the pinhole 
imaging, since confocality is only created in axis (perpendicular on the slit) and out of 
focus light has a higher contribution to the emitted signal on the other axis. 18 The 
scanning galvanometer mirror then guides the light via the dichroic mirror toward the 
same 60x high NAp WI objective that is described for FCS, which focuses the light 
inside the sample, which is placed in a glass-bottom 96 well plate. The excitation light 
from the fluorescent particles is then returned onto the dichroic mirror, where the beam 
is sent back over the scanning galvanometer mirror through the emission aperture slit. 
Via a mirror, the scanning galvanometer mirror again directs the light through an 
emission filter onto the electron multiplying CCD (EMCCD) camera. The NIS elements 
software (Nikon Instruments Europe B.V., Brussels, Belgium) then displays the 
recorded images. To ensure the acquisition of high quality images, all the different 
components are synchronized by a SFC controller module. 
Two imaging parameters always need to be known for a correct SPT analysis: 
the frame rate and the pixel size. These parameters are checked via the NIS software, 
where the scanning and acquisition parameters are set to the needs of the experiment. 
Very fast acquisition can be obtained by synchronizing the exposure time with the 
maximum acquisition rate of the camera. With our setup this gives rise to a maximum 
frame rate of 37.4 frames per second at a full frame (512 x 512 pixels). This is ideal for 
very bright, fast moving particles. For the imaging of slower moving particles, as is the 
case for pDNA, slower acquisition rates can be used (e.g., throughout this thesis an 
exposure time of 100 ms was used, giving rise to a frame rate of around 8-9 frames 
per second). This frame rate should always be checked during the analysis. The pixel 
size on the other hand is a parameter that is determined by the camera and the optical 
configuration of the microscope. Since the full surface of the camera’s detector was 
always used, it has a fixed number of pixels. Only the optical configuration will then 
FLUORESCENCE CORRELATION SPECTROSCOPY AND SINGLE PARTICLE TRACKING | CHAPTER 2 
PAGE | 85 
contribute to a change in image pixel size. Apart from the objective lens, our setup has 
two additional magnification steps which influence the pixel size. The first additional 
magnification is incorporated into the microscope body and makes it possible to add 
an optional extra 1.5x magnification. An additional adjustable magnification, between 
1x and 2.25x, is introduced in the emission pathway of our setup between the dichroic 
mirror and the EMCCD camera. For the experiments further in this thesis, the total 
extra magnification was set at 1.5x. For our camera with 16 µm pixels and the 60x WI 
objective this resulted in an image pixel size of 16 µm(60×1.5 =	0.18 µm pixel⁄ . 
 
Figure 6 Schematic representation of (A) the SFC scan head and (B) the slit apertures and pinhole 
arrays of the LiveScan system. Blue line: excitation light. Green line: emission light. Part (A) 
adapted from Castellano-Muñoz et al. (2012)18 
Calculation of Trajectories 
After the movies are recorded, two analysis steps need to be performed to 
calculate the trajectories (or tracks) of each particle that provide information on the 
mobility and concentration of the particles. First, the location of the particles is 
determined and the center location is calculated for each frame of the movie via the 
centroid algorithm.12 Next the locations belonging to the same particle should be linked 
together via a suitable nearest neighbor algorithm. 
When we take a look at these steps in more detail, we see that in the first step, 
the locations of particles in all the SPT images should be found. This can be done by 
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a variety of methods, such as a Gaussian fit, centroid identification or a pattern-
recognition method. 19, 20 Since all the work in this thesis is analyzed on our proprietary 
software, the analysis will be explained by the algorithms used for the image 
processing, which were described by Braeckmans et al. (2010)12, Deschout et al. 
(2012)14, and Forier et al. (2012)1. First, a background correction is performed with an 
unsharp filter, to remove a nonuniform background. In the filtered image  with a more 
uniform background, a first selection of possible particles can then be made by means 
of intensity thresholding. Since most of the pixels belong to the background, while the 
particles give rise to considerably less pixels (with higher intensities), the intensity 
histogram will consist of a Gaussian-like peak around the intensity of the background 
with a long tail for the higher intensities, stemming from the particles. The threshold 
should be set at an intensity that separates the background intensity from the particle 
intensity. This intensity threshold  is based on an algorithm that fits a Gaussian 
distribution to the intensity histogram and can be calculated as: 
Eq. 5 
with mean value L, standard deviation 7 and  a user-defined parameter to fine-tune 
the threshold for a particular series of experiment. A binary image M can now be 
created where all the pixels below intensity  have an intensity equal to zero and values 
above or equal to  as one. 
From M the contours of the objects can be determined which delineate potential 
particles in the original image N. These contours allow for the calculation of object 
properties, but most importantly allow for the calculation of the center location. This is 
calculated as the intensity-weighted center of the object pixels or ‘centroid’ given by 
coordinates OP and QP which are defined as: 
Eq. 6 
 
With R the set of all pixels with coordinates (O0, Q0 and intensities N0. S is the local 
background calculated from the mean pixel value along a contour drawn close around 
the object contour. Based on the object properties, a final selection is performed by the 
user, to retain only the objects that are coming from the particles of interest. It should 
be noted that although most of the particles that are imaged for SPT are smaller than 
 = L +  × 7 
OP = ∑ O0 × (N0 − S0∈U∑ (N0 − S0∈U , 	QP =
∑ Q0 × (N0 − S0∈U
∑ (N0 − S0∈U  
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the resolution of the microscope (<250 nm), SPT can obtain subresolution accuracy 
on the location of a particle by calculating the centroid of the diffraction-limited spot. 21 
Based on these particle locations the trajectories can be calculated by deciding, 
via a suitable algorithm, which particles in subsequent frames should be linked. In our 
work we used a nearest neighbor algorithm that connects positions of particles that are 
closest to each other in subsequent frames. In order not to connect particles that are 
too far from each other, the maximum distance that a particle can travel over the time 
between two subsequent frames needs to be taken into account. In the case of free 
diffusion, this maximum step size can be estimated according to the exponential 
distribution given by the following equation: 22 
Eq. 7 
 
with V = W the distance squared that a particle can travel after a time  due to free 
diffusion. This exponential distribution has the cumulative distribution function: 
Eq. 8 
This equation represents the probability that a particle with a diffusion coefficient $ 
traveled a square distance within the interval X0		OZ after a time . This means that the 
particle will not have moved further than a distance W = √O = \4$	]-(1 (1 − ^⁄  with 
a probability ^ .The maximum step size can thus be calculated for a certainty level when 
the diffusion coefficient $ and time between two subsequent frames () is given. 
Once this maximum step size is fixed, the nearest neighbor algorithm will 
connect the nearest particle positions in subsequent frames within the maximum 
search distance to obtain tracks. The algorithm used also takes the disappearance of 
particles, due to photophysical causes or due to movement out of the focus, and the 
appearance of new particles during the acquisition into account. For details on this the 
interested reader is referred elsewhere. 12 
(O = 1 − 9;& _`⁄  
a(V = 14$ 9;b _`⁄ !V 
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Analysis of the Mobility 
Once the trajectories are calculated, information on the mobility can be 
obtained. This is usually done by mean square displacement (MSD) analysis (Figure 
7). For a trajectory that is  steps long (thus  + 1 locations), the time between 
subsequent steps is , which is in fact the time between two consecutive frames in the 
SPT movies which we from now on call the first time-lag. This first time-lag is related 
to the so-called first step, which is the distance W3,` between the first two points. The 
distance between the second and third point is then given by W,` (see Figure 7). The 
MSD for the first time-lag is then given by: 
Eq. 9 
 
This MSD can be calculated for longer time-lags (2, 3, …, -) with - = 1, 2, … ,. In 
general, the MSD for time-lag - can be defined as: 
Eq. 10 
 
When the MSD is plotted against the time-lag, the diffusion coefficient can be 
calculated by fitting the experimental data. For free 2-D diffusion, the MSD is described 
by: 
Eq. 11 
with  the time-lag, ∆ the acquisition time, and 7 the localization precision which is 
dependent on the diffusion coefficient $ and the acquisition time. 
〈W〉` = ∑ W0,
`4023
  
〈W〉1` = ∑ W0,1`
4;1g3023
 − - + 1  
〈W〉 = 4	$ − 4 3+ $∆ + 47($, ∆ 
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Figure 7 The principle behind the MSD analysis of a trajectory consisting of six steps. For the 
first time-lag (h), the MSD is calculated from six distances. For the second time-lag (ih), only five 
distances are retrieved from this trajectory for the calculation of the MSD. The last time-lag has 
only one distance contributing to the MSD. 
To obtain a correct calculation for the diffusion coefficient two things should be 
noted. First, the number of distances, from which the MSD is calculated, decreases for 
increasing values of . This leads to an increase of the uncertainty of the obtained 
values. This increase is visualized in Figure 8. Therefore, it is suggested that the 
longest time-lag for which the MSD is calculated should be at most 25% of the length 
of the longest time-lag or a weighted fit should be used. 12 
 
Figure 8 The relation between the MSD for free diffusion and the time-lag (as a solid line) for a 
trajectory of 100 steps. The dashed lines represent the positive and negative standard deviation 
on the MSD at time-lag jh, which increases for larger lag-times 
Secondly, the localization precision value 7 can, in its most simple form, be 
determined by recording a movie of a sample with stationary particles in the same 
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imaging conditions as the samples, building the trajectories and taking the standard 
deviation of the calculated positions. Deschout et al. (2012)14, however, described that 
the value will deviate from this standard deviation due to 3-D movement of a particle 
during the acquisition. This alternative calculation method assumes that the average 
localization precision of diffusing particles is equal to the localization precision for a 
point spread function blurred by the average diffusion. 14 This was experimentally 
proven to be a more accurate description of the localization precision and it is therefore 
used in our program. 
By incorporating all these parameters in the fit, described by Eq. 11, to the MSD 
from the individual trajectories, a distribution of diffusion coefficients is calculated. This 
distribution is then even more refined by a maximum-entropy analysis (MEM). Via this 
method, the noise that is not statistically warranted is removed resulting in a more 
precise distribution of the diffusion coefficients. 13 
Concentration Analysis 
The concentration analysis that is used within this thesis has been developed 
and described in detail in Röding et al. (2013)15 and Röding et al. (2013)23. The analysis 
starts from a file containing information on the trajectories in a movie. Based on the 
data from the tracks, this method calibrates the volume of the detection region which 
makes it possible to calculate absolute number concentrations in a highly accurate 
fashion. Furthermore, these results were shown to be independent of particle 
brightness, instrumental settings and the image processing parameters. 
First, the volume of the detection region is determined by modeling the 
distribution of trajectory lengths within the detection region, which is shaped as a 
rectangular box. The lateral dimensions of this box can be obtained by calibration, but 
the axial dimension is unknown and should be derived from the measurements. Since 
the lateral size is typically much larger than the axial size, the model is simplified by 
assuming that a particle can only enter or leave the detection region via axial diffusion. 
By doing this, the 3-D problem is reduced to a one-dimensional problem. 15 For a 
monodisperse sample, it is assumed that the particles are uniformly distributed within 
the sample. This means that the position of a particle in the next time step is the current 
position plus a Gaussian increment. From this, the conditional probability density of the 
position of a particle that has just entered the detection region can be defined. This 
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probability density is then used to compute the probability distribution of the trajectory 
length once a particle enters the detection region. This probability distribution for a 
trajectory length K was shown to be implicitly a function of the axial size of the detection 
region and the diffusion coefficient of the particles. 
The distribution of trajectory lengths can be obtained from the experiment, while 
the diffusion coefficient can also be determined from the analysis of mobility (vide 
supra). A maximum likelihood estimate of the axial size (kl) is then obtained by fitting 
the theoretical trajectory length distribution to the experimental trajectory length 
distribution. This axial size estimate is thereafter used to calculate the absolute number 
concentration (Eq. 12). It is important to note here that a minimal track length threshold 
is imposed, since shorter track lengths are more likely to be false positives, caused by 
errors in the localization. In this thesis, this minimum track length is kept at 4. 
Next, the number concentration is given by: 
Eq. 12 
 
with 2	k& and 2	k& the lateral dimensions of the detection region in µm and m the mean 
number of particles per frame. This value can be estimated by: 
 
Eq. 13 
with - the number of frames, n the track length, no01 the minimum track length (as 
discussed before), p the number of tracks of length n and ^̂rMs a correction factor to 
compensate for the underestimation that is introduced by omitting shorter track lengths 
than no01. It’s defined by the estimated probability of a random particle position within 
the detection region to be observed with n ≥ no01. 15 
The standard error on the concentration estimate is calculated using 
bootstrapping on the level of the movie, since the movies can be considered to be 
independent measurements. Röding et al. (2013)15 showed by simulation experiments 
that 50 bootstrap samples returned standard errors which were very close to the actual 
standard errors. 
û = m8klk&k' × 10;3 	particles/ml 
m = 1^̂rMs
1
- @ -pwpxyz
p 
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In practice the parameters that need to be provided by the user of the 
concentration analysis are the dimensions of the field of view (512 x 512 pixels in our 
case), the pixel size (0.18 µm/pixel), and the time between two consecutive frames. 
Based on the provided movies, 10 movies per sample in this thesis, the analysis will 
return a number concentration expressed in particles/ml. 
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ABSTRACT 
The development of biotechnological pharmaceutics, like macro and 
nanocarriers, can benefit greatly from studying their characteristics in situ using 
advanced fluorescence microscopy methods. While choosing the optimal labeling 
method for visualizing the carrier or its cargo is crucial, it seldom receives attention. 
The possibility that high labeling densities alter the intracellular processing of the 
molecule is considered, but how and at which point this interference happens is not 
yet studied. The aim of this study was to elucidate the effect of labeling density on the 
cellular trafficking of labeled plasmid DNA (pDNA). Due to the drastic effect on 
expression levels for higher labeling densities, we tried to determine at which steps in 
the intracellular processing labeled pDNA behaves different than its nonlabeled 
counterpart. Therefore, different labeling densities, up to the manufacturer’s 
recommended density, were tested. It was found that the cellular uptake remains 
unaffected, while the affinity for lipids is increased, which affects dissociation from the 
lipid-based complex and may affect endosomal escape. Also, nuclear injections 
clearly demonstrated that transcription is affected. The information and methodology, 
included in this work, could be helpful in determining if the labeling method and 
density used yields biologically relevant results for the intended research question. 
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INTRODUCTION 
The administration of plasmid DNA (pDNA) is frequently used to introduce 
protein expression inside living cells. 1 pDNA has the advantage that it is easily 
produced and has great modulation possibilities. Virtually any protein of interest can 
be incorporated in the expression cassette. The delivery of pDNA, however, remains 
an important bottleneck. As naked nucleic acids are poorly taken up by cells, they 
need a delivery system for efficient intracellular delivery. While some successes have 
been obtained with viral vectors, 2-4 safety issues have stimulated the development of 
non-viral vectors for delivery of DNA therapeutics. 5, 6 In the research and 
development of non-viral therapeutics, the main goal is to find ways to make the 
transfection efficiency up to par with viral vectors. In order to optimize non-viral 
carriers, studies are conducted to obtain a better understanding of the intracellular 
barriers that are encountered during the transfection process. 7-10 When reaching the 
target cells, pDNA gene complexes are typically internalized through endocytosis. 
Then, the pDNA needs to escape the endosomal compartment into the cytosol, 
dissociate from its carrier and travel toward the nucleus. During the entire 
transfection process degradation of the pDNA should be avoided. 
Advanced fluorescence microscopy methods are increasingly being used to 
get a better understanding of the intracellular processing of gene complexes in cells. 
11-20
 This requires that the gene complexes are fluorescently labeled, either by 
fluorescent labeling of the carrier material, or by fluorescent labeling of the cargo, i.e., 
the pDNA in this case. Labeled DNA can be obtained through a variety of techniques. 
Covalent labeling, enzymatic labeling, intercalating dyes, and peptide nucleic acid 
(PNA) clamps are all commonly used techniques. 8 Due to the simple nature of the 
protocols, methods that label the molecules in a random fashion, e.g., intercalating 
and most covalent binding labels, are used extensively. 
A systematic study of labeled pDNA and its effect on the intracellular 
processing of gene complexes is currently missing. Yet this is required to correctly 
interpret microscopy-based intracellular trafficking studies. The aim of this study was 
to investigate the effect of labeling density of covalently labeled plasmids on the 
various steps of the intracellular processing and the final transfection efficiency of 
gene complexes containing labeled pDNA. As a case study, gene complexes 
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prepared from Cy5 labeled pDNA and the frequently used transfection agent 
Lipofectamine 2000 were investigated. It was found that for these gene complexes 
the cellular uptake and the intrinsic ability of lipoplexes to enable endosomal escape 
remains unaffected by the labeling of the pDNA, while other steps in the transfection 
pathway like dissociation from the complex and nuclear transcription are strongly 
inhibited at higher labeling densities which resemble the manufacturer’s 
recommended amount of pDNA over volume labeling reagent of 1:1 (w:v). 
These results clearly show that a good balance between fluorescent signal 
and labeling density of the pDNA is crucial in order to reliably study pDNA labeled 
gene lipoplexes during the different steps of the intracellular transfection pathway by 
means of fluorescence based techniques. The assays and protocols presented in this 
study could easily be used to evaluate the effect of labeling on the performance of 
other nucleic acid/carrier combinations and labeling techniques. 
MATERIAL AND METHODS 
Cell Culture 
A HeLa cell line was maintained at 37°C (5% CO2) in Dulbecco's modified 
Eagle's medium supplemented with growth factor F12 (DMEM:F12 (1:1)), 10% heat 
inactivated fetal bovine serum (FBS), 2 mM L-glutamine and 100 µg/ml 
penicillin/streptomycin. All cell culture reagents were purchased from GibcoBRL 
(Merelbeke, Belgium). 
Plasmid DNA Preparation and Fluorescent Labeling of Plasmid DNA 
gWIZ-GFP plasmids were purchased from Genlantis (San Diego, USA). The 
plasmids, expressing green fluorescent protein (GFP), were amplified in E. coli and 
isolated from a bacteria suspension using a Purelink HiPure Plasmid DNA Gigaprep 
kit K2100 (Invitrogen, Merelbeke, Belgium). Plasmid concentration measurements at 
a wavelength of 260 nm were performed on a NanoDrop 2000c (Thermo Fisher 
Scientific, Rockford, IL, USA) . The A260/A280 ratio was measured to assess the purity. 
25 µl aliquots at 1 µg/µl were prepared and stored at -20°C. 
Covalent labeling of Cy5 molecules to the plasmids was performed according 
to the protocol provided by the manufacturer (Label IT kit, Mirus Bio Corporation, WI, 
USA). Briefly, Label IT reagent, the volume depending on the labeling density, was 
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mixed with 12 µl of pDNA and 5 µl 10 x Reaction buffer and subsequently adjusted 
with nuclease free water to a reaction volume of 50 µl. The reaction mixture was 
incubated overnight in the dark at room temperature. DNA:Cy5 ratios of 1:1, 2:1, 4:1, 
6:1, 10:1, 20:1, 50:1 and 100:1 (w:v) were prepared. In Slattum (2003)21, it is stated 
that a 1:1 (w:v) labeling density labels on average one base every 60 base pairs. We 
therefore assumed the previous mentioned ratios to be corresponding with on 
average 100, 50, 25, 16.7, 10, 5, 2 and 1 label per plasmid. Ethanol precipitation was 
used for DNA extraction and the precipitated DNA was reconstituted in HEPES buffer 
(20 mM HEPES, pH 7.2). 
The intercalating dimeric cyanine nucleic acid stain TOTO-3 was used, as an 
alternative labeling method, according to manufacturer’s instructions (Invitrogen, 
Molecular Probes, Merelbeke, Belgium). TOTO-3 iodide (1 mM in DMSO) was added 
to the pDNA and incubated overnight at room temperature in the dark. The 
fluorescently labeled DNA was then recovered using ethanol precipitation and 
reconstituted in HEPES buffer. 
Liposome and Lipoplex Preparation 
Lipoplexes were obtained by mixing Lipofectamine 2000 (Invitrogen, 
Merelbeke, Belgium) and pDNA in a Lipofectamine - DNA ratio of 5:1 (v:w) in HEPES 
buffer according to the protocol (Invitrogen, Merelbeke, Belgium). A DNA 
concentration of 0.02 µg/µl complex was used throughout the experiments. 
Anionic liposomes were obtained by mixing phosphatidyl choline, DOPE and 
phosphatidyl serine (PS) in a 6/3/1 molar ratio in a chloroform/methanol solution 
(50:50). A lipid film is obtained by drying under vacuum. 1 ml of HEPES (20 mM 
HEPES, pH 7.2) was subsequently added for re-suspension and the mixture was 
vortexed for uniformity. 
Transfection 
HeLa cells were plated 1 day before transfection in 6 or 12 well plates at 
respectively 230.000 and 100.000 cells/well. Incubation of the cells with the 
lipoplexes prepared with pDNA at various labeling densities was done at 1 µg of DNA 
per well (in 500 µl lipoplex solution, prepared as described above) for 4 hours at 
37°C. Afterwards, the cells were washed with phosphate buffered saline (PBS) and 
fresh medium was added for overnight incubation. After 24 hours, the cells were 
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trypsinized and examined by flow cytometry (FACSCalibur, BD Biosciences Benelux 
N.V., Erembodegem, Belgium). 
Cellular Uptake 
HeLa cells were plated 1 day prior transfection in 6 or 12 well plates at 
respectively 230.000 and 100.000 cells/well. Lipoplexes were prepared as described 
above and incubated for 4 hours at 37°C, analogous to a transfection. The cells were 
washed with PBS, trypsinized and suspended in flow buffer (1% bovine serum 
albumin in PBS). The red fluorescence from the plasmids was measured by FACS. 
Alternatively, the cells were analyzed after 4 hours by confocal laser scanning 
microscopy (Nikon EZC1-si, Nikon Instruments Europe B.V., Brussels, Belgium). 
Bright field images were recorded of the cells in combinations with red fluorescent 
images obtained by excitation at 636 nm and emission captured with a 660 nm long 
pass filter. 
Dissociation from the Lipoplex 
Lipoplexes were prepared as described above. 10 µl of a lipoplex solution 
(0.02 µg DNA/µl) was incubated for 20’ at room temperature with different 
concentrations of sodium dodecyl sulphate (SDS) to obtain a total volume of 20 µl. A 
50% sucrose loading buffer was added and the mixture was loaded on a 1% agarose 
gel in 1 x TBE buffer (90 mM Tris-base/90 mM Borate/2 mM EDTA). The gel was run 
for 50’ at 100 V, stained with ethidium bromide and imaged. 
Anionic Vesicle-Induced DNA Release 
Lipoplexes and anionic liposomes were prepared as described above. Quant-
iT PicoGreen reagent (Molecular Probes, Eugene, OR, USA) was 200-fold diluted in 
1 x TE buffer (10 mM TRIS-HCl, 1 mM EDTA, pH 7.2). After initial fluorescence 
measurements, to determine the starting value, a 5-fold molar excess of anionic 
liposomes was added. The fluorescence emission (PerkinElmer 2104 EnVision, ʎex. 
492 nm, ʎem. 535 nm), indicating the amount of accessible DNA, was followed for at 
least 15’. 
Oligonucleotide Leakage Assay 
HeLa cells were plated 1 day prior transfection in CELLview glass-bottom 
dishes (Greiner Bio-One GmbH, Frickenhausen, Germany). Lipoplexes were 
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prepared as described above, but to the solution of plasmid DNA (unlabeled, 10 
labels/plasmid and 100 labels/plasmid), 5 µl of Cy5-labeled oligonucleotides (ODNs) 
at 2 µM was added before complexation. The cells were incubated with these 
complexes for 8 hours at 37°C and 5% CO2. Images were recorded by confocal laser 
scanning microscopy and fluorescence fluctuations for fluorescence correlation 
spectroscopy (FCS) were recorded with a Compact FCS Upgrade Kit (PicoQuant 
GmbH, Berlin, Germany) on the Nikon EZC1-si confocal laser scanning microscope 
setup. Cells were imaged with bright field microscopy to determine locations for 
intranuclear FCS measurements. For every condition three 60 s FCS measurements 
were performed in three different nuclei. Autocorrelation curves were calculated from 
time traces with a binning time of 1000 µs and analyzed by a single species fit with 
the triplet-state model incorporated in the SymPhotime Software (PicoQuant GmbH, 
Berlin, Germany) with κ value fixed at 6 for the red channel and 9 for the green 
channel (see Chapter 2 for a more detailed explanation of this model). All 
microscopy images were processed with ImageJ. 22 
Polymerase Chain Reaction 
In vitro amplification of labeled plasmids, was performed using the GoTaq 
Flexi DNA Polymerase protocol (Promega Corporation, WI, USA, revision 03/08) 
using a Polymerase Chain Reaction (PCR) nucleotide mix from Promega Corporation 
(WI, USA). 5’-tggctagcaaaggagaagaac-3’ was used as a forward primer and 5’-
tcatccatgccatgtgtaatc-3’ as the reverse primer. A reaction volume of 50 µl was 
prepared with an initial DNA concentration of 0.2 µg/50 µl. The PCR program 
consisted of 2’ at 95°C, 25 cycles of 45 s at 95°C - 45 s at 59°C – 45 s at 72°C and 
as a final extension step 5’ at 72°C. 
10 µl of PCR product was loaded on a 1% agarose gel prepared in 1 x TBE 
buffer, ran for 50’ at 100 V, stained with ethidium bromide, imaged and analyzed with 
ImageJ. 22 
Nuclear Microinjection 
Microinjection experiments were performed with a Femtojet microinjector and 
an Injectman NI 2 micromanipulator (Eppendorf, Hamburg, Germany) coupled to an 
EZC1-si confocal laser scanning microscope. 24 hour prior to injection, HeLa cells, 
suspended in DMEM F12 phenol red-free cell medium containing 10% FBS, were 
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plated in CELLview glass-bottom dishes (Greiner Bio-One GmbH, Frickenhausen, 
Germany). The dish was placed in a stage top CO2 incubator at 37°C and 5% CO2 
(Tokai Hit Co., Shizuoka, Japan). Injections, in the nuclei of 50 HeLa cells, were 
performed using non-labeled pDNA and labeled pDNA at labeling densities of 10 and 
100 labels/plasmid at a concentration of 10 ng/µl in water. 2h post-injection, confocal 
images were captured in the transmission, green (excitation with 488 nm) and red 
(excitation with 633 nm) channel. 
RESULTS 
Transfection 
pDNA encoding GFP was covalently labeled with Cy5 using the commercially 
available Mirus kit. The labeling density was varied between 0 and 100 labels on 
average per plasmid. Then, labeled plasmids were delivered to HeLa cells using the 
cationic lipid vector Lipofectamine 2000. Transfection efficiency was quantified by 
flow cytometry using the expressed GFP signal. 
Figure 1 A shows the percentage of cells expressing GFP in function of the 
pDNA labeling density. Up to 5 labels per plasmid no significant decrease (p < 0.01) 
in transfection efficiency can be observed when compared to non-labeled pDNA. 
However, a significant decrease (p < 0.05) in transfection efficiency was present 
starting from 10 labels per plasmid. The decrease in transfection efficiency became 
even more pronounced for higher labeling densities. The samples with the highest 
labeling intensities (50 and 100 labels per plasmid) did not show any significant 
transfection (p < 0.01) as compared to the non-transfected control cells (NC). 
The same experiment was repeated using an intercalating fluorescent dye, 
rather than a covalently coupled one. Figure 1 B shows transfection efficiencies in 
HeLa cells transfected with pDNA labeled with TOTO-3. It can be seen that with this 
intercalating dye markedly different results were obtained, with transfection levels 
that are independent from the labeling density. Since we do see an effect of the 
covalent labeling method on transfection, we wanted to know the reason behind this 
observation. To elucidate this, the effect of fluorescent labeling of pDNA on the 
different steps of the transfection process was investigated, as discussed below. 
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Figure 1 Relative transfection efficiency in function of labeling density, where cells transfected 
with unlabeled pDNA represent 100% transfection efficiency. (A) Relative transfection 
efficiency for the covalent labeled plasmids and (B) for the dimeric cyanine-labeled plasmids 
(TOTO-3). HeLa cells were incubated with lipoplexes (Lipofectamine/pDNA 5:1) for 4 hours, and 
green fluorescence was measured 24 hours post-transfection with flow cytometry. NC: 
Negative Control: no plasmids were added. PC: Positive Control: unlabeled plasmids; *: p < 
0.05, **:p < 0.01. All averages obtained from 3 independent transfection experiments with three 
repetitions with error bars representing the standard deviation. 
Cellular Uptake 
The first important step in the transfection pathway is the cellular entry of the 
complexes. Thus, it is of importance to investigate if cellular internalization is 
impeded. Cellular uptake was quantified by determination of the number of cells 
containing lipoplexes (with red fluorescently labeled pDNA) using flow cytometry. In 
Figure 2 A it can be seen that almost 100% of cells contain lipoplexes irrespective of 
the labeling density. Figure 2 B shows the average fluorescence intensity per cell. 
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The linear increase in fluorescence intensity as a function of labeling density, can 
most likely be attributed to the increasing number of labels per plasmid. Confocal 
images (Figure 2 C-D.) confirm that lipoplexes are effectively internalized into the 
HeLa cells (rather than sticking to the outer plasma membrane). Taken together, 
these results show no substantial effect on the cellular uptake of lipoplexes prepared 
with covalently labeled plasmids, regardless of the labeling density. 
 
Figure 2 Cellular uptake measured by the percentage of red fluorescence positive cells, red 
fluorescence intensity, and confocal imaging. HeLa cells were incubated for 4 hours with 
lipoplexes (Lipofectamine/pDNA 5:1) and measured with flow cytometry. (A) Percentage of red 
fluorescent cells was measured in the function of labeling density. The percentage represents 
the relative amount of cells which are associated with labeled pDNA. (B) Red fluorescence 
intensity was measured with FACS in the function of labeling density expressed as labels per 
plasmid. (C,D) Superposition of bright field and confocal images of HeLa cells after 4 hour 
incubation with lipoplexes containing pDNA with, respectively, 100 and 10 labels per plasmid. 
(A) and (B) depict the average values of 3 independent experiments with 3 repetitions. Error 
bars represent the standard deviation on the averages. 
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Dissociation from the Lipoplexes and Implications for Endosomal Escape 
After cellular uptake, which typically proceeds through endocytosis, lipoplexes 
are present in the endosomal compartment. Since the dissociation of pDNA from the 
lipoplex is essential to have free plasmids that potentially induce the expression of 
the target protein, the ability of pDNA to dissociate from a lipid environment was 
investigated using two assays. First, we tested the ability of pDNA to dissociate from 
lipoplexes by the addition of the surfactant SDS, which induces the rupture of 
lipoplexes. pDNA release was measured by agarose gel electrophoresis and 
ethidium bromide staining. Unlabeled pDNA was found to be released from the 
lipoplexes at a concentration of 5 mg/l SDS (Figure 3 A). While the same result was 
found for pDNA with 10 labels per plasmid (Figure 3 B), also intact lipoplexes were 
observed at all concentrations of SDS, indicating that not all DNA dissociated from 
the complexes. At 100 labels per plasmid, no dissociation from the lipoplex was 
observed, not even for SDS concentrations up to 3 g/l (Figure 3 C). It should be 
noted that the same results were obtained when another lipid based carrier such as 
DOTAP/DOPE liposomes were used to complex the plasmid DNA. 
Next, the ability of pDNA to release from lipoplexes upon addition of anionic 
lipids with an endosomal mimicking composition was measured. It is generally 
accepted that the mixing of the lipids from the lipoplexes with the lipid bilayer of the 
endosome is responsible for the release of the cargo in the cytosol. 23-25 Therefore, 
this DNA release assay is generally used to get an insight into the ability of lipoplexes 
to undergo lipid mixing, which is essential for a successful endosomal escape. 7, 26 
Lipoplexes are mixed with anionic liposomes in a solution containing PicoGreen, a 
compound that becomes green fluorescent when intercalated in the DNA double 
strand. When present in a lipoplex, DNA is not accessible and will not contribute to 
the fluorescent signal. However, as the pDNA is displaced from the lipoplexes upon 
adding the “artificial endosomes”, the fluorescent signal is expected to increase. As 
can be seen in Figure 4, the rate and the extent to which DNA is released clearly 
differs for different labeling densities. About 15 min after addition of the anionic 
liposomes, we observed around 70% release for unlabeled pDNA, 60% for pDNA 
with 10 labels per plasmid, and only around 20% for pDNA with 100 labels per 
plasmid when compared to the signal expected for free pDNA of the same labeling 
density. 
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Figure 3 Image of the 1% agarose gel of lipoplexes (Lipofectamine/pDNA 5:1) after addition of 
SDS and incubation for 20 min at room temperature. (A) Unlabeled pDNA. (B) pDNA containing 
10 labels per plasmid. (C) pDNA containing 100 labels per plasmid. pDNA control: pDNA diluted 
with HEPES buffer. SDS control: 500 mg/l of SDS in HEPES. Representive image of three 
independent experiments. 
To investigate if the lipoplexes are still able to interact with the endosomes and 
release cargo, an ODN leakage assay was performed. 27 Unlike pDNA, free ODNs 
are known to rapidly accumulate in the cell nucleus. 28, 29 The presence of ODNs in 
the nucleus of the cell thus indicates that endosomal escape and release of the 
ODNs from the liposomes has taken place. pDNA and labeled ODNs were co-
complexed and incubated on cells for 8 hours. Confocal images (Figure 5) showed 
that independent of the labeling density of the co-complexed pDNA, most of the cells 
displayed a uniform red signal in the nucleus. This indicates that labeled nucleic 
acids are able to escape the lipoplex as well as the endosomal compartment for all 
plasmid labeling densities. 
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Figure 4 Accessibility of pDNA toward PicoGreen in lipoplexes after addition of an anionic lipid 
mixture at t = 400 s. pDNA was complexed with Lipofectamine (LF/DNA, 5:1 (v/w)). The anionic 
lipid mixture was composed of Phosphatidyl Choline/DOPE/PS (6:3:1 molar ratio) and added to 
the liposomes in a 5-fold molar excess, as indicated with the arrow. Results are shown relative 
to the green fluorescence measured for free pDNA of the same labeling density. (●) unlabeled 
pDNA. (■) labeled pDNA containing 10 labels per plasmid. (▲) labeled pDNA containing 100 
labels per plasmid. Averages are calculated based on three independent experiments with 
three repetitions. Error bars are the standard deviation on the average. 
The diffusion coefficients of the red signal, as investigated by FCS, for the 
samples with 10 and 100 labels per plasmid, at respectively 7.88 ± 2.89 µm²/s and 
8.07 ± 2.09 µm²/s, were in accordance with the unlabeled pDNA sample, where only 
the ODNs were labeled, at 8.32 ± 3.36 µm²/s (Figure 6). This confirms that only 
released ODNs are responsible for this red fluorescent signal in the nucleus, since 
the presence of pDNA would induce a decrease in diffusion coefficient. As FCS can 
also detect the expressed GFP, also green autocorrelation curves were recorded in 
the nuclei of the transfected cells. In agreement with Figure 1, only the non-labeled 
plasmid DNA and the plasmid containing on average 10 labels were able to induce 
GFP expression (Figure 6). 
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Figure 5 Cy5-labeled oligonucleotide leakage assay. HeLa cells were incubated during 8 hours 
with lipoplexes containing Cy5-ODNs mixed with plasmids which are unlabeled, contain 10 
labels per plasmid, or contain 100 labels per plasmid. (Red channel) Cy5-ODNs and Cy5-pDNA 
signal. Only free ODNs accumulate in the nuclei of the cells. Nuclei are indicated with white 
arrows. (Green channel) GFP expression of the corresponding formulations. 
Taken together, our experiments indicate that labeled plasmid DNA has a 
higher affinity for lipid structures resulting in the inhibition of pDNA release from these 
structures, but without disturbing the intrinsic capabilities of the lipoplex to promote 
endosomal escape. Upon interaction of the lipoplexes with the endosomal 
membrane, however, pDNA with a higher labeling density will most likely not be 
released from the lipoplexes, in contrast to pDNA with lower labeling density or the 
shorter ODNs. 
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Figure 6 Representative autocorrelation curves derived from intranuclear FCS measurements. 
Left: derived from red fluorescent fluctuations. Right: derived from green fluorescent 
fluctuations. Diffusion coefficients calculated based on three measurements in three separate 
nuclei. 
Transcription 
To verify the effect of the labeling on the transcription properties of pDNA, in 
living cells, 50 nuclei of HeLa cells were microinjected with pDNA encoding for GFP. 
Confocal images were acquired immediately and 2 hours post-injection (Figure 7 A-
C.). In 90% of the cells injected with non-labeled plasmids, expression of GFP was 
observed after 2 hours. pDNA labeled with a density of 10 labels per plasmid showed 
green fluorescent protein expression in 50% of the injected cells after 2 hours, 
whereas in the case of 100 labels per plasmid expression of GFP was never 
observed, not even 24 hours after injection. These microinjection experiments clearly 
demonstrate the impairment of transcription by the random covalent attachment of 
labels to plasmids. It should be noted that the results obtained with microinjection are 
closely related to the results obtained from the transfection experiments. 
As an alternative technique, in vitro amplification of the plasmids was 
performed using semi-quantitative PCR. In Figure 7 D, the amplification is shown in 
relation to the labeling density of pDNA relative to unlabeled pDNA. A significant 
decrease is found starting from 25 labels per plasmid. All labeling densities, however, 
retain at least 30% of their amplification properties. Thus, although PCR acts as a 
fast assay to observe changes in the availability to transcriptionally active enzymes, 
like polymerase, it underestimates the effect of the labeling in living cells, when 
compared to nuclear injections. 
CHAPTER 3 | EFFECT OF COVALENT FLUORESCENCE LABELING OF PLASMID DNA ON ITS 
INTRACELLULAR PROCESSING AND TRANSFECTION WITH LIPID-BASED CARRIERS 
PAGE | 112 
 
Figure 7 Transcription of the labeled green fluorescent protein construct was tested by nuclear 
microinjection and a PCR assay was used to check for availability to transcriptionally active 
enzymes. (A–C) Confocal images of HeLa cells 2 hour after nuclear injection with (A) non-
labeled pDNA, (B) pDNA containing 10 labels per plasmid and (C) pDNA containing 100 labels 
per plasmid. Green: GFP expression. Red: fluorescently labeled plasmids. (D) Relative 
amplification in a PCR reaction of pDNA at different labeling densities. PC: Positive Control: 
Unlabeled pDNA. ** p < 0.01. Averages in (D) are based on three independent experiments with 
error bars depicting the standard deviation on the average. 
DISCUSSION 
The administration of pDNA to cells to induce protein expression is used in a 
variety of applications. In non-viral gene delivery, cationic polymers or liposomes are 
used to deliver the nucleic acids to the cells. Then, different extra- and intracellular 
barriers need to be overcome before protein expression is obtained. Fluorescent 
labeling of pDNA is frequently done, as fluorescence microscopy based techniques 
are widely used with respect to understanding the intracellular processing in drug 
delivery. The effect of the labeling itself on the intracellular behavior is however often 
overlooked. In this study the effect of random covalently attaching Cy5 fluorophores 
to pDNA on the transfection efficiency with lipid-based carriers in HeLa cells is 
assessed. The main questions raised in this work are: which labeling densities of 
plasmid DNA are still representative for the native pDNA molecule and at which point 
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in the transfection pathway do the used labeling densities start to alter the 
intracellular processing of gene complexes prepared with labeled pDNA and 
liposomes. To answer these questions, we performed a series of assays that mimic 
the different steps of the intracellular processing. Cy5 labeled pDNA, complexed with 
Lipofectamine 2000 as a carrier, was used throughout this study. 
We found that for labeling densities assumed to be lower than 10 labels on 
average per plasmid, the transfection pathway of lipoplexes can be considered 
unaffected (Figure 1 A). Transfection efficiency was affected dramatically, however, 
for a labeling density starting from 10 labels per plasmid. Since the average length of 
the pDNA used was about 5800 base pairs, this implies that on average one 
fluorophore every 580 base pairs already influences the intracellular processing of 
the pDNA when complexed in lipoplexes. 
Several experiments were conducted to verify which critical points in the 
transfection pathway with lipid-based carriers were affected at these higher labeling 
densities. The first step in the transfection pathway is the cellular uptake, which could 
be measured using flow cytometry. In case of the Lipofectamine complexes, uptake 
was not affected for any labeling density as more than 90% of the cells take up the 
plasmid DNA (Figure 2). This most likely can be explained by the fact that the 
plasmids, and thus the fluorophores, are inside the lipoplexes, covered by one or 
more lipid layers. Evidently, this might be different for other types of lipo or polyplexes 
and needs to be investigated on a case-by-case basis. A control by confocal 
microscopy was added to verify if all complexes are effectively internalized, rather 
than being bound to the outer plasma membrane. It should be noted here that no 
nuclear or cellular membrane stain was used in this microscopy experiment, so 
based on these images, we cannot be sure that the lipoplexes are inside the cells. 
Figure 5 confirms however that the lipoplexes with labeled pDNA are indeed inside of 
the cell. 
When the lipoplex is taken up by the cell, it is entrapped in the endosomal 
compartment. Without endosomal escape, the contents of the endosomes will 
eventually be digested by lysosomal degradation of the cell. It has been suggested 
that lipid-based carriers escape from the endosomal compartment by lipid mixing with 
the endosomal membrane, thereby releasing free pDNA in the cytoplasm of the cells. 
23-25
 To ensure release, the affinity of pDNA for the lipids should not be too high. We 
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found however, that dissociation of plasmids containing 100 fluorophores per plasmid 
from the lipoplexes, after addition of SDS (Figure 3) and anionic lipids (Figure 4), is 
not as efficient as for plasmids bearing 10 or no labels per plasmid. A possible 
reason for this impaired release can most likely be found in the increase of 
hydrophobicity of the labeled pDNA compared to unlabeled pDNA. As each 
fluorophore introduces a certain level of hydrophobicity, the affinity of the plasmid for 
the lipids (either those of the liposomes or the endosomal membrane) increases. 
Therefore, the ability to escape lipid structures like liposomes and endosomes can be 
challenging for labeled plasmids. 
In 2013, endosomal escape events in living cells were observed directly for the 
first time for gene complexes using state of the art microscopy equipment and a 
specific labeling method. 27 Here the complexes were prepared by a mixture of PEI 
and fluorescently labeled ODNs. As long as the endosome was intact, ODN 
fluorescence was quenched. When endosomal escape occurs, a burst in 
fluorescence is observed due to dequenching of the fluorescence. In the case of 
lipid-based carriers, this quenching does not occur, but released ODNs gradually 
accumulated in the nuclei of the cells, demonstrating their endosomal escape and 
release from the lipoplexes. Using this methodology, in living cells we found that 
regardless of the labeling density of the co-complexed plasmid DNA, all formulations 
showed fluorescent nuclei, demonstrating that lipid mixing, and thus release of cargo 
out of the lipoplex, can still occur (Figure 5). This indicates that the first step of 
endosomal escape, namely lipid mixing with the endosomal membrane, is most likely 
not affected. The higher affinity of the labeled pDNA for the lipid vesicles may lead, 
however, to a decreased or inhibited release into the cytosol during this endosomal 
escape event. As the amount of free pDNA in the cytoplasm most likely relates to the 
obtained transfection efficiencies, 30, 31 the higher affinity for lipid structures could be 
attributing to the decreased transfection efficiencies observed in Figure 1. 
The assay which induces dissociation of pDNA from the liposomes by SDS 
can be modified for polyplexes. The adjuvant used must then be selected based on 
the dissociation mechanism of the polyplexes. The anionic lipid release assay was 
used as an in vitro DNA release assay to study the lipid mixing and ability to release 
free pDNA of a carrier which, for lipid-based carriers, could give an indirect indication 
of endosomal escape properties. Live intracellular measurements, like the ODN 
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release assay, give additional insight into the cellular endosomal escape. One should 
keep in mind, however, that it is the escape of small ODNs that is observed, rather 
than the pDNA itself. Other options like dual-color colocalization of pDNA with the 
endosomal membrane, 32 are potentially interesting, but again imply the labeling of 
the pDNA itself. Therefore, this method was not applicable to compare both the 
labeled and non-labeled plasmid DNA that was used in this study. It should also be 
noted that the co-complexation was not verified, meaning that we are not sure that all 
lipoplexes contain both pDNA and ODNs. The fluorescent signal in the nucleus could 
therefore be coming from lipoplexes that only contain ODNs. The co-complexation 
could be checked by using red labeled pDNA and green labeled ODNs and 
inspecting the colocalization via confocal microscopy or FCS. 
The final step in a successful transfection pathway is the transcription of the 
plasmids in the nucleus of the cells. The in vitro amplification of pDNA with higher 
labeling densities was affected, suggesting there might be hindrance of the 
enzymatic interaction between DNA polymerase and the DNA backbone. It should 
however be noted that PCR is an assay for DNA amplification, rather than 
investigating the transcription process. Therefore nuclear injections of non-labeled 
and labeled pDNA were performed, directly following transcription in living cells 
(Figure 7 A-C). While 90% of cells injected with non-labeled pDNA expressed GFP, 
the levels decrease to 50% and 0% when plasmids with respectively 10 and 100 
labels attached were used. Transcription is thus clearly impaired when using higher 
labeling densities. It should be noted that the percentages of GFP positive cells 
found, corresponded well to the levels observed in Figure 1. These results point out 
that independent from the used carrier – pDNA combination, covalent labeled Cy5 
pDNA that reaches the nucleus will never be efficiently transcribed, when high 
labeling densities are used. 
Another factor that can lower the transfection efficiency is the fact that labeled 
plasmids are excluded from the nucleus of the daughter cells after mitosis, as was 
observed by Gasiorowski and Dean 10, thereby limiting the time frame in which they 
can be transcribed. Although we cannot exclude that nuclear entry of labeled pDNA 
is also impaired, several authors have seen that nuclear inclusion of labeled pDNA 
did not seem to be a problem. 8, 33 
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As shown in this study, the highest labeling density of pDNA, which is the 
recommended density by the manufacturer, can only be used to follow the first step 
in the transfection pathway, namely cellular uptake. Trying to tackle for example the 
question of where and when endosomal escape of these labeled pDNA molecules 
takes place, is however impossible. This could explain why the mechanism of 
endosomal escape has never been clearly visualized in literature before, as the 
affinity of the labeled pDNA for the endosomal membranes may prevent these 
endosomal escape events, which do occur for non-labeled pDNA molecules. 
Interference of your DNA labeling with the intracellular trafficking might be 
prevented in a number of ways. Other means of fluorescent labeling, such as 
intercalating dyes could be a valuable alternative 34 next to PNA clamp linked 
fluorophores, 8, 35, 36 chemical labeling, 37 enzymatic labeling, 38 etc. Another option is 
label-free imaging, which however still comes with some problems. 39 It should be 
noted that intercalating dyes had no effect on the level of transfection (Figure 1). This 
non-covalent labeling method has, however, as a drawback that the label can 
redistribute and integrate aspecifically into other DNA present in the cell. Therefore, 
intercalating dyes are not an option for intracellular trafficking applications. 
Apart from alternative labeling techniques, also lowering the labeling density of 
the pDNA could be an option for intracellular studies, provided that the fluorescence 
microscopy techniques used are sensitive enough to visualize the labeled pDNA. 
Fluorescence Correlation Spectroscopy and Single Particle Tracking (SPT) are 
promising techniques for this purpose (see Chapter 2 for a background on both 
techniques). 40 We have shown previously that FCS in combination with confocal 
microscopy could be used to follow the delivery and degradation of antisense 
oligonucleotides. 41 Also the dissociation of oligonucleotides from their carrier could 
be studied. 42 It should be noted that in both cases lipid-based carriers were used to 
deliver fluorescently labeled short antisense oligonucleotides. A deterioration in the 
dissociation from the lipid carrier was however not observed. Therefore, the effect of 
labeling will depend both on the type of DNA, the fluorescent labels and the delivery 
carrier used.  
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CONCLUSION 
We found that covalent attachment of Cy5 fluorophores to pDNA affects the 
transfection efficiency of lipid-based carriers on different levels, including an 
increased affinity for lipids, which may have implications for the dissociation from the 
lipoplex and endosomal compartment and most importantly a lowered intrinsic ability 
of the labeled pDNA to be transcribed in the nucleus of the cells. An increase in 
hydrophobicity and steric hindrance of the attached labels may be responsible for the 
quantifiable decrease in transfection efficiency. This points out that when designing 
an experiment where fluorescent microscopy is used to follow biomolecules 
intracellularly, one must balance fluorescent signal strength against the effect of the 
labeling on the cellular processing to prevent biased conclusions. The series of 
experiments that were used in this study to evaluate the intracellular processing of 
pDNA can easily be extrapolated to other labeling techniques and other nucleic 
acid/carrier combinations. Therefore, when one aims to follow fluorescently labeled 
biomolecules intracellular, we strongly recommend to study the effect of the labeling 
on the cellular processing to prevent biased conclusions.  
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ABSTRACT 
Degradation of plasmid DNA (pDNA) in the extracellular and intracellular 
environment is a significant barrier in gene replacement therapy. Viral and nonviral 
carriers can be used to protect the nucleic acids from degradation before they reach 
the cells, but enzymatic degradation in the cytoplasm of the cell may decrease the 
number of functional pDNA molecules that reach the nucleus. Fluorescence 
correlation spectroscopy (FCS) and single particle tracking (SPT) are both 
microscopy-based methods that give information on the diffusion and concentration 
of fluorescently labeled molecules in a solution. Here, we evaluate the use of these 
two advanced microscopy methods to detect the degradation of fluorescently labeled 
pDNA in a cellular environment. pDNA degradation results in a decrease in the 
concentration of intact pDNA, while the concentration of smaller fragments increases. 
Both techniques could be successfully used to measure the concentration of intact 
pDNA in a buffer solution. However, when pDNA degradation was induced by adding 
DNase I, FCS was not capable of retrieving the correct percentages of intact pDNA, 
while SPT could. SPT was finally used to follow plasmid degradation in a cellular 
environment. Fluorescently labeled pDNA was first delivered into cells by lipofection. 
Next, cell lysate was obtained at different time points and the concentration of intact 
pDNA was determined by SPT. The results showed that pDNA is significantly 
degraded already 8 hour after lipofection and is almost fully degraded after 24 hour. 
These results indicate that SPT is well-suited to investigate the degradation of pDNA 
in biological media like cell lysates. 
 
  
ADVANCED MICROSCOPY METHODS FOR DETECTING PLASMID DNA DEGRADATION IN A 
BIOLOGICAL ENVIRONMENT | CHAPTER 4 
PAGE | 125 
INTRODUCTION 
Plasmid DNA (pDNA) is a large, circular double-stranded DNA molecule with 
the potential to induce protein expression when delivered to the nucleus of living 
cells. As DNA by itself does not efficiently cross the cell membrane, it is mostly 
complexed with a cationic delivery system to guide the pDNA into the intracellular 
environment. Apart from cellular uptake, the carrier system also offers protection to 
the pDNA against degradation. As pDNA degradation abolishes the possibility to 
transcribe the pDNA sequence into the corresponding mRNA and thus the further 
translation into proteins, it is clear that pDNA degradation should be avoided during 
each step of the delivery process. Surprisingly, there are only very few techniques 
that can measure the degradation of pDNA during its extracellular and intracellular 
journey. To date, the stability of pDNA and pDNA complexes is mostly studied by gel 
electrophoresis. This technique, however, does not allow to measure degradation of 
pDNA directly in complex biologic environments. The presence of free DNA and other 
biomolecules in these environments will generate a background in which the pDNA’s 
signal is lost. Hence, there is a need for more advanced methods to follow the 
degradation of large nucleic acids such as pDNA in complex biological fluids and 
living cells. It should be noted that progress in quantitative polymerase chain reaction 
(qPCR) methods allow measurements in undiluted biological samples after an 
adjustment of the reaction conditions. 1 
Since its introduction, traditional fluorescence microscopy has raised itself as a 
cornerstone in life science research. Fluorescence microscopy employs cell staining 
and labeling of molecules to visualize cell morphology, or 2D (and 3D) structure. The 
most commonly found microscopy setups are wide field and confocal scanning laser 
microscopes. Due to the limited resolution of optical microscopy, however, direct 
visualization of the degradation of a 200 – 400 nm sized plasmid is virtually 
impossible. Instead, these microscopy techniques can be used to determine the size 
of molecules indirectly by diffusion measurements. 2 In particular, we evaluated 
fluorescence correlation spectroscopy (FCS) and single particle tracking (SPT) for 
their potential to follow the degradation of pDNA molecules in a complex biological 
fluid, by studying the dynamics of single fluorescently labeled pDNA molecules and 
their degradation products. 
CHAPTER 4 | ADVANCED MICROSCOPY METHODS FOR DETECTING PLASMID DNA DEGRADATION IN 
A BIOLOGICAL ENVIRONMENT 
PAGE | 126 
In FCS, a temporal correlation is measured between fluctuations in 
fluorescence intensities coming from molecules moving into and out of a confocal 
detection volume (~1 fl). From these fluctuations, the dynamic properties of the 
fluorescent molecules in solution can be obtained, including the concentration and 
the diffusion coefficient (which is inversely proportional to the molecule’s 
hydrodynamic size) (see Chapter 2). 3, 4 FCS has proven to be a valuable tool to 
follow the degradation of small antisense oligonucleotides, both in buffer and in living 
cells. 5 Hence, we were interested to know whether it is possible to study the 
degradation of larger nucleic acids such as pDNA by FCS. Theoretically, the 
degradation of pDNA into shorter fragments should lead to an increase of the 
average diffusion coefficient in function of time, as well as a decrease in the 
concentration of intact pDNA. 
Apart from FCS, also SPT was evaluated for its potential to follow pDNA 
degradation. In SPT, as the name indicates, single particles are tracked in 
microscopy video recordings (see Chapter 2). 2 The recorded movies are analyzed 
to determine the motion trajectories of the fluorescent particles. 6, 7 Based on these 
trajectories, the diffusion coefficients 8 and, via the Stokes-Einstein equation, the 
hydrodynamic diameter can be measured on a single particle level. 9-11 In addition, 
the nanoparticle concentration can be accurately determined as our group has 
recently demonstrated. 12-14 For speed and sensitivity SPT is typically performed on a 
wide field laser microscope with a fast and sensitive camera (e.g. EMCCD). We 
recently demonstrated, however, that SPT concentration measurements are better 
performed with a microscope configuration that avoids out of focus fluorescence. 15 
Therefore, in this work we have performed SPT experiments on a swept-field 
confocal microscope (SFC), which offers excellent speed and sensitivity while 
reducing out-of-focus light. 
The ability of FCS and SPT to measure molecular concentrations and 
dynamics in complex biological fluids makes both of them interesting for a broad 
range of applications in life sciences. 16, 17 In this paper, we investigate the use of 
FCS and SPT to study degradation of pDNA in a biological environment. pDNA 
degradation is one of the potential bottlenecks to efficient gene therapy. Our results 
show that SPT is the most suited to measure the concentration of intact pDNA in a 
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biological environment. We demonstrate that the degradation of pDNA can be 
accurately measured by SPT after it was delivered into cells by lipofection. 
MATERIALS AND METHODS 
Cell Culture 
A HeLa cell line was cultured at 37°C and 5% CO2 in Dulbecco’s modified 
Eagle’s Medium and growth factor F12 (1:1 DMEM:F12) supplemented with 10% 
heat-inactivated fetal bovine serum (FBS), 100 µg/ml penicillin/streptavidin and 2 mM 
L-glutamine. All cell culture reagents were ordered at GibcoBRL (Merelbeke, 
Belgium). 
Plasmid DNA Preparation 
gWIZ-GFP plasmids, expressing the green fluorescent protein (GFP) were 
purchased from Genlantis (San Diego, CA, U.S.A.). The plasmids were amplified in 
Escherichia coli and isolated from the bacteria suspension using the Qiafilter Plasmid 
Giga Kit (Qiagen, Venlo, The Netherlands). DNA concentration and purity was 
determined by UV absorption at 260/280 nm using the NanoDrop 2000c (Thermo 
Fisher Scientific, Rockford, IL, USA). The plasmids were suspended and stored in  
20 mM HEPES buffer (pH 7.2) at a final concentration of 1 µg/µl. Fluorescent labeling 
with Cy5 was performed using the Label-IT nucleic acid labeling kit (Mirus Bio LLC, 
Madison, WI, U.S.A.) at a pDNA to Label-IT reagent ratio of 10:1 (w:v). Free label 
was removed via ethanol precipitation. Briefly, 2.5 volumes of ice-cold ethanol and 
0.1 volume of 5 M NaCl were added to the labeled pDNA and kept at -80°C for 30’. 
The samples were centrifuged at 18000 x g at 4°C for 30’. The pellet is washed with 
70% ethanol and centrifuged again at maximum speed for 10’. Labeled plasmids 
were resuspended in 20 mM HEPES buffer (pH 7.2) and the concentration and purity 
was determined by UV absorption at 260/280 nm. 
Plasmid DNA Standard Curve 
A standard array of concentrations between 0 and 33 ng/µl was obtained by 
diluting the stock solution of Cy5-pDNA in 20 mM HEPES buffer (pH 7.2). From this 
array 50 µl was used for either gel electrophoresis or FCS and SPT, as advanced 
microscopy methods. For FCS, (PicoQuant, Berlin, Germany) 10 different spots in 
the solution were measured for 60 seconds and analyzed for each measurement. 
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The analysis was performed in the FCS software (SymPhoTime, PicoQuant, Berlin, 
Germany) and consists of the calculation of an autocorrelation curve for every 
recording. The obtained autocorrelation curves are then fitted with the correlation 
model: “Triplet-state” as described in Chapter 2 and the diffusion coefficient is fixed 
at 3.23 µm²/s for intact pDNA and 120 µm²/s for degraded pDNA. This fit returns 
values for the molecular concentration of each species in the solution during the 
measurement. Alternatively peak analysis was performed directly on the fluorescence 
intensity fluctuations recorded over time. Intact pDNA shows high intensity peaks, 
when passing through the detection volume. The number of times a signal, higher 
than the baseline, is detected, can be correlated with the concentration of intact 
pDNA in the solution. The baseline is set just above the maximal value for the fully 
degraded pDNA sample. 
For SFC (Nikon Instruments Europe B.V., Brussels, Belgium) 10 movies of  
200 frames were captured and analyzed in three steps using proprietary software in 
Matlab (The MathWorks, Inc., Natick, Massachusetts, U.S.A.). First, for every frame 
contours are plotted to identify fluorescent labeled pDNA molecules. Secondly, tracks 
are created for every movie, based on the calculated contours. Lastly, based on 
these tracks, concentrations in particles/ml were calculated according to the method 
described by Röding et al. (2011)12. Both analysis methods have been described in 
detail in Chapter 2. 
Measuring Intact Plasmid DNA 
Cy5 pDNA was fully degraded by the addition of DNase I (2 U/µl) (Invitrogen, 
Merelbeke, Belgium) and a 1 x degradation buffer during 30’ at 37°C, according to 
the manufacturer’s protocols. Mixtures of non-degraded (intact) and fully degraded 
Cy5 pDNA were prepared to have 0/100, 20/80, 40/60, 50/50, 80/20 and 100/0% of 
intact/degraded pDNA for FCS measurements and 0/100, 10/90, 25/75, 40/60, 50/50, 
60/40, 75/25, 90/10 and 100/0% of intact/degraded pDNA, for SFC recordings. Every 
sample was subsequently measured as described for the standard curve. 
DNase I Plasmid DNA Degradation Experiment 
First, DNase I (2 U/µl) (Invitrogen, Merelbeke, Belgium) was diluted in a 1 x 
degradation buffer (Invitrogen, Merelbeke, Belgium) in Nuclease-Free water (Ambion, 
Merelbeke, Belgium) to a concentration of 0.06 U/µl. Secondly, a 100 ng/µl Cy5 
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labeled pDNA solution was prepared in the same 1 x degradation buffer and 
thermostated in a heat block (VWR International, Leuven, Belgium) at 37°C. 
The DNase I solution was subsequently added to the pDNA solution resulting 
in 0.03 U/µg of pDNA. To follow the degradation in function of time, 10 µl of this 
solution was added to 40 µl of DNase I inhibitor solution (0.1 M Iodoacetate, 10 mM 
Tris-HCl, 50 mM EDTA, pH 7.4) on ice at time points 0’, 1’, 2’, 5’, 10’, 15’, 20’, and 
30’. 2 µl of these solutions was mixed with 3 µl of gel loading buffer (Ambion, 
Merelbeke, Belgium) and loaded onto a 1% agarose gel (UltraPure™ agarose, 
Invitrogen, Merelbeke, Belgium) supplemented with GelRed (Biotium, Hayward, CA, 
U.S.A.). After running the gel 50’ at 100 V, a picture of the gel was taken under UV 
light and analyzed using ImageJ. 18 FCS measurements and SFC microscopy were 
performed on the remaining 48 µl of the pDNA solutions, like described above. 
Intracellular Degradation 
Two 6 well plates were seeded with HeLa cells at 150,000 cells/well and the 
cells were allowed to grow overnight. The next day, complexes were prepared with 
Cy5-pDNA in 20 mM HEPES buffer (pH 7.2) and Lipofectamine 2000 in a 3:1 ratio 
(v:w) (Lipofectamine:pDNA). These complexes were then diluted in optiMEM and 
added to the cells at a concentration of 500 ng pDNA/50,000 cells and the plates 
were incubated at 37°C in an incubator for 4 hours. After 4 hours all cells were 
washed with Phosphate Buffered Saline (PBS) (-/-) and cell lysate was prepared from 
two wells of each plate with RIPA buffer (Sigma Aldrich, Bornem, Belgium) as 
described in the protocol. Briefly, cells were trypsinized for 5’ whereafter fresh cell 
medium was used to inhibit trypsin. Cells were collected by centrifugation at 1800 x g 
for 5’, the pellet was washed with PBS (-/-) and again spun down at 1800 x g. The 
supernatant was removed and the cells were resuspended in 1 ml of ice-cold RIPA 
buffer and incubated for 30’ on ice. After 30’, the solution was forced through a 20 
gauge needle to further break up the cells and placed back on ice. After 30’ the 
solution was spun down for 10’ at 10,000 x g and at 4°C. The supernatant can be 
stored at -80°C until microscopy measurements. The cell lysate obtained from the 
first two wells serves as the 4 hour time point. To obtain the 8 hour and 24 hour time 
point to follow plasmid DNA degradation, fresh medium was supplied to the 
remaining wells and one series of samples was kept on ice, from this point, in order 
to induce low enzymatic activity, while the other samples were incubated again at 
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37°C which should yield normal enzyme activity. After 8 hours and 24 hours, cell 
lysate was collected from two wells of each plate and stored at -80°C until the 
samples were measured. For all cell lysates, protein concentration was measured 
using the Pierce™ BCA protein assay kit (Thermo Scientific, Erembodegem, 
Belgium) to compensate for the amount of cells the cell lysate originated from. The 
intact plasmid concentration was measured in each cell lysate by agarose gel and 
SPT. pDNA concentrations were compensated for the amount of cells in the sample 
by equalizing to the measured total protein concentrations. 
RESULTS 
Figure 1 shows FCS and SPT measurements on fully intact and fully degraded 
pDNA solutions. The intact pDNA used in this study, was fluorescently labeled with 
the Mirus kit at a labeling density of 10 fluorophores per plasmid, which means on 
average one fluorophore per 600 base pairs. 19 After degradation, we expect that 
single labeled degradation fragments are formed. FCS measurements on the intact 
pDNA show high intensity fluorescence peaks each time a plasmid passes the 
confocal detection volume. Autocorrelation analysis gives a diffusion coefficient of 
3.23 ± 0.92 µm²/s, which corresponds to particles with on average a hydrodynamic 
size of 68 nm. When pDNA was degraded by the addition of DNase I, the highly 
intense fluorescence peaks disappeared as expected. Autocorrelation of these 
fluorescence fluctuations confirmed the presence of faster (i.e. smaller) degradation 
products, with an average diffusion coefficient of 120 ± 36 µm²/s, corresponding to 
molecules with on average a size of 1.8 nm. Also SPT was able to distinguish fully 
intact from fully degraded pDNA molecules. Intact pDNA was bright enough to be 
seen as individual particles. SPT diffusion analysis revealed an average diffusion 
coefficient of 2.29 ± 0.42 µm²/s. On the SPT image of degraded pDNA, however, no 
individual particles could be seen any more so that diffusion analysis was no longer 
possible.
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Figure 1 Overview of FCS and SPT measurements for intact and degraded pDNA. For FCS, fluorescence intensity fluctuations and autocorrelation 
curves are shown. For SPT, an overlay of tracks on a still from a movie and the distribution of diffusion coefficients are shown. 
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Standard Curves for Intact Plasmid DNA Solutions with Known 
Concentration 
Having shown that both FCS and SPT can detect intact pDNA, the next step is 
to evaluate their potential to measure the concentration of intact pDNA. A 
concentration series was prepared from a stock solution of intact pDNA from 0 to 33 
ng/µl. For FCS, the concentration of intact pDNA was determined by analyzing the 
autocorrelation curves with a single species fit in which the diffusion coefficient of the 
single species was fixed to 3.23 µm²/s according to the measurements on intact 
pDNA (vide supra). For SPT, the number concentration of intact pDNA molecules 
was calculated following the method of Röding et al. (2011)12 (see Chapter 2). Figure 
2 shows that SPT yields a slightly better correlation for the trend line (R = 0.98) when 
compared to FCS (R = 0.94). 
 
Figure 2 (A) Standard curve of measured DNA concentration in particles/ml derived from the 
autocorrelation curve after FCS measurement. Averages were based on two independent 
experiments with ten repetitions per sample. Error bars depict the standard deviation on the 
average. (B) Standard curve of measured concentration in particles/ml with SPT. Averages 
were based on three independent experiments with ten repetitions per sample. Error bars 
depict the standard deviation on the average. 
Measuring the Fraction of Intact Plasmid DNA in Mixed Intact/Degraded 
pDNA Solutions 
The standard curves above demonstrate that it is possible to measure the 
concentration of pDNA in a solution containing only intact pDNA. When pDNA 
degrades, however, smaller fragments will arise as well. To determine whether FCS 
ADVANCED MICROSCOPY METHODS FOR DETECTING PLASMID DNA DEGRADATION IN A 
BIOLOGICAL ENVIRONMENT | CHAPTER 4 
PAGE | 133 
and SPT are still able to detect the amount of intact pDNA in these more complex 
solutions, we prepared mixtures of intact and degraded pDNA at known ratios. The 
FCS data was analyzed in two ways, i.e. by autocorrelation analysis and by peak 
analysis. For autocorrelation analysis a 2 species fit was performed, for which the 
diffusion coefficients of 100% intact pDNA and fully degraded pDNA were fixed to 
3.23 µm²/s and 120 µm²/s, as determined before. The autocorrelation fit then returns 
the relative fractions of both components. In Suppl. Figure 1, the autocorrelation 
curves are depicted. From Figure 3 A it is clear that this procedure leads to an 
overestimation of intact pDNA. In the analysis method in the FCS software, the 
intensity of the particles could not be taken into account. This potentially contributes 
to the overestimation of the intact plasmids. As an alternative to autocorrelation 
analysis, we analyzed the number of intense peaks in the FCS time traces, which 
correspond to the diffusion of intact pDNA through the detection volume (cf. Figure 
1). Interestingly, fluorescence peaks do not appear in the fluorescence fluctuations 
recorded from a fully degraded pDNA sample. To calculate the percentage of intact 
pDNA from the fluorescence fluctuations profile, the baseline was set above the 
maximum fluorescence intensity obtained for fully degraded pDNA. Then, the number 
of peaks arising above this baseline was determined relative to the number of peaks 
in the intact sample. Figure 3 A shows that calculating the number of peaks clearly 
produces better results than autocorrelation analysis which could be fitted with a high 
correlation by a linear trend line (R = 0.99). In parallel we performed SPT analysis, 
which is based on the assumption that only intact pDNA will be bright enough to be 
visible as individual particles. Figure 3 B shows that the measured amount of intact 
pDNA molecules corresponds well with the expected values in the intact/degraded 
pDNA mixtures. A linear trend was also found here (R = 0.97), although it is clear that 
at lower intact pDNA concentrations, the experimental values become less accurate. 
This is likely due to the fact that a high concentration of degradation fragments gives 
rise to a higher background intensity and, therefore, a lower signal to noise ratio of 
intact pDNA. This makes it more difficult to reliably track the remaining intact pDNA 
molecules. 
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Figure 3 Percentage of intact pDNA calculated using (A) the ratio of slow moving components 
(intact pDNA) and fast moving components (degraded) after analysis of the autocorrelation 
curve and analysis of the number of peaks in the intensity fluctuations obtained with FCS. and 
(B) concentration analysis after SPT. Averages were based on ten repetitions per sample. Error 
bars depict the standard deviation on the average. 
Enzymatic Degradation of Plasmid DNA in Function of Time 
The experiments above demonstrate that peak analysis by FCS and 
concentration measurements of intact pDNA by SPT seem adequate to determine 
the concentration of intact pDNA in a solution containing varying ratios of 
intact/degraded pDNA. These solutions, however, contain only two pDNA 
degradation states (non-degraded versus fully degraded) and are not representative 
for the different lengths of degradation fragments that are expected to be formed 
during the actual enzymatic degradation of pDNA in function of time. Therefore, as a 
next step, we evaluated the potential of FCS and SPT to follow the amount of intact 
pDNA in the presence of degradation products of varying lengths formed during the 
enzymatic degradation of pDNA over time after the addition of DNase I. The DNase I 
enzyme is an endonuclease that nonspecifically cleaves DNA to oligonucleotides of 
four base pairs and smaller. 
As a reference, gel electrophoresis was used to visualize degradation 
fragments which are formed when the DNase I enzyme cuts the pDNA molecules into 
smaller pieces. It can be clearly seen that the pDNA indeed degrades into a wide 
variety of shorter DNA fragments, which appear as a smear on the gel (Figure 4 A). 
The supercoiled form of the pDNA is no longer detectable on the gel starting from 10 
minutes onwards. The graph shows the percentage of intact pDNA as determined 
from the gel images. The amount of intact pDNA decreases rapidly and reaches a 
plateau around 0% after 10 minutes. Figure 4 B shows the percentage of intact pDNA 
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as measured by FCS peak analysis. The time traces can be seen in Suppl. Figure 2. 
Here, intact pDNA is seen to be fully degraded within the first 2 minutes. After 20-30’, 
however, the apparent amount of intact pDNA increases again, although the gel 
confirms that these mixtures no longer contain intact pDNA. Therefore, FCS peak 
analysis as carried out by the provided tools in the SymphoTime software seems less 
suitable to detect the amount of intact pDNA in solutions which contain a high 
concentration of smaller degradation fragments. We do not exclude the possibility, 
however, that peak analysis with custom-made algorithms would yield a more 
acceptable result to follow pDNA degradation. 
 
Figure 4 Raw data and relative percentage of concentration of intact pDNA compared to t = 0. 
(A) Example photograph and results of gel electrophoresis. Averages were based on three 
independent experiments with ten repetitions per sample. Error bars depict the standard 
deviation on the average. (B) Results of FCS with peak analysis. Averages were based on ten 
repetitions per sample. Error bars depict the standard deviation on the average. (C) Results of 
SPT analysis. Averages were based on three independent experiments with ten repetitions per 
sample. Error bars depict the standard deviation on the average. 
Finally, Figure 4 C shows the amount of intact pDNA as determined by SPT. 
Here, a gradual decrease in the percentage of intact pDNA is found which closely 
resembles the data from gel electrophoresis. It should be noted that the number of 
intact pDNA molecules seems to increase in the first minute after adding the DNase I 
enzyme (cf. second data point in Figure 4 C). This is likely due to bigger fragments at 
early time points that are still detectable as single particles. In any case, based on 
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these results, SPT seems the most reliable to detect the amount of intact pDNA in 
more complex mixtures containing a broad range of degradation fragments. 
SPT to Follow Intracellular Degradation of Plasmid DNA 
As a final proof of principle that SPT is useful to measure pDNA 
concentrations in more complex biological environments, we followed the 
degradation of plasmid DNA in cell lysate obtained from transfected HeLa cells after 
different time points. pDNA was delivered in the cells by lipofection. After 4 hours at 
37°C, uptake is complete, so the collected cell lysate of these samples was used as 
a reference of the total amount of pDNA present in the cell. An agarose gel was ran 
with the cell lysate, but as shown in Figure 5 A no single bands were seen making it 
impossible to determine pDNA concentration. Figure 5 B shows the percentages of 
pDNA measured with SPT after 8 hours and 24 hours at 4°C (black bars) and 37°C 
(white bars) compared to this reference. After the uptake was complete after 4 hours, 
half of the samples were incubated at 4°C, which lowers the activity of the enzymes 
responsible for pDNA degradation, while the remaining samples were incubated at 
37°C. Figure 5 B demonstrates that at the 8 hour time point, the concentration of 
intact pDNA dropped significantly for the 37°C samples, while the 4°C control doesn’t 
differ significantly (p < 0.05) compared to the initial amount of intact pDNA that was 
taken up in the cells during the first 4 hours. After 24 hour, the concentration of intact 
pDNA in cell lysate from the 37°C samples dropped even further, demonstrating that 
enzymatic degradation of pDNA has proceeded. The amount of intact pDNA detected 
in the cell populations incubated at 4°C, also decreased when compared to the 8 
hour time point. When compared to the concentration of the 37°C samples at the 24 
hour time point, however, the concentration in the 4°C treated cells was still 
significantly higher (p < 0.1). Taken together, we conclude that intracellular 
degradation is a fast process that decreases the amount of functional pDNA available 
for transfection significantly, compared to the total amount of pDNA delivered to the 
cell. This indicates that loss of pDNA is an important barrier to efficient gene delivery. 
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Figure 5 Agarose gel of cell lysate (A) and percentage of pDNA from SPT measurements (B) in 
cell lysate 4, 8 and 24 hours after Cy5-pDNA lipofection. Percentages are relative to the 
concentration measured at t = 4 hours. All results were compensated for the amount of cells by 
taking total protein concentration into account. Both samples were incubated at 37°C up to the 
4 hour time point. Black bars: 4°C. White bars: 37°C. *: p < 0.05, **: p < 0.1. Averages were 
based on four independent experiments with two repetitions per sample. Error bars depict the 
standard deviation on the average. 
DISCUSSION 
Measuring the concentration of macromolecules in complex biological media is 
interesting in a range of applications from disease diagnostics to evaluation of 
administered drugs. In the case of gene therapy, for example, the macromolecule of 
interest is plasmid DNA, a large, double stranded circular DNA molecule 
administered with the aim to induce protein expression in living cells. Concentration 
measurements of pDNA in buffer and other simple solutions are routine practice. The 
fastest method is probably measuring the absorption at 260 nm. Another method that 
is often used is measuring the fluorescence after addition of an intercalating dye 
which can be performed in buffer or on agarose gel. The intensity of the signal can 
then be correlated when using a standard curve. For the detection of very low 
concentrations, qPCR is used. One of the biggest disadvantages of these techniques 
is that most of the times it needs a purification step, in which DNA is isolated from the 
medium prior to the quantification. DNA concentration in blood was for example 
compared between healthy patients and patients suffering from prostate cancer. It 
was seen that the cancer patients exhibited a higher amount of circulating DNA, 
caused by a decreased DNase activity compared to healthy individuals. 20 The same 
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was done for lung cancer patients, where circulating plasma DNA levels were 
investigated as a biomarker for lung cancer. 21 DNA concentration in blood and target 
organs was also detected in the evaluation of a gene therapy treatment. In blood, the 
pDNA had a half time of less than 5 min, while pDNA could be detected for longer 
using southern blot and qPCR in the lung, spleen, liver, heart, kidney, marrow, and 
muscle up to 24 hours postinjection. 22 
When pDNA is used as a therapeutic to induce protein expression in living 
cells, it is of interest to understand where and when the pDNA molecule is actually 
delivered. Also, as the pDNA sequence should be intact to obtain protein expression, 
degradation of pDNA should be avoided during each step of the delivery pathway. 
Surprisingly, there are only a few methods that allow to follow the degradation of 
pDNA in the extracellular or intracellular environment. Both Lechardeur et al. (1999)23 
and Pollard et al. (2001)24, employed fluorescence in situ hybridization (FISH) and 
quantitative single-cell fluorescence video imaging to measure total fluorescence 
intensity per cell and estimated an average half-life of 50-90 minutes. A two-step 
fluorescence resonance energy transfer (FRET) approach was able to monitor 
complexation and degradation of quantum dot (QD) labeled pDNA in a non-invasive 
way in living cells. 25 This approach has the disadvantage that at least two different 
fluorescent molecules need to be added to the pDNA. In this study, we evaluated two 
single molecule microscopy methods in their ability of measuring concentrations of 
intact pDNA with only one type of fluorescent label in complex biological media. This 
approach minimizes the effect of the fluorescent labels on the intracellular 
processing. More importantly, the use of measurements directly in a complex 
medium eliminates the need for purification of the samples before measurements, 
which on itself could potentially influence the obtained concentrations. 26 The first 
technique that was evaluated was fluorescence correlation spectroscopy (FCS) (see 
Chapter 2 for more detailed background). FCS has already proven to be able to 
detect the degradation of small nucleic acids such as oligonucleotides and small 
interfering RNA. 5, 27 It has however not been evaluated before to detect degradation 
of larger macromolecules such as pDNA. 
FCS was very well able to determine the concentration of intact pDNA in a 
simple dilution series based on single species autocorrelation analysis. However, it 
did not perform well in mixtures of intact pDNA and fully (DNase I) degraded pDNA. 
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Using two component autocorrelation analysis with fixed diffusion coefficients for 
intact and degraded pDNA, the fraction of intact pDNA molecules was over-estimated 
(see Figure 3 A). This might be caused by the fluorescence intensity of the intact 
molecules which is obviously higher than that of the fully degraded plasmids and will 
therefore contribute more to the fluorescence fluctuations than the smaller degraded 
fragments. By taking this difference in fluorescence intensity between the two 
fractions into account, this potentially could be solved. This was however not an 
option in our analysis software. Peak analysis of the FCS data, which counts the 
number of “peaks” above a baseline determined by the fully degraded sample, turned 
out to perform much better in this case (see Figure 3 B). This approach is based on 
the assumption that each peak which arises above the baseline intensity level can be 
attributed to intact pDNA. Unfortunately, peak analysis proved to be less successful 
in retrieving the percentages of intact pDNA (see Figure 4 B) in more complex 
mixtures where enzymatic degradation of pDNA was followed in function of time. The 
number of intact plasmids was underestimated at early time points, while 
overestimated after longer degradation times. A closer look at the corresponding 
fluorescence fluctuations shows that the peaks originate from a slight shift in the 
baseline fluorescence, and not from actual peaks (see Suppl. Figure 2). This means 
that peak analysis has difficulties to cope with the more complex mixture of DNA 
during enzymatic degradation, in which a large variety of pDNA fragments are formed 
with different sizes and fluorescence intensities. 
Apart from FCS, also SPT was evaluated as a technique to measure intact 
pDNA concentrations. As SPT relies on the visibility of individual fluorescent 
particles, only intact pDNA will be visible. Smaller - and thus faster - fragments which 
have less labels per molecule and which are present at higher degraded pDNA 
concentrations cannot be discerned as individual objects. Instead they contribute to 
the overall background signal. We used a previously published method (described in 
Chapter 2) to accurately determine particle number concentration measurements 
from SPT data to determine the concentration of intact pDNA. 12-14 Counting the 
number of intact pDNA molecules seemed feasible both in solutions containing only 
intact pDNA as well as in mixtures with fully degraded pDNA fragments. Also, the 
determination of the concentration of intact pDNA was possible after nuclease 
activity. The enzymatic degradation creates an even more complex mixture of labeled 
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fragments, distributed between fully intact and fully degraded pDNA. SPT showed an 
estimation of intact pDNA that matched closely with the data obtained with gel 
electrophoresis. 
In the end, the real advantage of using these microscopy technique compared 
to the established techniques as described before, lies in the possibility to measure in 
more complex environments. Here we measured pDNA degradation in cells after it 
has been delivered by lipofection. Cells were treated with pDNA-lipoplexes and cell 
lysates were prepared at distinct time points afterwards. SPT could show that the 
concentration of intact pDNA decreases gradually over time (Figure 5). After 24 
hours, only a small fraction of the originally delivered amount is still intact. Our 
measurements would put the half-life of the pDNA present after cellular uptake at 4 
hours in the range of 3 to 4 hours, which is longer than the 50 – 90 minutes reported 
for naked pDNA in the cytoplasm by Lechardeur et al. (1999)23. This shows that the 
complexation delays the degradation of the pDNA. As could be expected, putting the 
cells at 4°C did slow down the degradation process. 
While both FCS and SPT eliminate the need for purification of the pDNA from 
biological samples, which is needed for gel electrophoresis (Figure 5 A) and qPCR, 
both microscopy-based approaches require that the pDNA is fluorescently labeled. 
Obviously, this extra step does diminish the advantage in simplicity this microscopy 
techniques has over a purification step and subsequent measurement, but is still 
more representative for the situation encountered in the cell. 
In conclusion, the SPT technique presented in this paper shows potential to 
measure intact pDNA concentrations both in buffer and in more complex biological 
environments such as cell lysate obtained from living cells. In future experiments, 
SPT can also be used to determine the protection of non-viral gene delivery carriers 
towards pDNA, by measuring the amount of intact pDNA that can be retrieved after 
incubation of the complexes in different extracellular or intracellular environments. As 
SPT relies on the measurement of fluorescently labeled molecules, one should take 
care to investigate that the labeling method does not interfere with the process under 
investigation, such as the degradation of pDNA in this manuscript. When taking into 
account the appropriate controls, however, SPT proves to be a reliable method to 
measure the amount of intact pDNA in varying environments. 
ADVANCED MICROSCOPY METHODS FOR DETECTING PLASMID DNA DEGRADATION IN A 
BIOLOGICAL ENVIRONMENT | CHAPTER 4 
PAGE | 141 
CONCLUSIONS 
In this chapter, two advanced microscopy techniques, FCS and SPT were 
compared with regards to their ability to measure the concentration of intact pDNA. 
Both techniques are suited to measure intact pDNA in buffer, but when a more 
complex environment with different smaller sized fragments is created, either by 
mixing intact pDNA with fully degraded pDNA or by following the process of 
degradation, SPT proves to be more suited than FCS to estimate the amount of intact 
pDNA molecules. The power of SPT was confirmed by following degradation of 
pDNA after lipofection in the cell extract of HeLa cells. These experiments show the 
power of this technique to study these types of phenomena which include the 
measurement of DNA in more complex biological media. 
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SUPPLEMENTARY DATA 
 
 
Suppl. Figure 1 Representative autocorrelation curves (black), fitting curves (red) and residuals 
of the fit for the calculated ratios of Figure 3. Laser power = 10% ~0.05 mW. Triplet model, two 
species fit with fixed parameters:  = 1.06, κ = 6, = 5.1,  = 0.21 
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Suppl. Figure 2 Representative time traces for the degradation experiment depicted in Figure 4 
B. Binning time = 1000 µs, laser power = 1% ~ 0.0029 mW, threshold at 5 counts/ms, based on 
the control, which is fully degraded pDNA. 
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ABSTRACT 
Advanced fluorescence microscopy methods are great techniques to study the 
characteristics of nucleic acid delivery inside living cells. To follow the intracellular 
journey of nanoparticles, the nanoparticles should be made visible, which can be 
achieved by labeling the carriers themselves or by labeling the nucleic acids they 
carry. A wide variety of labeling methods are available to attach (mostly fluorescent) 
tags to nucleic acids. It has, however, already been demonstrated that random 
covalent attachment of a high density of fluorophores to plasmid DNA (pDNA) by the 
widely used Mirus nucleic acid labeling kit can negatively influence the intracellular 
processing of the pDNA. In this study, we aimed to evaluate alternative labeling 
strategies to label pDNA, and to evaluate their effect on the natural behavior of 
pDNA. As labeling strategies, the intercalating cyanine dimeric nucleic acid stain 
TOTO-3, the sequence-specific hybridization of fluorescently labeled peptide nucleic 
acid (PNA) probes, a sequence-specific methyltransferase (MTase) mediated 
enzymatic labeling, and a nonfluorescent method were evaluated. The potential of 
labeled pDNA to generate an efficient transfection after lipid-mediated transfection 
was evaluated. Also, the suitability of fluorescent pDNA to be measured by two 
advanced microscopy techniques, namely fluorescence correlation microscopy (FCS) 
and single particle tracking (SPT), was investigated. We found that all three 
fluorescent labeling techniques generated labeled pDNA that showed only a limited 
decrease in the transfection efficiency when compared to non-labeled pDNA. For the 
nonfluorescent labeling method, however, transfection efficiency was seriously 
hampered. With regard to the dynamic properties of the pDNA, all fluorescent labeled 
pDNA molecules showed acceptable diffusion coefficients as retrieved from the FCS 
and SPT measurements. In applications measuring the degradation of pDNA, 
however, none of the alternative labeling techniques proved to be more reliable than 
the previous results obtained with the Mirus kit labeling. In conclusion, although the 
alternative fluorescent labeling methods are promising, the ease of use and the 
reproducability of the diffusion coefficients retrieved by advanced microscopy 
methods still favor the use of the Mirus nucleic acid labeling kit when high labeling 
densities of pDNA are avoided. 
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INTRODUCTION 
The study of nucleic acids as a potential gene replacement therapy, has, 
despite being around for more than 40 years, 1 not yet resulted in a widely applied 
therapy. One of the big hurdles that needs to be tackled, is the design of nanocarriers 
that are stable in the hostile extracellular environment in the body, yet are efficient at 
delivering their cargo to the right cell compartment. To understand the individual 
barriers that reduce the intracellular delivery, (advanced) fluorescent microscopy 
methods are invaluable. 2, 3 Attaching the fluorescent label to the carrier is one way of 
enabling detection by fluorescence microscopes, but this approach might perturb the 
interactions between the delivery vehicle and the cell. For this purpose, fluorescent 
labeling of the cargo, which is encapsulated inside the nanoparticles formed with the 
carrier, might be more useful. In Chapter 1, an overview was presented of the 
available labeling techniques that can be utilized to attach fluorescent moieties to 
nucleic acids. We have observed, however, in Chapter 3 that some labeling methods 
might interfere with the biological activity of the nucleic acids under investigation. We 
hypothesized that the random labeling methods used before, hinders the transcription 
of the labeled plasmid DNA due to the presence of fluorophores in the coding region 
of the pDNA. To overcome this limitation of the widely applied Mirus kit labeling 
method, in this chapter we evaluated the potential of alternative labeling techniques 
to label plasmid DNA without interfering with its functionality. Cyanine dimeric nucleic 
acid stains, peptide nucleic acid (PNA) hybridization and enzymatic labeling were the 
three alternative labeling methods that were considered. 
The basic principle behind the first labeling strategy that was evaluated, the 
cyanine dimeric nucleic acid stains, is the mechanism of bis-intercalation. Each of the 
monomers, that make up the dimer, will undergo intercalation with the DNA, which is 
the insertion between the base pairs of the helix-structure. During intercalation, π-
stack interactions, hydrogen-bonding, van der Waals interactions, hydrophobic 
interactions, and steric hindrance effects all play a role 4 (see Chapter 1 for a more 
detailed explanation). The binding of the stains at random locations of the plasmid 
increase the fluorophore’s brightness, which enables visualization of the nucleic acid 
with a fluorescence microscope. 
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As a second pDNA labeling strategy, PNA probes that hybridize in a 
sequence-specific manner to nucleic acids were evaluated for the labeling of pDNA. 
The PNA probes used in this chapter, consist of two linear probes made up by 
nucleotides linked by a peptide-modified backbone. The two probes are linked to 
each other with a flexible spacer and are therefore called bis-PNA probes. 5 During 
hybridization, one of the linear probes is undergoing Watson-Crick base pairing, while 
the second probe undergoes Hoogsteen base pairing with their specific recognition 
sequence, resulting in a strong PNA-DNA-PNA triple helix structure. 6 When multiple 
recognition sequences are grouped in an array, several labeled PNA probes can 
hybridize in this region, creating a strong fluorescently labeled molecule. Plasmids 
can be designed to incorporate these arrays in a selected region, eliminating possible 
interference between the labels and the coding region. The GeneGrip gWIZ-GFP 
pDNA (Genlantis, San Diego, CA, U.S.A.) used throughout this thesis, for example, 
has two different arrays built into its sequence, outside the coding region of the 
pDNA. 
The third labeling method that has been evaluated is the enzymatic labeling 
with DNA methyltransferases (MTases). The MTases (M.TaqI) used in this chapter 
catalyze a covalent bond formation between the activated primary amine from a 
specifically designed co-factor (e.g. S-adenosyl-L-methionine) to the exocyclic amino 
group of guanine in the 4 base sequence: 5’ – TCGA - 3’. 7 By conjugating a 
functional group with a NHS ester-linker to the cofactor, the functional group can be 
attached to the DNA. 8 Choosing a different MTase will change the recognition 
sequence at which functional groups are attached. At the moment, most recognition 
sequences consist of 4 to 6 base pairs in which the nucleophilic attack will occur. 
This sequence specificity can be used to quickly make a “fluorocode”. The positions 
of the fluorescent labels will be unique for every species, enabling recognition of the 
origin of unknown DNA 9. For the labeling of pDNA,  the enzymatic labeling can also 
be used to label the naturally occurring recognition sequences in the plasmid or to 
label plasmids with a custom designed recognition sequence array. In this chapter, 
the enzymatic labeling method was applied to couple two types of functional moieties 
to the plasmid DNA. In one set of experiments, a fluorophore was coupled to obtain 
fluorescently labeled pDNA. Alternatively, the enzymatic labeling method was applied 
to couple poly-ethylene-glycol (PEG) chains to the pDNA. PEG is hypothesized to 
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increase the mobility of pDNA in the intracellular environment by hindering non-
specific protein binding. Therefore, a PEGylated DNA molecule could potentially be 
more potent to induce transfection efficiency, due to an increased intracellular 
mobility and decreased recognition by proteins of the intracellular innate immunity 
pathway. 
Apart from the alternative labeling methods based on the addition of 
fluorescent molecules, we also evaluated a nonfluorescent nucleic acid labeling 
method. This was achieved by making a modified plasmid in which a portion of the 
thymine residues were replaced by an alkyne-tagged deoxyuridine: 5’ – ethynyl – 2’ - 
deoxyuridine (EdU). These alkyne groups can be visualized in a living cell by 
stimulated Raman spectroscopy, as has already been shown by Wei et al. (2014)10. 
In this paper, EdU was supplied to the cell’s growth medium and incorporated by the 
cell during de novo DNA synthesis. This allowed the imaging of this process by 
stimulated Raman spectroscopy of the EdU containing DNA in real time. 10 In this 
chapter, an EdU modified pDNA was tested, to examine the potential of this 
nonfluorescent labeling technique for following extracellular DNA in their journey 
through the cell. 
All mentioned labeling techniques were evaluated in terms of transfection 
efficiency, as well as their suitability for use in (advanced) microscopy methods (e.g., 
fluorescence correlation spectroscopy (FCS) and single particle tracking (SPT) to 
measure pDNA diffusion properties and/or degradation of labeled pDNA (cf. Chapter 
4). Briefly, both microscopy methods can determine the hydrodynamic diameter and 
concentration of fluorescently labeled molecules in solution by diffusion analysis. In 
the case of FCS, diffusion analysis is based on the autocorrelation of fluorescence 
fluctuations over time, while for SPT individual fluorescent particles are tracked in 
time-lapse movies.  
In summary, this chapter deals with the search for an alternative for the Mirus 
labeling kit, which is currently the standard labeling technique in our and many other 
laboratories. The alternative labeling techniques all make use of different methods of 
fluorescent labeling. While intercalating dyes and EdU incorporation result in random 
labeling of the entire pDNA molecule, PNA probes and enzymatic labeling result in 
sequence-specific labeling enabling the researcher to control the location of the 
fluorescent labels on the nucleic acid. The latter could potentially be important to 
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minimize the effect of the chosen labeling method on the intracellular path of the 
labeled nucleic acids for gene replacement therapy. 
MATERIALS AND METHODS 
Cyanine Dimeric Nucleic Acid Staining 
The intercalating dimeric cyanine nucleic acid stains YOYO-1 (λabs. 491 nm, 
λem. 509 nm) and TOTO-3 (λabs. 642 nm, λem. 660 nm) were used according to the 
manufacturer’s instructions (Invitrogen, Molecular Probes, Merelbeke, Belgium). The 
stock iodide (1 mM in DMSO) was diluted in TE buffer (10 mM Tris-base, 1 mM 
EDTA, pH 8.0) and added to the DNA in molar ratios pDNA over TOTO-3 of 200:1, 
50:1, 10:1, 5:1, assumed to be corresponding to labeling densities of respectively 30, 
120, 500, and 1000 TOTO-3 labels per pDNA molecule. This assumption was based 
on the protocol provided by the manufacturer. These solutions were incubated 
overnight at room temperature in the dark. The fluorescently labeled pDNA was then 
recovered using ethanol precipitation and reconstituted in HEPES buffer (20 mM, pH 
7.2). 
Peptide Nucleic Acid Hybridization 
The gWIZ-GFP plasmid has been designed with two PNA recognition 
sequence arrays by Genlantis (San Diego, CA, U.S.A.). Two PNA sequences were 
ordered at Panagene (Daejeon, Korea). One sequence was a 5’ – Alexa Fluor 647-
OO-TCTCTCTC-(AEEA)-(AEEA)-(AEEA)-CTCTCTCT-(AEEA)-(AEEA)-3’ (λex. 650 
nm, λem. 665 nm) and the second PNA sequence was 5’ – Alexa Fluor 488-OO-
CCTTCCTT-(AEEA)-(AEEA)-(AEEA)-TTCCTTCC-(AEEA)-(AEEA) – 3’ (λex. 490 nm, 
λem. 525 nm) with O, E and A as linker molecules. To label the plasmids, a 30 molar 
excess of PNA molecules was added to finally obtain a labeling density of maximal 
10 PNA molecules per plasmid. Therefore, PNAs and pDNA were mixed in a 
hybridization buffer (50 mM Tris-HCl, pH 8) after which the mixture was incubated for 
2h at 55°C. To recover labeled DNA, ethanol precipitation was performed and the 
DNA was reconstituted in HEPES buffer. Alternatively, size exclusion spin column 
chromatography was performed to remove unbound PNA molecules. 
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Methyl Transferase Mediated Enzymatic Labeling 
Enzymatic Atto647N (λex. 644 nm, λem. 669 nm) labeled pDNA was directly 
obtained from the collaborating laboratory of Prof. Hofkens at the KULeuven, or 
labeled by a three step labeling kit provided by the laboratory of Prof. Hofkens. In the 
first step, a functional NHS ester is coupled to the amine-cofactor in the presence of 
“Buffer 1”. This reaction is mixed and left for reaction on ice. After 20’, the first 
reaction is quenched completely by addition of “Buffer 2” and incubation during 1’ on 
ice. In the meantime, a separate tube is prepared with the target DNA and the 
MTase: M.TaqI, which specifically targets the 4 base sequence 5’ - TCGA – 3’. This 
mixture is added to the tube containing the cofactor and is incubated at 60°C for 1h. 
The labeled DNA is then recovered via ethanol precipitation and the pellet is 
resuspended in HEPES buffer. 
5-Ethynyl-2’-deoxyuridine Incorporation 
The modified nucleotide EdU is incorporated via nick translation, according to 
the protocol provided by the manufacturer (Nick translation system, Invitrogen, 
Merelbeke, Belgium). Briefly, the dNTP mix (0.2 mM each of dATP, dCTP, dGTP, 
500 mM Tris-HCl, pH 7.8, 50 mM MgCl2, 100 mM 2-mercaptoethanol), DNA, the 
modified nucleotide (EdU), and water were mixed in a tube. To this tube the DNase 
I/Polymerase I mixture was added, mixed thoroughly, and incubated at 15°C. After 1h 
the reaction was stopped by addition of a Stop buffer (0.5 M EDTA, pH 8.0). Ethanol 
precipitation was used to recover the modified DNA in HEPES buffer. 
Plasmid Preparation 
gWIZ-GFP plasmids were purchased from Genlantis (San Diego, CA, U.S.A.). 
The plasmids, that express GFP, were amplified in Escherichia coli and isolated from 
a bacteria suspension using a PurelinkHiPure Plasmid DNA Gigaprep kit K2100 
(Invitrogen, Merelbeke, Belgium). Plasmid concentration measurements at a 
wavelength of 260 nm were performed on a NanoDrop 2000c (Thermo Fisher 
Scientific, Rockford, IL, USA). The A260/A280 ratio was measured to assess the 
purity of the pDNA. Twenty-five microliter aliquots at 1 µg/µL were prepared and 
stored at −20 °C. 
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Gel Electrophoresis 
An agarose gel was prepared by adding 1% agarose (UltraPore™ agarose, 
Invitrogen, Merelbeke, Belgium) to a 1 x TBE buffer (90 mM Tris base/90 mM  
borate/2 mM EDTA) supplemented with GelRed (Biotum, Hayward, CA, U.S.A.). Gel 
loading buffer (Ambion, Merelbeke, Belgium) was mixed with the samples and this 
mixture was loaded onto the agarose gel. After running the gel for 50’ at 100 V, a 
picture was taken under UV light. 
Cell Culture 
A HeLa cell line was maintained at 37 °C (5% CO2) in Dulbecco’s modified 
Eagle’s medium supplemented with growth factor F12 (1:1 DMEM/F12), 10% heat 
inactivated fetal bovine serum (FBS), 2 mM L-glutamine, and 100 µg/mL 
penicillin/streptomycin. All cell culture reagents were purchased from GibcoBRL 
(Merelbeke, Belgium). 
Transfection 
HeLa cells were plated 1 day prior to transfection in 12 or 24-well plates at, 
respectively, 100 000 and 50 000 cells/well. Incubation of the cells with the 
Lipofectamine 2000 (Invitrogen, Merelbeke, Belgium) complexes (3:1 volume:weight 
ratio of Lipofectamine:pDNA), prepared with labeled or unlabeled pDNA, was done at 
1 µg of DNA per 100 000 cells (in 500 µL lipoplex solution per well) for 4 h at 37 °C. 
At this point, the cells were washed with phosphate buffered saline (PBS), and fresh 
medium was added for overnight incubation. After 24 h, the cells were trypsinized 
and examined by flow cytometry (FACSCalibur, BD Biosciences Benelux N.V., 
Erembodegem, Belgium) to detect the GFP expressing cells. 
Degradation of Plasmid DNA 
Two degradation experiments were performed. In the DNase I degradation 
experiment, DNase I (2 U/µl) (Invitrogen, Merelbeke Belgium) was added to a 0.1 
µg/µl solution of labeled pDNA prepared in a 1 x degradation buffer kept at 37°C. 
After different time points a sample was taken out of the reaction mixture and added 
to a DNase I inhibitor solution (0.1 M Iodoacetate, 10 mM Tris-HCl, 50 mM EDTA, pH 
7.4) on ice. These samples were then measured using FCS as described in Chapter 
2. 
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In the second type of experiment, labeled pDNA was fully degraded by the 
addition of DNase I (2 U/µl) (Invitrogen, Merelbeke, Belgium) and a 1 x degradation 
buffer and incubation over 30’ at 37°C, according to the manufacturer’s protocols. 
Mixtures of non-degraded (or intact) and fully degraded Cy5-pDNA were prepared to 
have 0/100, 20/80, 40/60, 50/50, 80/20 and 100/0 % of intact/degraded pDNA for 
FCS measurements (cf. Chapter 4) and 0/100, 10/90, 25/75, 40/60, 50/50, 60/40, 
75/25, 90/10 and 100/0% of intact/degraded pDNA for SFC recordings. Ten movies 
of 200 frames were subsequently recorded for every sample with SFC microscopy 
(cf. Chapter 4) and diffusion coefficients or number concentrations were obtained as 
described in Chapter 2. 
RESULTS 
Cyanine Dimeric Nucleic Acid Stains 
YOYO-1 and TOTO-3 are two of the cyanine dimeric nucleic acid stains which 
were evaluated for their use as fluorescent pDNA labels. YOYO-1 was used by 
multiple colleagues (e.g., Vercauteren et al. (2011)11) to quantify cellular uptake of 
the resulting green fluorescently labeled pDNA with flow cytometry. Here, we 
evaluated TOTO-3, which results in red fluorescent labeling of the pDNA upon 
intercalation. Red fluorescent labeled pDNA was chosen as the detection does not 
interfere with the possible expression of GFP which is detected in the green channel. 
Since it is known that these cyanine dimeric stains have an influence on DNA 
conformation and integrity, 12-15 the effect of the stain on the transfection efficiency 
was tested. To examine the compatibility of the stain with FCS, experiments on 
degradation of pDNA were also performed. 
Transfection Efficiency of TOTO-3 Labeled Plasmid DNA 
Results from Chapter 3 indicated that transfection with lipid-based carriers can 
be hampered by the labeling density of pDNA, upon the at random labeling by 
covalent attachments of fluorophores using the Mirus kit. Therefore, we were 
interested to see if the transfection efficiency of TOTO-3 labeled pDNA would also be 
hampered. The percentages of GFP positive cells resulting from transfection with 
pDNA labeled with TOTO-3 at different labeling densities were compared to the 
positive control, which is the lipofection with unlabeled plasmids. As can be seen in 
Figure 1 A, the transfection efficiencies of the pDNA, containing different labeling 
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densities of the intercalating dye TOTO-3, are not significantly different (p < 0.01) to 
the positive control, containing unlabeled pDNA. The mean fluorescence intensity 
(MFI) was, however, lower for the higher labeling densities. This indicates that the 
intercalating dyes have some influence on the potential of the cellular machinery to 
transcribe the fluorescent pDNA into mRNA and the translation into the 
corresponding GFP molecules, but not significant enough to decrease the 
transfection efficiency. The red fluorescence intensity and % red fluorescent cells 
inside the cell increased, as expected, with an increasing labeling density (Figure 1 
B). 
 
Figure 1 (A) Percentage GFP expressing cells and (B) percentage red fluorescent cells 
following lipofection with pDNA in function of the labeling density with TOTO-3, expressed as 
the ratio between mol pDNA : mol TOTO-3 and mean fluorescence intensity (MFI) (grey) of 
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respectively the (A) GFP fluorescent signal and (B) the TOTO-3 signal per cell. Negative Control 
= no pDNA. The average depicted is based on one representative experiment with three 
repetitions. Error bars are standard deviation on the average. 
Fluorescence Correlation Spectroscopy 
In Chapter 4, FCS measurements were performed on pDNA labeled with the 
Mirus kit. In this chapter, we evaluated if pDNA labeled with the TOTO-3 dye can be 
detected by FCS as well. FCS autocorrelation analysis resulted in a diffusion 
coefficient of 3.81 ± 0.86 µm²/s, which is comparable with the diffusion coefficient of 
3.23 ± 0.92 µm²/s that was measured in Chapter 4 for Mirus Kit labeled pDNA. 
In a next set of experiments, the endonuclease activity of the enzyme DNase I 
was followed by measuring TOTO-3 labeled pDNA with FCS in function of time. In 
parallel, agarose gel electrophoresis was performed to visualize the degradation of 
pDNA. As expected, the DNA concentration diminishes in function of the reaction 
time and after 30’, almost all DNA is degraded (Figure 2). To follow the degradation 
of pDNA with FCS, peak analysis on fluorescence intensities over time was 
performed to determine the concentration of intact pDNA. The intensity threshold to 
determine the peaks is set just above the maximum intensity recorded for a fully 
degraded sample. This was 12.5 counts/ms (see Suppl. Figure 1 for the time traces). 
Initially, the number of peaks decreases, in comparison to the number of 
peaks counted at t = 0’, during the first 2 minutes of reaction with the DNase I 
enzyme. After 5 minutes, however, the number of peaks reaches a constant 
percentage around 70% although the agarose gel clearly demonstrates further 
degradation of the pDNA. Therefore it seems that peak analysis of pDNA 
fluorescently labeled with intercalating dyes such as TOTO-3 is not suited to follow 
the pDNA degradation over time. As intercalating dyes are spread throughout the 
DNA backbone, also smaller degradation fragments are expected to contain more 
than 1 dye molecule. Therefore, it is possible that the number of peaks does not 
decrease significantly when smaller degradation products are being formed. Although 
the average fluorescence intensity is expected to decrease for shorter pDNA 
fragments, the peak analysis will consider a fluorescent peak as a single event as 
soon as it rises above the background level, irrespective of the absolute intensity 
value of the peaks. This could explain why the peak analysis was less suitable to 
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follow TOTO-3 labeled pDNA, when compared to the Mirus kit labeled pDNA used in 
Chapter 4. 
 
Figure 2 Degradation of TOTO-3 labeled pDNA by DNase I. (A) Graphic representation of 
degradation of TOTO-3 labeled pDNA. (B) Image of agarose gel. (C) Peak analysis after FCS 
measurements. Data points are averages from a single experiment with five repetitions per 
sample. Error bars are standard deviation on the average. 
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Peptide Nucleic Acid Hybridization 
The second labeling strategy evaluated in this chapter is the sequence-
specific labeling of pDNA by fluorescent PNA clamps, complementary to a pre-
designed recognition site in the pDNA. The gWIZ-GFP plasmid that is used 
throughout this work was originally designed to include two so-called GeneGrip sites. 
These sites are recognition sequence arrays, aimed at the hybridization of PNA 
probes. The labeling technique in itself is based on PNA-DNA-PNA triple-helix 
formation. As 10 PNA recognition sites are positioned one after the other in an array 
on the pDNA, up to 10 fluorophores can be attached to the pDNA by hybridization 
with fluorescently labeled PNA probes. A PNA probe with Alexa Fluor 488 was 
designed and ordered to fit the plasmid recognition site 2. Incubation of the pDNA 
with the PNA clamp will result in the fluorescent labeling with one type of fluorophore. 
The transfection efficiency of this fluorescent labeled pDNA was checked, as well as 
the potential of PNA clamp labeled pDNA for use in FCS and SPT experiments. 
Transfection Efficiency of PNA-Labeled Plasmid DNA 
Chapter 3 learned us that the random labeling of pDNA, by using the Mirus 
labeling kit, interfered with the potential of pDNA to be transcribed, due to the 
presence of fluorophores that are covalently attached to nucleotides in the coding 
region of the pDNA. Zelphati et al. (1999)16 described PNA-labeled plasmids as being 
functional, while the conformation is preserved. We in turn evaluated the transfection 
efficiency of PNA clamp labeled pDNA as an indicator for the functionality of the 
labeled pDNA. Figure 3 demonstrates that the single-color PNA-labeled pDNA 
reaches the same transfection efficiency as unlabeled pDNA upon delivery with 
Lipofectamine. Therefore, we could demonstrate that pDNA that carries fluorescent 
labels outside the coding region does not suffer from a decrease in transfection 
efficiency and, in other words, is still transcriptionally active. 
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Figure 3 Percentage GFP expressing cells following lipofection of unlabeled and PNA labeled 
pDNA and mean fluorescence intensity (MFI) (grey) of GFP fluorescent signal. Negative control 
= no pDNA. The average depicted is based on one representative experiment with three 
repetitions. Error bars are standard deviation on the average. 
Fluorescence Correlation Spectroscopy 
In a first set of experiments, the diffusion coefficients of the free PNA probes 
and PNA labeled plasmids were characterized. Then, we evaluated the potential to 
use PNA-labeled pDNA to study degradation of the pDNA molecules  
In PNA-labeled pDNA, all the fluorescent labels are concentrated at the 
recognition sequence array. During the labeling procedure, fluorescently labeled PNA 
clamps are incubated with pDNA to allow hybridization to the recognition sequence. 
Unbound PNA probes are removed via ethanol precipitation, but a small fraction 
remains in the solution. To take these free fluorescent labeled probes into account, 
autocorrelation curves are always fitted with a two species fit with fixed diffusion 
coefficients for PNA probes and intact pDNA as described in Chapter 2 (respectively 
193.47 ± 5.47 µm²/s and 3.44 ± 1.24 µm²/s). This diffusion coefficient for intact pDNA 
corresponds to the diffusion coefficient of Mirus kit labeled pDNA as measured in 
Chapter 4. 
Now that the diffusion coefficient of intact PNA labeled pDNA is determined, 
this knowledge can be used to follow degradation. Degradation by endonuclease 
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activity of DNase I shortens the DNA strands, which should produce faster moving 
labeled DNA fragments since all the fluorescent labels are located in one short 
sequence. As depicted in Figure 4 A, the fluorescent fragments are becoming 
smaller, but the number of fluorophores will be more or less the same. This means 
the small fragments are still detectable whereas these small fragments did not emit 
enough signal to be detectable in the case of the random labeling techniques (e.g., 
Figure 2 A). 
Due to the formation of smaller fluorescent degradation fragments, we 
expected that the diffusion coefficient of the slow component (originally 
corresponding to intact pDNA) should increase until degradation is complete. The 
fast components was therefore fixed. DNase I was added to a mixture of intact pDNA 
and samples were collected at different time points. These samples were in parallel 
run on an agarose gel and measured with FCS. The agarose gel in Figure 4 B shows 
how the amount of intact pDNA decreases with increasing incubation times. At t = 20’ 
all DNA is degraded. This was reflected in the FCS measurement, where a gradual 
increase in the diffusion coefficient of the slow component is found over time. 
Single Particle Tracking 
Next to FCS, SPT analysis is a technique that can provide information on the 
dynamic properties of fluorescently labeled molecules and their concentration. We 
evaluated whether SPT was suitable to follow the degradation of PNA labeled pDNA 
over time, as was reported for Mirus kit labeled pDNA in Chapter 4. 
Starting with intact PNA labeled pDNA in a buffer solution, a diffusion 
coefficient of 1.94 ± 0.19 µm²/s was found. This diffusion coefficient is lower than the 
one obtained by FCS, but comparable to the diffusion coefficient found for Mirus 
labeled pDNA with SPT (see Figure 10 B). Next, similar to what was done in Chapter 
4, mixtures of intact and fully degraded pDNA were made. Based on the 
concentration algorithm, the percentage of intact pDNA from these mixtures was 
calculated, and compared to the known amount of intact pDNA present in the 
solutions. This approach is based on the fact that degraded pDNA fragments are too 
fast to successfully be imaged by the microscope. Therefore, degraded pDNA will not 
result in analyzable tracks and only contribute to the background signal. 
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Figure 4 DNase I degradation of labeled pDNA over time.(A) Graphic representation of 
degradation of PNA labeled pDNA. (B) Agarose gel. (C) Diffusion coefficients over time 
measured with FCS on the degrading pDNA solutions. Average diffusion coefficient based on 
ten repetitions from one experiment. Error bars are the standard deviation on the average. 
As can be seen in Figure 5, a slight underestimation of the amount of intact 
pDNA was found for all mixtures. It should be noted that when PNA labeled pDNA 
degrades, the fluorescence intensity of the degradation products will only decrease 
when the degradation occurs at the PNA recognition sequence. In all other cases, 
shorter pDNA fragments are formed, which still bear a maximum of 10 fluorescent 
labels at the PNA recognition site (see Figure 4 A). This is a clear difference when 
compared to the random fluorescent labeling method evaluated in Chapter 4, where 
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almost each cut in the pDNA molecules results in shorter degradation fragments that 
contain less fluorophores since there is on average only one fluorophore about every 
600 base pairs. Possibly, this difference in fluorescent labeling of the degradation 
fragments that are formed, could explain why SPT could more reliably measure the 
amount of intact pDNA in Chapter 4, where the degradation products are more 
rapidly falling under the detection limit of the SFC microscope while the small 
fragments in this chapter, with a high amount of fluorescent labels, contribute more to 
the background signal, making it harder to detect intact pDNA. 
 
Figure 5 Percentage of intact pDNA retrieved by concentration analysis in function of known 
percentage intact pDNA. Dashed line indicates the theoretical expected values. Averages 
calculated from ten movies of the same sample. Error bars are the standard deviation on the 
average. 
Sequence-Specific Enzymatic Labeling of pDNA 
As an alternative for PNA probe mediated site-specific labeling of pDNA, in 
collaboration with the research group of Prof. Hofkens at the KU Leuven, a newly 
developed labeling kit was tested. This labeling kit (called “Chrometra”) is derived 
from the technique used to produce a fluorocode as described in Neely et al. (2010)9 
and provides sequence specific attachment of fluorescent labels to DNA (also see 
Chapter 1, for a more detailed explanation). It makes use of the DNA 
methyltransferase TaqI (mTaqI) which targets the four base sequence 5’ – TCGA – 3’ 
where it attaches the label via a covalent bond formation between the activated 
methyl group from a specifically designed cofactor to the exocyclic amino group of 
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the nucleobase. In case of the gWIZ-GFP vector, which is used throughout this 
thesis, this enzymatic labeling results in the attachment of a fluorophore to nine 
recognition sites which are naturally present in the pDNA sequence. Two of those are 
present in the coding region of the pDNA (see Figure 6). In a first set of experiments, 
we evaluated the enzymatic attachment of the Atto647N dye to the pDNA. The 
labeling procedure was evaluated by a number of experiments. The transfection 
efficiency was compared to unlabeled pDNA. Also, detection of the fluorescent pDNA 
was performed with advanced microscopy techniques like FCS and SPT. Apart from 
the fluorescent labeling, also the potential of adding polyethylene glycol (PEG) chains 
to the pDNA (also called PEGylating) by enzymatic labeling was evaluated, with the 
aim to improve intracellular mobility of the pDNA and potentially limit the recognition 
of PEGylated pDNA by the key players of the innate intracellular immunity pathways. 
 
Figure 6 Graphic map of gWIZ-GFP vector with the nine mTaqI recognition sites (5' - TCGA - 3') 
indicated in blue. CMV promotor is indicated in red. The sequence coding for GFP is indicated 
in green. 
Transfection Efficiency of Enzymatic Labeled Plasmid DNA 
One of the factors of the enzymatic labeling kit that needed to be optimized, 
was the use of the cofactor in the labeling reaction. Therefore, different cofactors 
were compared to see if there was a difference in labeling efficiency, and to evaluate 
the influence of the cofactors on the conformation and functionality of the labeled 
pDNA. A transfection of HeLa cells was performed using Lipofectamine. The positive 
control consists of complexes with unlabeled pDNA and the negative control lacks 
pDNA. In Figure 7 A, it can be seen that the transfection efficiency of the enzymatic 
labeling for pDNA obtained with the cofactors MTC-3 and MTC-6 is slightly lower 
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than the positive control (p < 0.05). The MTC-7 cofactor seemed to result in labeled 
pDNA with a lower transfection efficiency than the positive control and also slightly 
lower than the transfection efficiency obtained from pDNA labeled with the other 
cofactors (p < 0.05). A look at the red fluorescence signal showed that the % of red 
fluorescent cells is lower (around 15% red fluorescence cells), compared to ~99% 
seen for the other cofactors, indicating that cellular uptake is probably less efficient or 
that the pDNA is not labeled efficiently and the fraction of pDNA that is labeled is 
degraded before reaching the cell. Therefore, it seems that the cofactors MTC-3 and 
MTC-6 are most suitable for enzymatic labeling of the pDNA, with MTC-6 leading to a 
higher red fluorescence signal per cell compared to MTC-3, which is probably due to 
a more efficient labeling process that leads to more labels per plasmid (Figure 7 B). 
Hereafter, MTC-6 is always used as the cofactor. 
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Figure 7 (A) Percentage GFP expressing cells and (B) percentage red fluorescent cells 
following lipofection with of unlabeled and enzymatic labeled pDNA and mean fluorescence 
intensity (MFI) (grey) of respectively the (A) GFP fluorescent signal and (B) the Atto647N signal 
per cell. The right y-axis of (B) is truncated. Negative control = no pDNA. MTC-3, MTC-6 and 
MTC-7 are different cofactors used in the mTaqI-mediated labeling reaction. *: p < 0.05. The 
average depicted is based on one representative experiment with three repetitions. Error bars 
are standard deviation on the average. 
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Diffusional Properties Measured with Fluorescence Correlation Spectroscopy 
and Swept Field Confocal with Single Particle tracking 
When the diffusion coefficient of the enzymatically labeled pDNA was 
measured by FCS, a diffusion coefficient of 2.64 ± 0.21 µm²/s was found which is a 
bit lower than what is seen with the PNA clamp labeling, or the Mirus kit labeling. This 
value, however, falls into the expected range of diffusion coefficients for a 6000 bp 
plasmid DNA, demonstrating the enzymatic labeling of pDNA results in labeled pDNA 
that can reliably be detected by FCS. 
Also SPT proved to be able to detect the motion of enzymatically labeled 
pDNA in buffer. A diffusion coefficient of 2.08 ± 0.50 µm²/s was obtained, which is in 
line with the value obtained with SPT for the PNA labeled plasmids and the Mirus kit 
labeling. 
PEGylation of Plasmid DNA 
Experiments in which plasmids were labeled with PEG-2000, making use of 
the enzymatic labeling technique, were conducted to see if PEGylation of plasmids 
could potentially increase the transfection efficiency, by increasing the mobility of 
pDNA in the intracellular environment and limiting interactions with intracellular 
compartments. In drug delivery, PEGylation is often used to increase mobility of 
nanoparticles and to reduce aggregation. 17 Whether or not PEGylated would also be 
beneficial for increasing the diffusion of PEGylated pDNA, however, remains unclear. 
Transfection efficiency of the PEGylated pDNA was compared to the transfection with 
unlabeled pDNA, both complexed with Lipofectamine. In Figure 8, it can be seen that 
transfection efficiency of PEGylated pDNA decreased in comparison with the 
lipofection of unlabeled pDNA. The drop in transfection efficiency was slightly larger 
than the one seen in Figure 7 A, when the same cofactor (MTC-6) was used to 
couple the fluorescent dye Atto647N instead of the PEG-2000 chains. Therefore, it 
seems that PEGylation has a more pronounced (negative) influence of the 
transfection efficiency of enzymatic labeled pDNA, when compared to the smaller 
Atto dyes. 
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Figure 8 Lipofection of unlabeled and enzymatic PEGylated pDNA and mean fluorescence 
intensity (MFI) (grey) of the GFP fluorescent signal. Negative control = no pDNA. The average is 
based on one experiment with three repetitions. Error bars are standard deviation on the 
average. 
5-Ethynyl-2’-Deoxyuridine 
A final method that was evaluated in this chapter was the nonfluorescent 
nucleic acid labeling method. These methods are gaining more and more interest 
among researchers who were previously relying solemnly on fluorescent labeling 
techniques. 18 Since DNA is present throughout the cell, a modification should be 
implemented to the DNA molecule under investigation, to allow specific imaging of 
the target DNA molecules. A possible modification is the introduction of an alkyne-
bearing nucleotide analog, 10 which was already known for its use in the fluorescent 
labeling with click-chemistry. 19 The detection of the modified pDNA is then possible 
using Raman spectroscopy. To obtain this pDNA, the modified nucleotide EdU was 
incorporated into the pDNA via nick translation. As a first test to examine if this 
method of labeling holds promise, transfection efficiency of the modified pDNA was 
assessed. As can be seen in Figure 9, the transfection efficiency of EdU modified 
pDNA dropped to a negligible percentage, indicating that functionality is disrupted. 
Since the interest of our research group revolves around following the progress of 
functional nucleic acids through the cell, this fluorescent label free modification of 
pDNA was not considered for further evaluation. 
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Figure 9 Lipofection of unlabeled and EdU modified pDNA. Negative control = no pDNA. The 
average depicted is based on one experiment with three repetitions. Error bars are standard 
deviation on the average. 
DISCUSSION 
In Chapter 1, an overview is presented of the most interesting nucleic acid 
labeling strategies that are currently available. In Chapter 3 and 4, the covalent 
fluorescent labeling kit of the Mirus Bio company was used for all experiments. 
Despite the use in those papers, Chapter 3 clearly indicated that the Mirus labeling 
kit should be used with care for intracellular processing studies. Therefore, different 
alternative strategies were compared to the Mirus kit and their potential to be used in 
cell studies and for microscopy based degradation studies (cf. Chapter 4). Cyanine 
dimeric nucleic acid stains, PNA hybridization, and enzymatic labeling were the 
alternative fluorescent labeling methods that were considered. 
From a user perspective, all labeling methods were relatively easy to perform. 
For the Mirus labeling kit and the cyanine stains, the commercial kit can be readily 
used. This is somewhat different for PNA probes and the enzymatic labeling method. 
Both sequence-specific labeling approaches need to be specifically tailored for the 
used target DNA. Especially PNA probes need to be designed and ordered to fit a 
specific sequence. These design steps require knowledge of the exact sequence and 
of the hybridization mechanism. When a recognition sequence array (36 bp per 
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probe) is not built into the plasmids on purpose, the chance that significant labeling of 
a random plasmid will take place is slim. This decreases the interchangeability 
between different plasmids. The enzymatic labeling approach is in this regard more 
flexible, since the sequence specificity is limited to a four to six base sequence which 
is most likely found by chance at least once in every plasmid. The MTase and 
cofactor, however, need to be synthesized and optimized, which needs an extensive 
knowledge of protein production. Of course this problem will be alleviated as soon as 
the optimized labeling kit will be commercially available. 
The applications tested within this chapter are analogous to the ones 
described in Chapter 2 and performed in Chapters 3 and 4. A labeling method 
therefore should be compatible with the advanced microscopy techniques, while the 
pDNA’s functionality is not disturbed. In Figure 10, a short resume is presented of the 
obtained results for the transfection efficiency and the diffusion coefficient measured 
throughout this chapter. 
 
Figure 10 Summary of the (A) transfection efficiencies and (B) the obtained diffusion 
coefficients with FCS (black bars) and SPT (white bars) for the labeling strategies discussed. 
By studying the transfection efficiency, the functionality of the pDNA (e.g., 
expression of GFP), as well as the ability of the (red or green) labeled pDNA to enter 
the cells can be measured by flow cytometry. This last parameter is evaluated by 
looking at the red fluorescent signal. These results are presented visually in Figure 1 
B and Figure 7 B, but are due to absence of red fluorescent labels not available for 
the PNA, PEGylation and EdU transfections. With regard to functionality, TOTO-3 
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and PNA labeled pDNA do not seem to be affected by the attachment of fluorescent 
labels (Figure 10 A). In the case of TOTO-3, DNA binding enzymes, responsible for 
the transcription, may be able to (temporarily) detach the intercalator to interact with 
the DNA strands. 20 The PNA probes on the other hand, are located outside of the 
coding region of the plasmids. No interference with the DNA binding enzymes is to be 
expected. A small difference between the PNA probe labeled pDNA and unlabeled 
pDNA could be observed. Hydrophobicity of the fluorescent labels probably might 
come into play at this point, increasing the affinity of the pDNA to “stick” to cellular 
lipid structures. 21 Enzymatic labeled pDNA showed a lower transfection efficiency 
than unlabeled pDNA. In Figure 6, the location of each of the nine fluorescent 
recognition sites is indicated. It can be seen that three of them are within or near the 
coding region of GFP. This could disturb interactions with transcriptional proteins, 
which might explain the reduction in transfection efficiency. When instead of 
fluorescent labels, PEG chains are attached, the percentage of transfection drops 
further, which is probably because PEG chains induce more steric hindrance and can 
block protein interactions. 
FCS is a valuable microscopy technique to study the mobility of fluorescent 
labeled molecules. 3 In Chapter 4, FCS is used to study the concentration and 
degradation of pDNA in buffer systems. In this chapter, degradation was looked at in 
more detail, for the different labeling strategies. First of all, labeled pDNA needs to be 
characterized, which means that the diffusion coefficient needs to be determined. 
This was feasible for all labeling strategies and results were more or less 
comparable, indicating that FCS could be performed (Figure 10 B). Degradation was 
studied for the TOTO-3 stained pDNA as well as for the PNA probe labeled pDNA. In 
the case of TOTO-3, the results of the FCS data analysis didn’t match the trend that 
became apparent in the agarose gel. This peak number method for counting the 
number of intact pDNA molecules has also been used in Chapter 4, but it could not 
retrieve the amount of degradation, while still keeping a high number of detectable 
peaks (see Suppl. Figure 1). This happens even when all DNA seems to be 
degraded. This last observation can probably be attributed to the labeling method. 
The dimeric labels will redistribute over the remaining larger fragments, giving rise to 
smaller peaks, which are still detectable. In the case of the PNA labeled pDNA, the 
average diffusion coefficient of the “slow” moving fraction was taken as a measure for 
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degradation since the pDNA molecules are becoming shorter, and thus more mobile. 
The results represent the degradation in a sufficient manner, although the standard 
deviation becomes larger at long degradation times. This is probably due to the 
influence of single intact DNA molecules. If these, at this point, rare molecules pass 
through the focal volume a high intensity peak is registered. These high intensities 
influence the autocorrelation curve and the subsequent fitting, leading to a higher 
variation between measurements with and without the presence of a large molecule. 
For an agarose gel, stained with GelRed, these concentrations of molecules are 
below the limit of detection. 
SPT has become an invaluable technique in our laboratory. Mobility has been 
studied in biofilms 22, in the vitreous of the eye, 23 and in much more applications. 2 
Being able to visualize, localize, and track labeled plasmids is a prerequisite for the 
correct determination of diffusion coefficients and subsequently the size. This proved 
to be no problem for Mirus kit labeled pDNA, PNA probe labeled pDNA, or enzymatic 
labeled pDNA. Furthermore, the diffusion coefficients seem to be consistent between 
the labeling methods (Figure 10 B). PNA labeled pDNA was also used in an 
experiment which tests if the correct amount of intact pDNA can be retrieved from a 
mixture of intact and fully degraded pDNA. It was observed that the amount of intact 
pDNA was underestimated for all samples. In Chapter 4, this experiment was 
performed with Mirus labeled pDNA and in contrast with the results presented in this 
chapter, percentages of intact pDNA could be retrieved. This might be due to the 
presence of a strong background signal, in the case of PNA labeled pDNA, caused 
by the presence of small labeled DNA fragments and free PNA probes. Some intact 
plasmids may therefore not be recognized by the localization software as particles. In 
the case of the Mirus labeling, only very fast moving fluorescent linker molecules are 
present, which probably contribute less to the background fluorescence. 
Additionally, two completely different approaches were included with the test 
of the EdU modification of pDNA and the PEGylation of pDNA via enzymatic labeling. 
The nonfluorescent labeling approach may potentially be the future in nucleic acid 
labeling, but in this work, it was seen that the potential to transfect HeLa cells was 
lost when the modification was implemented. Also the PEGylation of pDNA did not 
result in the increase in transfection efficiency that was hoped for.  
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CONCLUSIONS 
Three alternative labeling methods were compared to the frequently used 
Mirus nucleic acid labeling kit since there are issues with this labeling method at 
higher labeling densities. Furthermore, sequence-specific labeling enables the 
researcher to adjust the labeling to the needs of the experiment. This could, for 
example, potentially be of interest for transfections when the coding region can be left 
untouched. The different alternative approaches and especially the PNA labeling 
method seem the most promising for further use in the lab, but in applications the 
results obtained with the Mirus kit labeled plasmids (described in Chapter 4) proved 
to be more accurate. The enzymatic labeling could be the perfect cross between the 
Mirus kit and the PNA probe labeling, but proprietary plasmids should be designed to 
combine the advantages of both. 
Without much success, less common approaches were tested by PEGylating 
plasmids and a small venture into a nonfluorescent approach, but they did not deliver 
the hoped results. 
Although all tested labeling methods could be interesting for the use within our 
research field, the ease of use and the results in advanced microscopy experiments 
show that the Mirus kit labeling is still the best choice when the labeling density is 
kept low enough. 
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SUPPLEMENTARY DATA 
 
Suppl. Figure 1 Representative time traces for the degradation experiment with TOTO-3 
depicted in Figure 2. Binning time = 1000 µs, laser power = 1% ~ 0.0029 mW, threshold at 12.5 
counts/ms. 
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Suppl. Figure 2 Representative autocorrelation curves (black line), fitting curves (red line) and 
residuals (bottom) in function of the lag time for the different degradation times corresponding 
with Figure 4. Laser power = 0.5% ~ 0.0578 mW. Fixed values in triplet model fit (see Chapter 2: 
 = 0.55, κ = 9, = 0.09. 
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ABSTRACT 
Polycationic amphihilic β cyclodextrins (paCDs) are a versatile family of 
molecules, which are promising candidates for the delivery of nucleic acids for gene 
therapy. In this study, three different modified paCDs were investigated as carriers for 
plasmid DNA (pDNA) as well as messenger RNA (mRNA). Complexation, stability 
and transfection efficiency were assessed in both serum free and in serum-
containing environments. While transfection efficiency of paCDs in serum-free 
conditions was only slightly lower than for the Lipofectamine-based transfections, the 
presence of serum completely abolished the expression of the reporter protein for 
pDNA as well as for mRNA. Our results indicated that for pDNA containing paCDs, 
cellular uptake was significantly lower in a serum-containing environment. It was 
hypothesized that the CDplexes need interactions with the cellular cholesterol to 
result in a successful transfection. Therefore, the most efficient pDNA CDplexes were 
saturated with cholesterol before they were added to the cells in serum-free 
conditions. Cellular uptake was significantly decreased, indicating a connection 
between the uptake mechanism of CDplexes and interactions with cellular membrane 
cholesterol. Our hypothesis is that also serum proteins block the interactions 
between CDplexes and the cellular membrane by the formation of a protein corona, 
leading to a loss of uptake and consequently a loss of transfection. Further 
optimization of the paCDs is thus required to result in complexes than remain 
efficient in protein-rich environments such as cell culture medium. 
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INTRODUCTION 
Already four decades ago, the use of nucleic acids (NAs) in gene replacement 
therapy was proposed as a method to alleviate genetic disease. 1 Gene replacement 
therapy can be described as the introduction of a healthy gene into a patient to 
replace the function of a defective gene. This healthy gene is provided by plasmid 
DNA (pDNA) or mRNA. The lack of a broad range of gene-based pharmaceuticals on 
the market indicates that no general approach has been found yet to translate the, 
relatively simple, concept of gene therapy into practice. 
Intensive research has been done to increase the efficiency of the transfer of 
NAs into cells. NAs are degraded by nucleases (see Chapter 4), or cleared from the 
body due to their physical properties (size and charge), which prevent the diffusion 
through cellular membranes. After reaching the target cells, the NAs still need to 
reach their intracellular location which is the nucleus for pDNA or the cytoplasm for 
mRNA. To help NAs with stability, improve their physical properties, and facilitate 
cellular entry, mechanic and physical methods (e.g. injections, electric field, etc.), 
recombinant viral vectors, non-viral vectors, and combinations of the above (e.g., 
ultrasound-mediated gene delivery by microbubbles) were developed. Mechanical 
and physical methods prove to be interesting for target cells and tissues that are 
easily accessible. 2, 3 For harder to reach tissues and cells, vector-based approaches 
could be more promising. To ensure an efficient NA delivery, the vector needs to 
display the following characteristics: (i) protection of the NAs from enzymatic 
degradation by systemic nucleases, (ii) avoid being cleared by the innate immune 
system, (iii) enable the therapeutic NAs to reach the target cells, (iv) induce NA 
release in the desired cell compartment (e.g., mRNA to the cytoplasm, pDNA to the 
cell nucleus) and (v) don’t induce toxicity, inflammation or mutagenic effects. 
The two types of vectors that can be used as gene carrier are viral and non-
viral vectors. The use of recombinant viral vectors hijacks the natural ability of viruses 
to enter the cell and use the cell’s machinery to replicate their NA. These properties, 
that in normal circumstances induce illness, are used to transfect (transient 
expression of a protein in the cell) or transduce (the introduction of foreign DNA into 
the host its genomic DNA) cells with a therapeutic gene. This is accomplished by 
replacing the viral genes, that lead to replication and toxicity by therapeutic genes. 
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These attenuated viruses are therefore called recombinant viral vectors and are very 
efficient. Several hundreds of clinical trials have therefore been performed with these 
type of vectors, 4 but there is one big drawback: safety. 5 The transduction of the 
therapeutic genes happens in a random manner, but with a preference for actively 
transcribed genes, which can lead to insertional mutagenesis. This means that the 
disruption of the host genome will induce uncontrolled cell proliferation. 6 
Furthermore, the presence of high concentrations of viral particles, can still induce a 
strong and even lethal immunogenic response, identical to the reaction on natural 
occurring viruses, as was observed in clinical trials with adenoviruses. 7, 8 
Additionally, the production of these recombinant viral particles proves to be costly 
and hard to scale-up. 5 Not surprisingly, these vectors have found, and still find, 
strong opposition when attempts are made to translate them to the clinic. 
Under the title of non-viral vectors, a diverse group of synthetic nanocarriers 
that support the transfection of cells is grouped. Opposed to the viral carriers, the 
non-viral counterparts, in general, are candidates for large scale production, while 
having lower toxicity, oncogenicity and immunogenicity. This is achieved by using 
lipid – or polymer-based particles that allow for a broad range of modifications. These 
modifications lead to a near endless range of possibilities. 9 However, when the 
efficiency of NA transfer and transgene expression is compared to their viral 
counterpart, non-viral carriers cannot compete. Two types of non-viral vectors are 
mainly used: liposomal NA carriers (lipoplexes) and polymeric NA carriers 
(polyplexes). As the name indicates, lipoplexes are complexes formed by (a 
combination of) lipids and NAs. To generate an electrostatic interaction between the 
negatively charged NAs with the liposome, positively charged (cationic) lipids (e.g., 
DOTAP is the most widely used cationic lipid 10) are combined with helper lipids (e.g., 
cholesterol) in a formulation. During complexation, NAs are adsorbed to the surface 
or bound between the different phospholipid layers. 11, 12 Polyplexes are another 
important category of non-viral carriers, and most relevant for this chapter. They are 
constructed by the complexation of NAs with a cationic polymer. A large amount of 
possible polymers has been described that show promise in providing good 
protection of the NA, efficient transfection, and low immunogenicity and toxicity. 13 In 
this chapter, a specific type of polymers is used, namely cyclodextrins. 
EVALUATION OF CATIONIC AMPHIPHILIC β-CYCLODEXTRINS FOR GENE DELIVERY | CHAPTER 6 
PAGE | 189 
Cyclodextrins (CDs) are cyclic (α-1,4)-linked oligosaccharides of α-D-
glucopyranose. The number of α-D-glucopyranose units determines the type of CD 
that is encountered. α-CDs consist of six, β-CDs of seven and γ-CDs of eight α-D-
glucopyranose units (Figure 1 A-C). This structure results in molecules that are 
shaped in a torus-like manner (see Figure 1 D). X-ray experiments revealed that in 
CDs the primary hydroxyl groups (C6) are located on the small edge of the ring, the 
secondary hydroxyl groups (C2 and C3) are located on the wide edge of the ring, and 
the apolar (C3 and C5) hydrogens and ether-like oxygens are at the interior of the 
molecule. 14 The result is an amphiphilic molecule that has both a hydrophilic cavity 
at the exteriors and an apolar hydrophobic cavity at the interior (see Figure 1 D). This 
provides a unique micro-environment that is perfect for the encapsulation and 
solubilization of hydrophobic molecules in water. 15-17 Besides being used for the 
encapsulation of small hydrophobic drugs, CDs gained interest in gene delivery. 18-20 
Initially, CDs were used as an addition to other gene carriers since β-CDs were seen 
to lower the cytotoxicity of the gene carriers and increase the cellular entry. 21 
Although the evidence on the CD-mediated absorption is still obscure and further 
study is required, it was hypothesized that cholesterol depletion (by CDs) improves 
membrane permeability. 17, 22, 23 
 
Figure 1 Structure of (A) α-CD, (B) β-CD, and (C) γ–CD. (D) Schematic representation of a CD. 
Structure adapted from Lai (2014)17. 
It should be noted that the standard, non-modified CD molecules carry no net 
positive charge and therefore do not complex NAs. Therefore, derivatives were 
synthesized with the aim to induce the potential of NA binding. Polycationic 
amphiphilic CDs (paCDs) gained the most interest. By the adjustment of the ratio and 
type of cationic and hydrophobic elements, the size, charge, and affinity for NAs can 
be controlled. This allowed for the synthesis of a large group of possible paCD-based 
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gene carriers. Three of these derivatives were evaluated in this chapter, namely 
ADM-65, ADM-70 and IP202-libre. Their structure is given in Figure 2 C-E and 
consists of 14 hexanoyl chains at the secondary hydroxyl face (wide edge) and 
respectively 21, 14 and 21 protonable amino groups at the primary face (small edge). 
This conformation is represented schematically in Figure 2 A. ADM-65 and IP202-
libre have polycationic side chains at their small edge with a virtually identical 
composition. The main difference is that the side chain of ADM-65 is branched, while 
that of IP202-libre is linear. ADM-70 on the other hand eliminates one amino group in 
each side chain, compared to ADM-65, resulting in a shorter branched polycationic 
side chain. These paCDs can be complexed with negatively charged NAs and will be 
called CDplexes from now on. In their most simple form, these CDplexes are 
organized in a bilayer structure with the lipophilic tails facing each other and the 
positive charges facing the aqueous environment and cavity as schematically 
depicted in Figure 2 B for a pDNA - CDplex. One of the hypotheses is that these 
CDplexes can interact with the negatively charged proteoglycans on the cell surface. 
From there on, endocytosis would be the main pathway of cellular uptake. 24-27. Díaz-
Moscoso et al. (2010)28 determined via inhibition experiments that clathrin-dependent 
and clathrin-independent cellular internalization were both mechanisms by which 
CDplexes are taken up by Vero cells. When cholesterol was depleted from the 
cellular membranes by the addition of a methyl β-CD, a drop in transfection efficiency 
was observed. These results, combined with the reports that indicate a connection 
between the membrane permeability and the interactions between CDs and cellular 
cholesterol, indicate that interactions of the paCDs with cholesterol highly likely are 
crucial for the efficient delivery of NAs. These interactions would likely involve the 
interaction of cellular cholesterol with the hydrophobic interior. 
In this chapter, the use of the three paβ-CDs, as delivery vehicles for pDNA 
and mRNA, was evaluated in buffer, optimized transfection medium, and in serum-
containing cell culture medium. The CDplexes were characterized in each medium, 
as well as evaluated in cell experiments. In these cell experiments, the transfection 
efficiency, cytotoxicity, and cellular uptake were evaluated. Additionally, we looked 
deeper into the necessity of the CDplexes to interact with cellular cholesterol to 
succeed in an efficient cellular uptake. 
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Figure 2 Schematic presentation and structures of the polycationic amphiphilic β-CDs and 
CDplex used in this chapter. (A) Schematic presentation of the CDs with hydrophobic lipid tails 
at the wide edge and polycationic side chains at the smaller edge. (B) Schematic presentation 
of the possible organization of a pDNA (in red) - CDplex. (C) Structure of ADM-65. (D) Structure 
of ADM-70. (E) Structure of IP202-libre. Encircled + signs stand for positively charged groups. 
Orange rectangles indicate spacer elements. 
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MATERIALS AND METHODS 
Cell Culture 
A HeLa cell line was maintained at 37 °C (5% CO2) in Dulbecco’s modified 
Eagle’s medium supplemented with growth factor F12 (1:1 DMEM/F12), 10% heat 
inactivated fetal bovine serum, 2 mM L-glutamine, and 100 µg/mL 
penicillin/streptomycin. All cell culture reagents were purchased from GibcoBRL 
(Merelbeke, Belgium). 
pDNA and mRNA 
gWIZ-GFP plasmids were purchased from Genlantis (San Diego, CA, U.S.A.). 
The plasmids, expressing green fluorescent protein (GFP), were amplified in 
Escherichia coli and isolated from a bacteria suspension using a Plasmid Gigaprep 
Kit (Qiagen, Thermo Fisher Scientific, Merelbeke, Belgium). Plasmid concentration 
measurements at a wavelength of 260 nm were performed on a NanoDrop 2000c 
(Thermo Fisher Scientific, Rockford, IL, USA) . Purity was assessed via the 
A260/A280 and a 1 µg/µl stock solution was prepared in 20 mM HEPES buffer (pH 
7.2) and stored at −20 °C. 
pDNA and mRNA were labeled with Cy5 using the Label IT® nucleic acid 
labeling kit (Mirus Bio LLC, Madison, WI, U.S.A.) at a NA to Cy5 Label IT reagent 
ratio of 10:1 (w:v). Free fluorescent reagent was removed with ethanol precipitation 
and labeled NAs were resuspended in 20 mM HEPES buffer (pH 7.2). NA 
concentration, purity and labeling density were checked respectively at wavelengths 
260 nm, 260 nm/280 nm and 647 nm. 
Nucleic Acid Complexation 
β-cyclodextrins, named ADM-65, ADM-70 and IP202-libre were synthesized at 
the laboratory of Professor J.M. García Fernández. The freeze dried products were 
resuspended in a Dimethyl Sulfoxide (Sigma Aldrich, Diegem, Belgium):ddH2O (1:3 
v:v) mixture resulting in a concentration of positive charges of 300 mM. A working 
solution (3 mM positive charges) is obtained through a 1:100 dilution of the stock 
solution with ddH2O. CDplexes were prepared by mixing the CDs with pDNA or 
mRNA at the desired concentration to obtain Nitrogen/Phosphate (N/P) ratios of 4, 6 
and 8. 
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Agarose Gel Electrophoresis 
1% agarose gel was prepared in 1× TBE buffer (90 mM Tris base/90 mM  
borate/2 mM EDTA) and prestained with the GelRed stain (Biotum, Hayward, CA, 
U.S.A.). Samples were mixed with gel loading buffer II (Ambion, Merelbeke, Belgium) 
and loaded onto the gel which was ran for 45’ at 100 V and visualized under UV. 
Physical Characterization of Complexes 
Hydrodynamic diameter and zeta potential were determined using dynamic 
light scattering (DLS). Complexes were prepared as described above, diluted in 20 
mM HEPES buffer (pH 7.2), optiMEM, or cell culture medium and measured in 
triplicate on a NanoZS Zetasizer (Malvern Instruments, Hoeilaart, Belgium). 
Cellular Uptake and Transfection Efficiency 
HeLa cells were plated in 24 well plates at 50,000 cells/well and were allowed 
to grow overnight. For uptake experiments, complexes were prepared with Cy5-
pDNA or Cy5-mRNA in 20 mM HEPES buffer (pH 7.2), as described above, and 
diluted in optiMEM or regular growth medium. The complexes were added to the 
cells at a concentration of 500 ng pDNA/50,000 cells and the plates were incubated 
at 37°C for 4 hours. As a negative control, plates were pre-incubated on ice for 1 
hour and incubated with the particles on ice for 4 hours. To obtain information on the 
uptake, cells were washed and trypsinized after the 4 hours incubation. Cells were 
collected from the neutralized cell suspension by centrifugation and resuspended in 
flow buffer (1% bovine serum albumine (Sigma Aldrich, Bornem, Belgium) in PBS 
Ca2+/Mg2+ -/-). Red fluorescence from the pDNA or mRNA inside the cells was 
measured using flow cytometry (FACSCalibur™, BD Biosciences Benelux N.V., 
Erembodegem, Belgium). For transfection experiments, CDplexes were prepared 
with non-labeled pDNA or mRNA. Cells were incubated with the CDplexes for 4 
hours, after which the cells were washed to remove free CDplexes, supplied with 
fresh growth medium, and allowed to grow in the incubator. 24 hours after the 
transfection, the cells were prepared for flow cytometry, as described above. Green 
fluorescence from GFP expression inside the cell was measured with flow cytometry 
and used as a measure for a successful transfection. All samples were prepared and 
measured in triplicate. 
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Toxicity 
Cytotoxicity of the CDplexes was evaluated with the MTT assay. HeLa cells 
were plated in 24 well plates at 50,000 cells per well. Identical to the transfection 
protocol, complexes, prepared as previously described, were added to the cells in 
optiMEM or growth medium and incubated for 4 hours at 37 °C. After removal of the 
polyplexes, fresh growth medium was added to the cells. 24 h after addition of the 
complexes, MTT reagent was added to the medium for 4 hours at 37 °C. Afterwards, 
cells were washed and lysed with cell lysis buffer (0.04 N HCl and 1% Triton-X in 
isopropanol) for 1 hour on a shaker. Then, absorbance at 590 nm and 690 nm was 
measured on a plate spectrophotometer (PerkinElmer 2104 EnVision). The 
absorbance at 590 nm relates to the metabolic activity, while the absorbance at 690 
nm is used as a baseline reference. 
Pre-Incubation with Cholesterol 
The effect of pre-incubation of the pDNA – CDplexes with free cholesterol on 
uptake and transfection was tested. Cholesterol (Sigma Aldrich, Bornem, Belgium) 
was dissolved in absolute ethanol to a concentration of 0.1 M. Cholesterol was added 
to the CDplexes at a mol:mol ratio of 20:1 (CD:Chol).29 After 15’ of pre-incubation, 
the Chol:Cy5-pDNA:CDplexes were incubated in optiMEM with HeLa cells plated in 
24 well plates at 50,000 cells/well. After 4 hours, cells were washed and harvested. 
All measurements were conducted on the FACS, as described above for cellular 
uptake and transfection. 
RESULTS 
Complexation 
Complexation properties were checked on agarose gel for CDplexes with N/P 
4, 6, and 8 in HEPES buffer, optiMEM and full cell growth medium. Free NAs will be 
mobile on the gel and migrate like the free NA control, while complexes will be 
stationary in the loading well. For pDNA (Figure 3) in HEPES buffer, complexation is 
complete for N/P ratios 6 and 8 for all CDs. IP202-libre complexes pDNA completely 
at all N/P ratios. When CDplexes are exposed to the serum-free medium optiMEM, 
complete complexation shifts to higher N/P ratio’s when compared to the HEPES 
buffer conditions. In full cell culture medium, again, IP202-libre shows the best 
complexation efficiency, with no free pDNA detectable in the gel at N/P ratios 6 and 
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8. For ADM-70, a fraction of free pDNA remains visible on the gel, demonstrating 
ADM-70 is not able to fully complex all pDNA at the studied N/P ratios.  
 
Figure 3 Complexation of pDNA by ADM-65, ADM-70 and IP202-libre. pDNA: free pDNA control. 
N/P: Nitrogen/Phosphate ratio. HEPES: 20 mM HEPES buffer (pH 7.2). CM: Cell Culture Medium. 
Gel is representative for the results seen in three independent experiments and was edited to 
delete empty lanes. 
For mRNA (Figure 4), the complexation efficiency seems less dependent on 
the biological environment the complexes are in. All studied CDs complex mRNA 
completely at all studied N/P ratios and all incubation fluids. 
 
Figure 4 Complexation of mRNA by ADM-65, ADM-70 and IP202-libre. mRNA: free mRNA 
control. N/P: Nitrogen/Phosphate ratio. HEPES: 20 mM HEPES buffer (pH 7.2). CM: Cell 
Medium. Gel is representative for the results seen in three independent experiments and was 
edited to delete empty lanes. 
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Physical Characterization: Size and Charge 
After the NA complexing potential of the different CDs was established on 
agarose gel, the size and zeta potential were checked with DLS for both pDNA and 
mRNA complexes. The change in size and zeta potential of a particle over the 
different N/P ratios and in the three different media is a good representation of the 
stability of a complex. A positive zeta potential is essential to avoid electrostatic 
repulsion by the negative charged cell membrane, while a small size is believed to 
enhance cellular uptake. In Table 1, the average hydrodynamic diameter and the 
zeta-potential of the CDplexes are shown in HEPES buffer, optiMEM and cell culture 
medium for different N/P ratios. 
In general, the zeta-potential dropped from positive (HEPES buffer) to neutral 
(optiMEM) and negative values (culture medium) due the presence of a higher 
amount of ions in the optiMEM and cell medium compared to the HEPES buffer and 
the presence of serum proteins in culture medium which all interact with the surface 
of the particles. This was represented in the size of the CDplexes which formed large 
aggregates for the more neutral absolute values of the zeta potential as seen in 
optiMEM. These larger sizes were also observed for the N/P ratios of 4 of both pDNA 
and mRNA with ADM 65 and ADM 70 in HEPES buffer, which indicated incomplete 
complexation as seen on the agarose gel (Figure 3). In cell culture medium the size 
of all particles dropped to very small sizes, due to interactions with the serum 
proteins. Based on these results, IP202-libre with both pDNA and mRNA seemed to 
be the most stable in all three media with a decrease in size when the N/P ratio went 
up. 
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Table 1 Size (.) and zeta-potential (ξ) for all CDplexes complexed with pDNA and mRNA in 
HEPES buffer, optiMEM and cell culture medium. All values are averages of three independent 
experiments with three repetitions and errors are the standard deviation on the average. 
  HEPES buffer optiMEM Cell Culture Medium 
Carrier N/P 	
. (nm)  (mV) 	
. (nm)  (mV) 	
. (nm)  (mV) 
pDNA 
ADM-65 
4 565 ± 744 35 ± 1 1706 ± 110 -20 ± 2 68 ± 4 -12 ± 1 
6 147 ± 30 38 ± 3 1829 ± 11 -4 ± 1 68 ± 1 -10 ± 1 
8 152 ± 23 35 ± 1 2135 ± 50 6 ± 1 78 ± 1 -10 ± 1 
ADM-70 
4 1167 ± 1483 34 ± 1 676 ± 28 -30 ± 1 98 ± 28 -14 ± 1 
6 144 ± 21 40 ± 1 1473 ± 62 -23 ± 1 91 ± 17 -14 ± 1 
8 137 ± 14 42 ± 1 2128 ± 28 -7 ± 2 53 ± 14 -14 ± 1 
IP202-
libre 
4 156 ± 20 35 ± 3 340 ± 17 12 ± 1 88 ± 12 -10 ± 1 
6 154 ± 24 35 ± 2 1205 ± 57 10 ± 1 129 ± 25 -9 ± 1 
8 128 ± 30 34 ± 3 469 ± 14 14 ± 1 134 ± 15 -8 ± 1 
mRNA 
ADM-65 
4 1586 ± 218 -2 ± 1 2095 ± 548 -8 ± 1 25 ± 1 -10 ± 2 
6 292 ± 9 17 ± 1 1079 ± 73 4 ± 1 22 ± 1 -8 ± 1 
8 141 ± 1 32 ± 4 1412 ± 23 15 ± 2 22 ± 1 -7 ± 1 
ADM-70 
4 1054 ± 107 14 ± 1 1976 ± 107 -25 ± 2 189 ± 70 -12 ± 1 
6 174 ± 2 34 ± 2 1529 ± 338 -8 ± 1 425 ± 120 -11 ± 1 
8 162 ± 3 34 ± 1 2050 ± 408 -5 ± 1 892 ± 394 -13 ± 1 
IP202-
libre 
4 131 ± 1 21 ± 1 145 ± 1 16 ± 1 28 ± 1 -10 ± 1 
6 128 ± 7 13 ± 2 116 ± 1 16 ± 1 27 ± 1 -11 ± 1 
8 109 ± 24 16 ± 2 114 ± 1 16 ± 1 34 ± 1 -9 ± 1 
 
.
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Transfection Efficiency 
GFP expressing pDNA and mRNA were complexed with CDs at N/P ratios 4, 
6, and 8 and incubated on HeLa cells. Flow cytometry was used to measure the 
transfection efficiency by determining the percentage of cells that express GFP. A 
cell was deemed positive for green fluorescence when the signal exceeded a 
threshold, which was determined by the negative control. The commercially available 
Lipofectamine 2000 was used as a positive control. Transfections were carried out in 
optiMEM, which is a protein-free transfection medium, while cell culture medium 
containing serum proteins was used as the transfection medium which is more 
representative for the in vivo situation. In Figure 5 A, the transfection with pDNA in 
optiMEM is depicted together with the mean fluorescence intensity (MFI) of green 
fluorescence from GFP per cell. It can be seen that the transfection efficiency 
increases with increasing N/P ratio’s for each type of cyclodextrin. Percentages of 
transfections with ADM-70 show the highest level of GFP positive cells, but remain 
lower than those seen with the commercially available lipid-based Lipofectamine. The 
ADM-65 CDplexes and IP202-libre N/P 4 and N/P 6 reach very low efficiencies. 
IP202-libre N/P 8 on the other hand is as efficient as the ADM-70 CDplexes. Also, 
the trend for the MFIs over the different CDplexes seemed to follow the transfection 
efficiency closely. When the transfections are carried out in serum-containing cell 
culture medium, transfections drop for all samples to nearly 0%. ADM-70 at N/P 8 is 
the only sample that could still transfect a small percentage of cells, but the MFI 
suggests this is also very limited (Figure 5 B). The protein rich conditions in cell 
culture medium thus clearly interfere with the potential of the CDs to transfect the 
HeLa cells. 
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Figure 5 Percentages GFP positive cells after transfection with pDNA-Lipofectamine and pDNA-
CDplexes and mean fluorescence intensity (MFI) of GFP fluorescence. Averages obtained from 
three independent experiments with three repetitions. Error bars depict the standard deviation 
on the average. (A) Transfections performed in optiMEM, (B) Transfections performed in full 
cell culture medium. N/P: Nitrogen/Phosphate ratio. Black bars: N/P 4, grey bars: N/P 6, white 
bars: N/P 8. ▼: N/P 4, ♦: N/P 6, ●: N/P 8. 
mRNA transfections are depicted in Figure 6. Also here, transfection efficiency 
increases with increasing N/P ratio’s. In optiMEM (Figure 6 A), ADM-70 again 
reaches the highest level of GFP positive cells, while ADM-65 and IP202-libre 
perform less. MFI values again follow this trend closely. When compared to 
transfections with pDNA, however, it is clear that all CDs containing mRNA reach a 
higher percentage of GFP positive cells with a higher MFI per cell. This is most likely 
attributed to the fact that, unlike pDNA, mRNA does not have to cross the nuclear 
membrane to result in GFP expression. In serum-containing cell culture medium, 
however, all transfection values again drop to less than 1%, confirming the negative 
influence of the protein-rich culture medium on the transfection efficiency of the CD 
complexes. 
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Figure 6 Percentages GFP positive cells after transfection with mRNA-Lipofectamine and 
mRNA-CDplexes and mean fluorescence intensity (MFI) of GFP fluorescence. Averages 
obtained from three independent experiments with three repetitions. Error bars depict the 
standard deviation on the average. (A) Transfections performed in optiMEM. (B) Transfections 
performed in full cell culture medium. N/P: Nitrogen:Phosphate ratio. Black bars: N/P 4, grey 
bars: N/P 6, white bars: N/P 8. ▼: N/P 4, ♦: N/P 6, ●: N/P 8. 
Toxicity 
Toxicity of the CDplexes on the HeLa cells was assessed via an MTT assay. 
Viability of the cells 24 hours after addition of the pDNA-CDplexes is depicted in 
Figure 7 A. In general, toxicity of the CDplexes increases with higher N/P ratios, with 
ADM-70 being the most toxic one. In fact ADM-70 pDNA complexes were statistically 
significantly more toxic than the Lipofectamine-based pDNA complexes, which were 
used as positive control (p < 0.05). Also for mRNA-CDplexes (Figure 7 B) this trend 
can be observed. Toxicity of all samples was statistically not different from that of 
Lipofectamine-based mRNA complexes, except for the mRNA - ADM-70 complex at 
N/P 8, which was significantly (p < 0.05) more toxic than the Lipofectamine 
complexes, and the mRNA - IP202-libre complex at N/P 4, which was significant less 
toxic than Lipofectamine complexes (p < 0.05). 
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Figure 7 MTT assay for (A) pDNA-CDplexes and (B) mRNA-CDplexes in optiMEM. Blank were 
non-treated cells. Dead cells were treated with ethanol. *: p < 0.05. Averages in each graph 
obtained from three independent experiments with three repetitions. Error bars depict standard 
deviation on this average. 
Cellular Uptake 
The transfection efficiency of the CDplexes clearly dropped whenever the 
transfections were carried out in serum-containing cell culture medium. Therefore, we 
were interested to know whether a difference in cellular uptake of the CDplexes in 
optiMEM, when compared to cell culture medium, could present an explanation for 
this observation. To determine the cellular uptake of CDplexes, complexes were 
prepared containing red fluorescent pDNA and the amount of red fluorescence inside 
the cell was determined using flow cytometry. 30 Figure 8 demonstrates that in 
optiMEM, all complexes are taken up in the cells, with ADM70 N/P 4 showing the 
highest amount of red fluorescence per cell (black bars). In cell culture medium, 
however, all CDplexes except for ADM-70 N/P 4, show a lower value for the red 
fluorescence per cell, indicating cellular uptake has indeed decreased (white bars). 
Most likely, the proteins in the cell culture medium interfere with the interaction of the 
CDplexes with the cell membrane, thereby limiting their cellular uptake. The fact that 
ADM70 N/P 4 is most efficiently taken up in the cells could potentially result from the 
formation of larger complexes, which sediment onto the cell surface. The higher 
uptake, however, did not result in good transfection of the ADM70 complexes at N/P 
4, suggesting there is also no direct correlation between the amount of red 
fluorescence detected in the cells and the obtained GFP expression efficiency. 
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Figure 8 Cellular uptake of pDNA complexes determined by the quantification of red 
fluorescence inside the cell in function of the used CDplexes after 4 hours of incubation. 
Negative control was optiMEM or cell medium. Averages obtained from three independent 
experiments with three repetitions. Error bars depict the standard deviation on the average. 
Pre-incubation with Cholesterol 
It has been hypothesized that the extraction of cholesterol from the cell 
membrane, induced by the specific CD structure, is essential for membrane 
permeability and thus cellular entry and transfection potential of the CDplexes. A 
possible explanation for the lower transfection efficiency of the CDplexes in cell 
culture medium could be that the presence of serum proteins blocks this cholesterol 
depletion from the cell membrane. To mimic the effect of the cell culture proteins, the 
CDplexes were saturated with free cholesterol by pre-incubation, to prevent the 
extraction of cellular cholesterol from the cell membrane and to assess the effect on 
the cellular uptake of the CDplexes. 
Figure 9 shows the uptake of ADM-70 CDplexes at N/P 8 in optiMEM, cell 
culture medium or after pre-incubation of the CDplexes with cholesterol. Uptake was 
measured by determination of the red fluorescence intensity inside cells, as an 
indication for the amount of Cy5-pDNA inside each cell. Again, it can be seen that 
less particles were taken up in the cells when the CDplexes were administered in cell 
culture medium, when compared to optiMEM (p < 0.05). Also, pre-incubation of the 
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CDplexes with cholesterol resulted in a decrease in cellular uptake, similar as to what 
was seen for the incubation of complexes in the serum proteins containing cell 
culture medium. Therefore, it seems that interfering with the potential of the 
CDplexes to deplete cholesterol from the cellular membrane, either by incubating in 
cell culture medium or by pre-incubation with cholesterol, indeed results in less 
efficient uptake of the CDplexes. 
 
Figure 9 Cellular uptake of pDNA - ADM-70 complexes at N/P ratio 8 in optiMEM (OM), cell 
medium (CM) or in optiMEM after pre-incubation of the CDplexes with cholesterol (chol) in 
HeLa cells. Negative control is optiMEM alone. *: p < 0.05. Averages obtained from one 
experiment with three repetitions. Error bars depict the standard deviation on the average. 
DISCUSSION 
Three different polycationic amphiphilic β-cyclodextrins: ADM-65, ADM-70 and 
IP202-libre (see Figure 2 B-D), were characterized and evaluated as non-viral carrier 
for NAs in gene therapy. Several reports already showed that paCDs are a potential 
carrier for the cellular delivery of NAs. 27, 28 A potent NA carrier should form stable 
complexes with the NAs and transfect cells in an efficient way, especially in protein-
rich media, which more closely resemble the in vivo situation. The stability of the 
CDplexes is determined using three parameters: complexation, size, and zeta 
potential. 
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In HEPES buffer, the stability and complexation behavior of the pDNA and 
mRNA CDplexes showed stable complexes (Figure 3, Figure 4, and Table 1), starting 
from N/P ratio 6. N/P ratio 4 mostly gave rise to large particles, indicating incomplete 
complexation and aggregation. Generally, the charge of the CDplexes became more 
neutral to negatively charged when incubating them in optiMEM or cell culture 
medium. In optiMEM, CDplexes aggregated to larger particles, except for IP202-libre-
mRNA. In cell culture medium, most particles became smaller than 100 nm, a size 
that is considered interesting for cellular internalization. 31 IP202-libre complexes 
seemed to be most stable, when complexation, size and zeta potential were 
considered, for both pDNA and mRNA (Figure 3, Figure 4, and Table 1), but this 
stability was not represented in the transfection efficiency of the CDplexes. All 
CDplexes become more efficient with increasing N/P ratio, but both the pDNA and 
mRNA ADM-70 CDplexes transfected HeLa cells the best, although the efficiency 
remained lower than that of the Lipofectamine-based complexes (Figure 5 A and 
Figure 6 A). Unfortunately, these ADM-70 CDplexes also induced the highest 
cytotoxicity (Figure 7). For mRNA, the transfection efficiencies in optiMEM were 
higher than those of pDNA, most likely because mRNA has to reach the cytoplasm to 
be translated, while pDNA needs to overcome the extra barrier of the nuclear 
membrane to be transcribed into mRNA. 
In a serum protein-containing environment, no transfection was seen for both 
pDNA and mRNA CDplexes. Only pDNA complexed with ADM-70 at N/P 8 had more 
than 1% transfection, which is still very low. Zeta potentials for both pDNA and mRNA 
CDplexes were slightly negative, which is known to have a negative influence on 
cellular internalization. This change was most likely induced by the binding of 
negatively charged serum proteins to the positively charged surface of the CDplexes. 
30, 32
 At low absolute values for the zeta potential, electrostatic repulsion is low, 
leading to aggregation. Nonetheless, a big decrease in size was observed for all 
CDplexes in culture medium (Table 1). This indicates that very small particles were 
formed, stabilized by a protein corona in the protein-rich culture medium. 
Alternatively, large aggregates could sediment in the DLS cuvette, preventing their 
detection during the size measurements and biasing the results toward smaller 
particles. Taken together, size and zeta potential measurements alone do not explain 
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the observed differences in transfection efficiency between the CDplexes and in the 
different cell culture media. 
A prerequisite for good transfection efficiency is the uptake of the CDplexes in 
the cells. Internalization of Cy5 - pDNA CDplexes, confirmed a decrease in cellular 
uptake for all CDplexes in cell culture medium with the exception of ADM-70 at N/P 4 
(Figure 8). The high uptake values for ADM-70 at N/P 4 in both optiMEM and cell 
culture medium are puzzling since both complexation efficiency, size and zeta 
potential and transfection efficiency of these CDplexes is not optimal. Why 
complexes that are taken up in a good way do not lead to transfection efficiency is 
not clear. In general, we can conclude that cellular uptake is clearly limited in the 
presence of serum proteins, but that the amount of internalized CDplexes cannot be 
directly correlated to transfection efficiency, since the CDplexes with the highest 
transfection (ADM70 N/P 8), did not have a higher uptake compared to the other 
CDplexes. 
To explain the drop in cellular uptake in the presence of culture medium, an 
exploratory experiment was performed with the pDNA - CDplex with the highest 
transfection efficiency to test if blocking the interactions between cellular cholesterol 
and the CDplex had a negative effect on the cellular uptake. Therefore, Cy5 pDNA – 
ADM-70 at N/P ratio 8 was pre-incubated with cholesterol, forming a Cy5 pDNA – 
cholesterol – ADM-70 CDplex. Figure 9 shows that the uptake of the cholesterol-
saturated complexes in optiMEM dropped to the level of the pDNA - ADM-70 
complexes in cell culture medium. This suggests that the cholesterol interactions 
which normally occur between non-saturated CDplexes and the cell membrane are 
essential for the cellular uptake. It should be noted that this hypothesis can only be 
made, however, when cholesterol does not induce a displacement of the pDNA from 
the CDplex. Several reports were published describing the connection between the 
uptake mechanism of the CDplexes and cell membrane cholesterol. 17, 22, 23, 28 Díaz-
Moscoso et al. (2010)28 also observed a drop in uptake and transfection efficiency of 
pDNA paCDs when cholesterol was depleted from the cell membrane by the addition 
of methyl β CDs. We therefore hypothesize that blocking the interaction between the 
hydrophobic moieties of CDs, by serum proteins, saturation with free cholesterol, or 
the depletion of cholesterol from the cellular membrane, is responsible for the 
disruption of the cellular uptake and consequently the lack of transfection efficiency. 
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Facilitating these interactions in serum-containing conditions could potentially retain 
the full functionality. Further experiments are certainly necessary to find a correlation 
between the presence of serum proteins and the loss of interactions with cellular 
cholesterol, but this preliminary result indicates that this is a possible explanation 
worth investigating. 
CONCLUSION 
Three cationic amphiphilic β-cyclodextrins were evaluated in their potential to 
act as non-viral vectors for the delivery of pDNA and mRNA, as a gene replacement 
therapy. The complexation behavior, as well as the physical characteristics (size and 
charge), were in a good range for a non-viral vector in HEPES buffer. CDplexes 
showed acceptable transfection efficiencies in a protein-reduced medium, in which 
mRNA gave higher transfection efficiency than pDNA. The more efficient 
formulations, however, also showed the highest toxicity toward the HeLa cells. When 
transfections were performed in protein-rich cell culture medium, no transfection 
could be detected. Cellular uptake seems to be hampered, which most likely explains 
the drop in transfection efficiency. A preliminary experiment indicates that there might 
be a disruption of the interactions between the CDs and cellular cholesterol by the 
presence of serum proteins. Further experiments should be performed to test this 
hypothesis. 
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Since the beginning of 2015, Science Direct reports around 6.000 scientific 
articles when a query is performed with the words “non-viral”, “gene”, and “therapy”. 
This comes down to a daily average of 15 papers within this field of research. Yearly, 
these numbers are steadily increasing since the beginning of the 21st century. The 
articles dealing with non-viral gene therapy can roughly be divided into two 
categories. In the first category, new gene delivery methods are introduced or 
evaluated, while in the second category the mechanisms behind the barriers 
encountered during gene delivery are investigated. Ultimately, both papers in the first 
and second category aim to contribute to the development of a non-viral gene 
therapy approved for use in the clinic. 
Nucleic acid-based non-viral therapy mostly involves one of the following three 
possible nucleic acids: small interfering RNA (siRNA), messenger RNA (mRNA), or 
plasmid DNA. siRNA is a small double stranded RNA molecule of 20-25 bp that 
silences the expression of a target gene via RNA interference. 1 To achieve this, the 
siRNA needs to be delivered into the cytoplasm of the cell. This is also the case for 
mRNA, which is a single stranded RNA molecule that can be translated into a 
functional protein in the cytoplasm of the cell. Plasmid DNA (pDNA) is a double 
stranded circular DNA molecule that can be transcribed in the cell’s nucleus into 
mRNA. This mRNA will migrate back to the cytoplasm where it will be translated into 
a functional protein. The delivery of nucleic acids to respectively the cytoplasm or the 
nucleus of the cell is one of the biggest challenges in this field. Not only does the 
therapeutic nucleic acids need to be protected from the harsh extracellular 
environment, it also needs to be taken up and be transported to the right intracellular 
compartment. For viral gene therapy recombinant viruses are used to achieve this. In 
early clinical trials, however, problems with deadly immunogenic responses and 
insertional mutagenicity occurred. Additionally, the viral particles are difficult and 
expensive to produce in a controlled manufacturing process. In the non-viral 
alternative, the nucleic acids are complexed with lipids or polymers, which are easier 
to synthesize on a large scale and can be modified in many ways. Additionally, they 
are less immunogenic and allow for the use of larger constructs that are necessary 
for the production of some larger proteins. Unfortunately the delivery efficiency is 
lower when compared to viral carriers, which have naturally evolved to accomplish 
efficient nucleic acid delivery into a variety of cell types. 
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A broad range of papers typically evaluate newly synthesized lipid or polymer 
particles, 2-4 follow-up on particles after a (pre-) clinical trial, 5-7 or deal with the 
evaluation of a new delivery technique to address the delivery challenge. 8, 9 Although 
the amount of newly described carriers for nucleic acids is high, the translation to 
further in vivo (human) studies is limited. The reason behind this discrepancy lies in 
the observation that high transfection efficiencies in vitro are predominantly obtained 
in optimized transfection media, or so-called serum reduced media, which contain the 
bare minimum of serum proteins that are necessary for cell growth and survival 
during the (limited) incubation period of cells with the carriers. When transfections are 
performed in cell culture medium or in vivo in an animal model, the carriers encounter 
a more complex environment with a whole range of (serum) proteins and the 
efficiency often decreases. 10 It is believed that the interactions with the serum 
proteins change the surface properties of the carefully synthesized particles, which 
disturbs uptake, leads to aggregation or to dissociation. 11 Therefore, when a drop in 
transfection efficiency is already seen in vitro in serum-containing media, further in 
vivo attempts seem premature and carriers should be optimized first before the in 
vitro evaluation process is started again. 12 Particles that do obtain high efficiencies in 
animal studies, however, are interesting to translate to the clinic, but from the 
hundreds of particles that show promise in animal studies, a very small amount 
makes it to clinical trials. Up until 2012, only 456 clinical trials with a non-viral 
approach (of which 75% are naked nucleic acids) have been started worldwide, 13 
leading to 1 approved non-viral therapy in Russia: Neovasculgen. This formulation 
treats peripheral arterial disease by intraneural injection of a naked plasmid, 
containing the vascular endothelial growth factor. Globally, three other gene therapy 
products with viral vectors are approved: 1) Glybera, which restores the patients 
lipoprotein lipase deficiency by the introduction of the gene for a functional lipase by 
an adeno-associated virus 1, 2) Gendicine, which treats head and neck cancer via a 
recombinant adenovirus engineered to contain the gene that expresses the wildtype-
p53, and 3) T-VEC, which is a melanoma immunotherapy that introduces an oncolytic 
granulocyte macrophage colony-stimulating factor gene carried by a herpes simplex 
virus type 1. 14 Despite this apparently discouraging number, especially for non-viral 
gene therapy, the results of some early phase (I/II) trials show great promise. 15 This 
optimism is represented by the renewed interest of major players in the 
pharmaceutical development, indicating that non-viral gene therapy is a realistic 
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option for the future of gene therapy. 14 Yet it is clear that more and better concepts 
need to be explored, guided by a better fundamental insight into the (cell) biology of 
nucleic acid delivery. 
Most research papers dealing with fundamental aspects of non-viral gene 
delivery focus on unravelling the mechanisms of the extra and intracellular barriers, 
16, 17
 or try to understand the effect modifications have on the interaction of the non-
viral particles with the extra and intracellular environment. 18, 19 The knowledge that is 
obtained in this research field, aids in understanding the challenges that non-viral 
particles encounter during gene delivery. Based on this, the design of particles can 
be adapted to anticipate the efficiency limiting steps posed by these barriers. 
Both in the in vitro research toward the synthesis and evaluation of new 
particles, as well as in the studies on the mechanisms involved in gene delivery, a 
very diverse collection of experiments and technologies are used. Nonetheless, some 
techniques recur throughout the articles. For example, fluorescent microscopy 
techniques have proven useful to study intracellular barriers to gene therapy. Live-
cell colocalization microscopy was, for example, used to study the different modes of 
cellular uptake and endocytosis, 20 endosomal escape, 21-23 and nuclear entry, 24 
while advanced microscopy techniques like fluorescence correlation spectroscopy 
(FCS) and raster image correlation spectroscopy (RICS) were used, for example, to 
measure nuclear concentration and mobility of different sizes of pDNA. 25 All these 
experiments give more information on the intracellular barrier or determine the 
mechanism behind the cellular process, which shows that fluorescence microscopy is 
a powerful tool in the field of non-viral nucleic acid delivery. 
The work in this thesis should be situated within the same category of 
research, since the main goal is to increase the understanding of the degradation of 
pDNA as a potential barrier to non-viral gene delivery. As there are currently no 
straightforward techniques available for the determination of pDNA degradation in 
complex biological environments or in living cells, we made use of advanced 
microscopy methods and in particular FCS and SPT for that purpose. These 
fluorescence microscopy methods both use fluorescence to obtain information on the 
level of the individual molecule. Therefore, this fluorescence needs to be introduced 
into the system under investigation. A variety of fluorescent dyes, probes, and stains 
to label the carrier, the nucleic acids, or particular cellular components are available 
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for these applications. We focused on the evaluation and application of fluorescent 
labeling techniques for nucleic acids to investigate their functionality after delivery by 
non-viral carriers. When we look at the attachment of fluorescent labels to nucleic 
acids, a diverse range of labeling methods is available. All these options have 
interesting properties (versatility, broad range of dyes, sequence specificity, etc.) that 
in some cases could provide additional information on the studied intracellular 
process, but could also alter the properties of the nucleic acid, inducing artefacts. For 
that reason, we felt the need for a clear and concise description and evaluation of a 
broad spectrum of labeling techniques that are of interest for live-cell imaging 
experiments. Special attention was given to the effect of random covalent labeling on 
transfection efficiency. The results indicated that labeling in itself has an influence on 
the performance of pDNA after transfection with Lipofectamine. This is important, 
since the labeling method has an influence on the process under investigation. For 
this reason, this work gives important information on which processes exactly are 
affected at a high labeling density. To put it differently, our work offers the possibility 
to choose a labeling density that is low enough to have no or a low effect on the 
performance of the nucleic acid, while still being high enough to be detectable by the 
microscopy techniques used. Brighter labels and more sensitive detection technology 
may in the future also further reduce the number of labels needed. In microscopy, 
this more sensitive detection is obtained by using advanced methods like FCS-based 
methods and SPT, which provide the tools to use very low concentrations of 
fluorescent labels, while delivering detailed information on the diffusion coefficient 
and concentrations of the molecules of interest. We evaluated different analysis 
methods for FCS and SPT for their potential to measure the concentrations of large 
pDNA molecules in buffer and in a biological environment to quantify DNA 
degradation. SPT, after imaging with a swept field confocal microscope, proved to be 
a suitable technique to follow degradation of pDNA in cell lysate obtained 4, 8, and 
24 hour after lipofection. These results indicated that degradation over this period is 
significant, since a large portion of the pDNA that is taken up by the cells (4 hour 
mark) is lost for protein expression. This again illustrates the difficulties non-viral 
nucleic acid therapy has to overcome, to reach a high transfection efficiency. In the 
future, this type of experiment could be used to asses if intracellular degradation is 
dependent on the delivery method or that it is a logical consequence of the presence 
of pDNA in the cytoplasm before nuclear entry. 
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Furthermore, this experiment shows the total loss of pDNA over the complete 
cellular pathway, but it would be interesting to identify the losses induced by each 
barrier. This could be done by colocalization or FRET microscopy. It was, for 
example, already shown that the combination of colocalization microscopy and 
double labeled pDNA could be used to follow degradation, 26 but information of the 
cell compartment was lacking. With the knowledge obtained through these 
experiments, not only the carriers’ chemical composition or surface chemistry could 
be optimized, but also better estimations for the total dose that needs to be 
administered to have a sufficient therapeutic effect can be derived. This dose 
optimization cannot only be advantageous with regard to obtaining a higher 
efficiency, but is also important to avoid the administration of too much therapeutic 
product for a number of reasons. First, too high doses might induce high levels of 
cytotoxicity and secondly production of non-viral vectors is expensive, so knowledge 
of the right dose is also beneficial for the manufacturer and for the patient. 
When we now focus on the future of fluorescent labeling, it is our belief that 
the labeling methods, that are used at this moment for the labeling of exogenous 
DNA, are sufficient for the live-cell imaging applications. The opportunities lie in the 
smart use of these techniques for the study of certain cell barriers. An easy example 
of this is that when transcription is studied, a method needs to be used that does not 
label the DNA in the coding region. The option of a sequence-specific labeling 
method with an affinity for a recognition array outside of the coding region would in 
this case be a logic choice. If we think one step further, designing the nucleic acids 
with a particular research question in mind can also increase the information that can 
be obtained from the experiment. Jude et al. (2013)27, for example, designed their 
own so-called cruciform DNA, which enabled them to look at DNA topology in real 
time. A fluorescent dye and a quencher were attached to opposing sites of an 
inverted repeat sequence. A conformational change, due to the presence of a 
topoisomerase or gyrase, resulted in the gain or loss of fluorescence, detected by a 
plate reader. For our research designing our own type of double labeled pDNA would 
be one of the next steps which were already initiated at the end of my PhD period. 
pDNA, labeled at two recognition arrays with spectrally different labels would then be 
used to follow the intracellular degradation. Live-cell imaging as well as SPT could be 
used in this case to visualize this. Since we don’t expect much mobility of the pDNA 
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inside the cell, FCS would be less suitable here. The cruciform pDNA, that is 
described before, would also be an interesting alternative since a change in topology 
is also induced by endonuclease activity and has been seen to lower transfection 
efficiency, 28 this type of plasmid could be introduced into a living cell to monitor DNA 
degradation in real time by sensitive live-cell microscopy. 
Another interesting development is the increasing amount of in situ labeling 
methods which enable visualization of nucleic acids directly inside the cell. Therefore, 
target cells express nucleic acid-binding proteins that are fused to fluorescent 
proteins (GFP, for example) 29-32 or –alternatively- nucleic acid-binding small 
molecules, 33 or detection probes 34 are introduced into the cell via microinjection, 
electroporation, bioballistics, chemical cell permeation, or via photoporation after 
which they can bind to their target sequence. The binding of multiple labels on each 
target nucleic acid allows for their detection the moment they reach a cell 
compartment or are transcribed in the nucleus, while the unbound molecules are not 
visible. 35 This would for example allow for the detection of endosomal escape or 
nuclear entry in real time, since binding of the fluorescent moiety can only occur 
respectively in the cytoplasm or in the nucleus. 
Label-free detection of polynucleotides is another promising development. The 
biggest advantage is that the use of bulky fluorophores or haptens is avoided by 
employing the molecule’s own chemical fingerprint for visualization. Additionally, the 
lack of the disadvantages of fluorescent labels, like photobleaching and phototoxicity, 
should allow for longer acquisition periods, eliminating a bottleneck for fluorescence 
live-cell imaging. One of the most promising techniques to achieve the visualization 
of nucleic acids in vitro and in vivo is stimulated Raman spectroscopy. 36-38 
All these new techniques and labeling options should ultimately be used to 
obtain a better knowledge of the cellular environment. It is in our opinion of 
importance that this information is translated into the development of new particles. A 
direct collaboration between an imaging specialist and a cell biologist is a first step to 
incorporate the most recent advances in imaging with the research questions posed 
in cell biology. These new fundamental insights into the cellular mechanisms should 
in turn lead to chemical modification of particles by chemical synthesis experts to 
obtain favorable properties. The evaluation of these particles can then again benefit 
of the developed microscopy techniques. In this way, the synthesis of new particles 
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could be steered by fundamental observations. This type of multidisciplinary 
approach offers, in our opinion, the best possibility for non-viral gene therapy 
products to reach the clinic. 
In summary, non-viral gene delivery is a field that is investing much effort in 
the synthesis and evaluation of new carriers. Despite all these efforts in the last two 
decades, the clinical translation is still lagging behind. A more directed design of the 
carriers seems to be the key to unlock the gateway to efficient non-viral nucleic acid 
delivery. Multidisciplinary research facilities could aid in this regard. The association 
of fundamental research with fast and adaptive chemical synthesis, backed up by the 
most advanced evaluation techniques, should create an atmosphere were progress 
in the field of non-viral drug development can be made. To move forward from such a 
successful research drug to a clinical used medicine, collaboration with the 
pharmaceutical industry will also be necessary. For this reason, an optimistic view 
toward the future of non-viral gene therapy is justifiable. The newly found interest and 
investments of major pharmaceutical companies in gene therapy, can be the boost 
that is needed to get non-viral nucleic acid therapy from bench to the bedside. 
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Gene replacement therapy is a field of research in which the scientific 
community has spent a tremendous amount of effort over the last two decades. The 
idea of not only treating the symptoms of a disease, but foremost treating the cause, 
is indeed promising. To that end, a correct therapeutic gene needs to be introduced 
into the cell in the right cellular compartment (cytoplasm for mRNA and nucleus for 
plasmid DNA (pDNA)). Different strategies to achieve this have been developed over 
the years. Originally, the main delivery strategy consisted of inserting unprotected 
nucleic acids into the body close to their target and hoping that they spontaneously 
reach and internalize into the cells. Low efficiency was obtained with this approach, 
with instability of the nucleic acids in the body as one of the major reasons. Nucleases, 
for example, that are present in the extra and intracellular environment, not only act as 
a defense mechanism toward foreign genetic material from viral or bacterial origin, but 
also function as a clearing mechanism for endogenous nucleic acids that originate from 
the normal regeneration cycle of cells. To protect the therapeutic gene vectors from 
degradation, protective vehicles were adapted from nature, in the form of recombinant 
viral particles, or developed by chemical synthesis. The viral vectors have the 
advantage that evolution has adapted them to hijack the cellular machinery of 
organisms for the expression of viral genes, needed for their own reproduction. This 
leads to highly efficient gene carriers, but next to being limited in their therapeutic cargo 
and requiring a challenging production process, the main concern for clinical use is 
immunogenicity. Clinical trials have shown that these concerns were not idle. 
Non-viral nucleic acid carriers are in this regard a safer choice. Two main types 
of non-viral vectors can be distinguished. On one hand we have the cationic lipid-based 
carriers and on the other hand we have the cationic polymer-based gene carriers. The 
addition of negatively charged nucleic acids leads to nucleic acid – carrier complexes 
with low immunogenicity coupled to a controllable chemical production process. 
However, the efficiency of gene expression cannot compete with their viral 
counterparts, as they are less adapted to overcome the biological barriers that are 
encountered during the delivery process. First of all, after intravenous injection, 
nucleases as well as immune cells in blood try to eliminate circulating exogenous 
materials. Also, blood proteins may lead to aggregation of the nanocarrier, dissociation 
of the nucleic acid – nanocarrier, or loss of targeting functionality. Therefore, protective 
and stabilizing characteristics of the carrier are required. While protecting the nucleic 
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acids, the complexes need to extravasate out of the circulation into the surrounding 
tissues to avoid clearance by, among others, the liver, spleen or kidneys and to reach 
the target cells. Following extravasation and transport across the extracellular space, 
the nanocarrier finally reaches its target cell where it can commence its intracellular 
journey. The cellular uptake poses a first barrier. In general uptake happens through 
endocytosis, leading to particles that are located in early and sorting endosomes at 
first. From there on the endosomes mature into late endosomes and finally fuse with 
lysosomal vesicles to become endolysosomes. Due to the low pH and presence of 
degradation enzymes in endolysosomes, nanocarriers should preferably escape to the 
cytoplasm while being in early to late endosomes. Successful endosomal escape is, 
however, currently recognized as one of the major bottlenecks on the intracellular level 
to successful gene therapy. Those carriers that successfully reach the cytoplasm need 
to be able to release their nucleic acid cargo in order to produce a biological effect. In 
case of mRNA the cytoplasm is the suitable end location. Plasmid DNA, however, 
needs to overcome one additional barrier, namely the nuclear envelope, as it should 
be transcribed into mRNA in the nucleus before being ultimately translated into the 
therapeutic protein. For pDNA it is well-known that nuclear translocation only happens 
efficiently after cell division. This means that the pDNA might reside a relatively long 
time in the cytoplasm before cell division occurs. During that time, degradation can 
again occur due to the presence of nucleases. Considering all those barriers, it comes 
as no surprise that successful delivery of therapeutic nucleic acids is a major challenge 
with ample room for improvement. Rational development of gene therapy nanocarriers 
requires thorough understanding of how they interact with each of those barriers. 
Fluorescence microscopy, and especially live-cell fluorescence imaging, has proven to 
be a particularly powerful tool to investigate the interactions of gene therapy carriers 
with the biological barriers. It offers detailed insight in the cellular processing of 
nanocarriers, especially on the intracellular level. 
The general aim of this thesis was to investigate the barrier posed by enzymatic 
degradation encountered by pDNA during the different steps of the transfection. As 
currently there are only limited methods available to follow pDNA degradation in more 
complex biological environments, we evaluated the use of two advanced fluorescence 
microscopy methods for this purpose, namely fluorescence correlations spectroscopy 
(FCS) and single particle tracking (SPT). To be able to measure the pDNA with these 
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techniques, evidently they need to be labeled with a fluorescent tag. In the design of 
microscopy experiments, however, attention to the labeling method that best suits the 
eventual application is often lacking. In Chapter 1, we therefore presented an overview 
of the full range of methods to attach fluorescent molecules to pDNA and mRNA. This 
detailed overview lists the advantages and disadvantages encountered when working 
with the different labeling methods. It is clear that there is more than one method that 
is ideal for every fluorescence microscopy experiment. For this reason, considerations 
like ease of use and cost can play an important role while choosing a labeling method. 
With the information included, a researcher designing a live-cell imaging experiment 
that follows nucleic acids during intracellular trafficking should be able to make an 
informed decision on which labeling methods suit the experiments best. Special 
attention is given to the effect of the nucleic acid labeling methods on the intracellular 
processes that lead to the induction of protein expression in the cell, a process also 
called transfection. 
In Chapter 2, the theory and methodology behind the two advanced 
fluorescence microscopy techniques, that are used throughout this thesis, are 
presented. This should improve the understanding of the terms and the analysis 
methods that are used further on in the thesis. 
Building onto Chapter 1, a deeper look into the effect the fluorescent labeling 
methods have on the intracellular processing and transfection is presented in Chapter 
3. Different amounts of fluorescent labels were attached to pDNA with a frequently 
used commercial labeling kit. This covalent attachment couples a fluorophore directly 
to the nucleobase, with a preference for the guanine nucleotides, but without any 
sequence specificity. This results in random labeling of nucleotides in plasmids. Using 
Lipofectamine as a transfection agent, it was seen that a maximum of on average 10 
labels could be attached per plasmid without inducing a problematic drop in 
transfection efficiency. We then investigated the reasons behind this observation. Our 
experimental data showed that, while cellular uptake was not affected, the dissociation 
of the pDNA from the lipoplex, the endosomal escape, and the transcription of the 
pDNA by the cell were altered. We hypothesize that the presence of hydrophobic 
fluorescent labels induces a higher affinity towards the lipophilic transfection agent and 
endosomal membranes, thus leading to problems with pDNA release and endosomal 
escape. In addition, attachment of fluorescent labels to the nucleobase also might 
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induce steric hindrance to the cellular machinery for transcription, leading to reduced 
protein expression. Our results show that plasmid labeling density should not be too 
high in order not to disturb the normal pDNA intracellular processing. 
One of the intracellular barriers to gene therapy is the potential degradation of 
nucleic acids after being delivered in the cell’s cytoplasm. In Chapter 4, we evaluated 
two advanced microscopy techniques which might have the capacity to measure the 
degradation of (fluorescently labeled) pDNA. FCS and SPT are both microscopy 
techniques that have been reported to be able to measure the concentration of 
fluorescently labeled compounds. In this chapter we compared both of them to see 
which one is better fit to the task of measuring degradation of pDNA. It was found that 
FCS could not reliably retrieve the ratio of intact and degraded pDNA in well-defined 
mixtures. Likely this is due to the fact that intact plasmids contribute more strongly to 
the intensity-based autocorrelation curve. SPT measurements performed on a swept-
field confocal microscope (SFC), in combination with an in-house developed and 
previously published concentration analysis method, could very well retrieve the 
expected ratios between intact and degraded pDNA. FCS and SPT were subsequently 
applied to measure the degradation of pDNA subjected to DNase I degradation. SPT 
was the only technique that could successfully retrieve a profile that represented the 
degradation pattern as observed on the control agarose gel. SPT was finally applied 
to follow plasmid degradation in a biologic medium. Cell lysate was obtained at different 
time points after lipofection with fluorescent labeled pDNA. The results showed that 
pDNA is significantly degraded already 8 hour after lipofection and almost fully 
degraded after 24 hour, demonstrating that SPT is suited to investigate the degradation 
of pDNA in biologic media. 
In both Chapter 3 and 4, the random covalent attachment of fluorophores to 
pDNA was used. In Chapter 5 we explored a selection of alternative pDNA labeling 
strategies, namely the intercalating cyanine dimeric nucleic acid stains, hybridization 
of fluorescent labeled peptide nucleic acid (PNA) probes, methyltransferase-mediated 
enzymatic labeling, and a label-free method. Building forth on the results of Chapter 
3, a change in transfection efficiency was taken as a hallmark of the potential negative 
influence of the labels on the intracellular pDNA processing. None of the tested labeling 
strategies influenced the transfection efficiency of pDNA, except to the label-free 
labeling method. The sequence-specific methods (PNA hybridization and enzymatic 
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labeling) have the advantage that plasmids can be designed with special arrays of 
recognition sequences. This allows for plasmid designs that minimize the interference 
of the fluorophores with the coding sequence. Also double labeling and the attachment 
of interesting non-fluorescent molecules is possible, enabling a wide range of 
modifications. These custom designs are on the other hand very specific and decrease 
the interchangeability of the labeling method for other plasmids of interest. In the label-
free approach, a modified nucleotide with an alkyne group was incorporated in the 
pDNA to enable visualization by stimulated Raman spectroscopy. Our data showed 
that this modification resulted in the loss of functionality of the pDNA. In this regard, 
the random Mirus nucleic acid labeling kit, might still be the best choice when used at 
the right fluorophore density (cf. Chapter 3 and 4).  
Finally, the potential of three new non-viral carriers was evaluated in Chapter 
6. Three polycationic amphiphilic β-cyclodextrins (paCDs) were complexed with pDNA 
and mRNA and stability and transfection efficiency were assessed. Transfection 
experiments in an optimized serum-free transfection medium showed efficiencies 
slightly lower than Lipofectamine for one of the paCDs, while the others were slightly 
less efficient. When the transfections were carried out in serum-containing cell culture 
medium, the efficiencies decreased over the whole line. Cellular uptake was found to 
be significantly lower for most paCDs when the transfections were carried out in the 
presence of serum. Further experiments indicate that the interaction between paCDs 
and cellular cholesterol might play an important role in the cellular uptake of the 
complexes. The pre-incubation of the paCD-pDNA complexes with cholesterol before 
addition to cells, resulted in a drop in cellular uptake. This indicates that the saturation 
of the hydrophobic cavity of the paCDs, disturbs the interactions with the cellular 
cholesterol and subsequently the cellular uptake. Our hypothesis is that serum proteins 
also block these interactions by adsorption to the paCD complexes. 
Taken together, we conclude that the use of microscopy methods is highly 
valuable in the study and evaluation of barriers for non-viral nanoparticles. SPT on the 
images obtained by fast SFC microscopy is a suitable technique to study degradation 
of pDNA in a biological environment. It is, however, important that, next to the 
microscopy technique and the biologic parameters of the experiment, attention is given 
to the used fluorescent labeling method, since it might influence the cellular processes 
under investigation when a non-optimal labeling method was used. Also, one should 
SUMMARY AND GENERAL CONCLUSIONS 
PAGE | 228 
take into account that apart from the enzymatic degradation of nucleic acids, many 
other extracellular and intracellular barriers exist that might limit the transfection 
efficiency. Therefore, we recommend to always study the transfection efficiency of 
newly developed carriers in conditions that are as close as possible to the eventual in 
vivo situation in which the carriers are expected to be used. The tremendous efforts to 
optimize new delivery systems and to understand the hurdles nucleic acids have to 
overcome before successful transfection will continue to shape the future of non-viral 
gene delivery. 
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Gentherapie is een onderzoeksgebied waarin de wetenschappelijke wereld de 
laatste twee decennia sterk heeft geïnvesteerd. Het idee dat niet enkel de symptomen, 
maar in de eerste plaats de oorzaak wordt behandeld is veelbelovend. Om dit te 
verwezenlijken moet een correct therapeutisch gen afgeleverd worden in het juiste cel 
compartiment (cytoplasma voor mRNA en de nucleus voor plasmide DNA (pDNA)). 
Over de jaren werden verschillende strategieën ontwikkeld om dit doel te bereiken. 
Oorspronkelijk bestond de belangrijkste afleveringsstrategie uit het injecteren van 
onbeschermde nucleïnezuren rechtstreeks in de nabijheid van de te behandelen 
cellen, waarna verwacht werd dat ze spontaan hun doelcellen bereikten en werden 
opgenomen. Dit resulteerde echter in een lage efficiëntie, die grotendeels te wijten was 
aan de instabiliteit van de nucleïnezuren in het lichaam. Eén van de oorzaken is de 
aanwezigheid van nucleasen in de extra- en intracellulaire omgeving. Deze familie van 
eiwitten doet niet enkel dienst als afweermechanisme tegen vreemd genetisch 
materiaal afkomstig van virale of bacteriële afkomst, maar is ook verantwoordelijk voor 
de vernietiging van nucleïnezuren afkomstig van de normale vernieuwingscyclus van 
lichaamseigen cellen. Om de toegediende therapeutische genen te beschermen 
werden dragers uitgezocht die gebaseerd zijn op de natuur, in de vorm van 
recombinante virale partikels, of aangemaakt via chemische synthese. De virale 
dragers hebben het voordeel dat ze door genetische evolutie aangepast zijn om de 
processen in cellen over te nemen om hun eigen genen tot expressie te brengen, wat 
leidt tot hun vermenigvuldiging. Ondanks dat deze aanpak aanleiding geeft tot zeer 
efficiënte genetische dragers, hebben deze virale dragers als nadeel dat ze beperkt 
zijn in de grootte van de therapeutische cargo en dat ze een zeer veeleisend 
productieproces hebben. Het grootste struikelblok om deze dragers toe te passen in 
de praktijk is echter dat ze een sterke immuunrespons kunnen opwekken, wat reeds 
werd aangetoond in klinische tests. 
Met deze kennis indachtig zijn niet-virale dragers voor nucleïnezuren een 
veiligere keuze. Twee belangrijke types van niet-virale dragers worden onderscheiden. 
In de eerste plaats hebben we de kationische dragers die bestaan uit polymeren. 
Wanneer hier negatief geladen nucleïnezuren aan worden toegevoegd ontstaan er 
nucleïnezuur- drager complexen die een lage immuunrespons verenigen met een 
eenvoudig te controleren chemisch productieproces. De efficiëntie om genexpressie 
op te wekken kan echter niet tippen aan hun virale tegenhangers doordat ze minder 
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aangepast zijn om de verschillende biologische barrières, die ze tijdens de aflevering 
van de therapeutische genen tegenkomen, te overwinnen. Wanneer deze dragers via 
intraveneuze weg worden toegediend, denken we hierbij in de eerste plaats aan de 
aanwezigheid van nucleasen en immuuncellen die aanwezig zijn in het bloed om 
lichaamsvreemd materiaal te verwijderen. Ook de aanwezigheid van eiwitten in het 
bloed kan leiden tot aggregatie van de dragers, loskomen van de nucleïnezuren van 
de drager, of het verlies van de werking van de complexen. Daarom worden dragers 
ontworpen zodat ze beschermende en stabiliserende eigenschappen tentoonspreiden. 
Dit is noodzakelijk aangezien de complexen vanuit het bloed naar de omliggende 
weefsels moet migreren om te ontsnappen aan de verwijdering uit de bloedbaan door, 
onder andere, de lever, milt, of nieren en om vervolgens de doelcellen te bereiken. 
Nadat ze de extracellulaire ruimte hebben bereikt moeten de complexen naar de 
doelcellen migreren waar de uiteindelijke intracellulaire aflevering zal plaatsvinden. 
Allereerst moeten de complexen opgenomen worden door de cellen, wat meestal 
gebeurt via het proces van endocytose. Dit leidt initieel tot complexen die zich in vroege 
en sorterende endosomen bevinden, waarna deze vesikels zich ontwikkelen tot late 
endosomen. Dit type endosoom zal zich uiteindelijk samenvoegen met lysosomale 
vesikels wat resulteert in endolysosomen die gekenmerkt worden door een lage pH en 
de aanwezigheid van enzymen verantwoordelijk voor de afbraak van biomoleculen. 
Om afbraak te vermijden moeten de complexen ontsnappen uit deze endosomen. 
Deze stap wordt over het algemeen beschouwd als één van de belangrijkste 
knelpunten voor de aflevering van producten voor gentherapie op het niveau van de 
cel. Wanneer de complexen hierin slagen moeten de nucleïnezuren loskomen van de 
drager om hun therapeutisch effect te hebben. Voor mRNA vindt dit plaats in het 
cytoplasma, maar in het geval van pDNA moet er nog een extra barrière overwonnen 
worden, namelijk de nucleaire envelop, waarna het pDNA wordt omgezet in mRNA dat 
uiteindelijk zal zorgen voor de expressie van het therapeutische eiwit. Het is reeds 
beschreven dat het nucleaire transport enkel plaatsvindt na de celdeling. Dit betekent 
echter dat het pDNA een relatief lange tijd moet doorbrengen in het cytoplasma voor 
er celdeling plaatsvindt. Gedurende deze tijd wordt het pDNA opnieuw blootgesteld 
aan nucleasen die zorgen voor afbraak. Met al deze barrières in het achterhoofd, mag 
het geen verrassing zijn dat het afleveren van nucleïnezuren allesbehalve een 
eenvoudige taak is waarbinnen verscheidene stappen ruimte bieden tot verbeteringen. 
Het op een rationele manier ontwikkelen van dragers voor gentherapie producten vergt 
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echter een vergaand begrip van de interacties die plaatsvinden tussen de betrokken 
componenten tijdens elke stap van de aflevering. Fluorescentiemicroscopie, en in het 
bijzonder het in beeld brengen van levende cellen, vormt hierbij een bijzonder krachtig 
wapen om deze interacties in kaart te brengen, vooral op het niveau van de cel. 
Het algemene doel van deze thesis was het onderzoeken van de enzymatische 
afbraak van pDNA die tijdens verschillende stappen van een transfectie plaatsvindt. 
Aangezien er momenteel slechts een beperkt aantal methoden beschikbaar zijn om 
afbraak van pDNA op te volgen in een complexe biologische omgeving, hebben we 
hiervoor twee geavanceerde fluorescentiemicroscopietechnieken geëvalueerd. Deze 
twee technieken zijn fluorescentie correlatie spectroscopie (FCS) en ‘single particle 
tracking’ (SPT). Om met deze technieken experimenten uit te voeren met pDNA is het 
noodzakelijk dat een fluorescent label wordt toegevoegd. Tijdens het ontwerpen van 
microscopie-experimenten wordt er echter weinig aandacht besteed aan het type 
labelingsmethode dat het meest geschikt is voor de gekozen toepassing. In Hoofdstuk 
1 is om deze reden een overzicht gegeven van het volledige assortiment van methoden 
die gebruikt worden om fluorescente labels te bevestigen aan pDNA en aan mRNA. 
Zowel de voor – als de nadelen van elke techniek werden opgelijst. Hieruit blijkt dat er 
vaak meer dan één methode is die, technisch gezien, het beste past bij elk 
fluorescentiemicroscopie-experiment. Om deze reden werd er ook rekening gehouden 
met het gebruiksgemak en de kostprijs van elke methode. Met de informatie die 
aangereikt werd in dit hoofdstuk zou een onderzoeker die nucleïnezuren wil 
visualiseren tijdens hun weg door de cel, gebruik makend van 
fluorescentiemicroscopie, voldoende moeten weten om een onderbouwde keuze te 
maken tussen de verschillende labelingsstrategieën. Extra aandacht is besteed aan 
het effect dat deze verschillende technieken hebben op de intracellulaire processen 
die leiden tot een succesvolle eiwitexpressie, ook wel transfectie genoemd. 
Vervolgens werd in Hoofdstuk 2 de theorie en methodologie achter beide 
geavanceerde fluorescentiemicroscopietechnieken (FCS en SPT) uitgediept. Hierdoor 
zou alle terminologie en de analysemethoden die doorheen de thesis gebruikt worden, 
duidelijk moeten zijn, zodat de experimenten in de volgende hoofdstukken makkelijker 
te interpreteren zijn. 
Op het effect van de fluorescente labeling op de intracellulaire verwerking en 
transfectie werd dieper ingegaan in Hoofdstuk 3. Verschillende hoeveelheden van het 
SAMENVATTING EN CONCLUSIES 
PAGINA | 234 
fluorescente label werden op het pDNA aangebracht gebruikmakend van een 
veelgebruikte commerciële kit. Hierbij worden fluorescente moleculen covalent 
gekoppeld aan een nucleobase en bij voorkeur op de guanine nucleotiden zonder 
enige voorkeur voor de rest van de sequentie. Het resultaat van deze reactie zijn 
plasmiden met willekeurig verspreide fluorescent gemerkte nucleotiden. Door gebruik 
te maken van het transfectiereagens Lipofectamine 2000, werd vastgesteld dat een 
gemiddelde van 10 labels het maximale aantal fluorescente labels is dat bevestigd kan 
worden aan één plasmide zonder een problematisch negatief effect te hebben op de 
transfectie-efficiëntie. We toonden aan dat de opname door de cel niet beïnvloed werd 
door de labels, maar dat het loskomen van het pDNA van de drager, de ontsnapping 
uit de endosomen, en de transcriptie van het pDNA naar mRNA in de celkern negatief 
werden beïnvloed. Onze hypothese stelde dat de aanwezigheid van hydrofobe 
fluorescente labels de affiniteit van het pDNA ten opzichte van zowel het lipofiele 
transfectiereagens alsook de endosomale membranen verhoogt. Dit leidt vervolgens 
tot problemen met de vrijgave van het pDNA van het complex en de ontsnapping uit 
de endosomen. Bijkomend zorgen de labels op de nucleobasen voor sterische 
hindering voor de enzymen in de celkern verantwoordelijk voor de transcriptie, wat leidt 
tot een lagere eiwitexpressie. Al deze resultaten geven aan dat de hoeveelheid labels 
per plasmide niet te hoog mag zijn om de normale werking van de intracellulaire 
processen te verzekeren. 
Eén van de intracellulaire barrières die nucleïnezuren tegenkomen nadat ze het 
cytoplasma van de cel bereiken, is enzymatische afbraak. In Hoofdstuk 4 werden 
twee geavanceerde microscopietechnieken vergeleken die mogelijk de afbraak van 
fluorescent gemerkte pDNA moleculen kunnen volgen. FCS en SPT zijn allebei 
microscopietechnieken waarvan reeds werd aangetoond dat ze in staat zijn om de 
concentratie te meten van fluorescent gemerkte moleculen. In dit hoofdstuk werd 
gekeken welke techniek beter geschikt was om de afbraak van pDNA te volgen. Onze 
bevindingen toonden aan dat diffusiemetingen via FCS de verhoudingen tussen intact 
en afgebroken plasmiden op onvoldoende wijze kon onderscheiden in vooraf 
samengestelde mengsels van beide varianten van pDNA. Dit was waarschijnlijk te 
wijten aan de grotere invloed die door de intacte plasmiden werd uitgeoefend op de 
intensiteit-gebaseerde correlatiecurve. De SPT metingen die werden uitgevoerd op 
een swept-field confocal (SFC) microscoop, gecombineerd met een 
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concentratieanalyse die binnen onze onderzoeksgroep werd ontwikkeld, slaagden er 
wel in om de verwachte verhouding tussen intact en afgebroken pDNA te achterhalen. 
FCS met piekanalyse en SPT werden vervolgens ingezet om de afbraak van pDNA 
met het endonuclease DNase I op te volgen over de tijd. SPT was de enige techniek 
die het afbraakprofiel kon achterhalen dat via de controle op agarosegel bepaald werd. 
Uiteindelijk werd SPT gebruikt om de afbraak van plasmiden te volgen in een 
biologische omgeving. De concentratie aan intact pDNA werd, op verschillende 
tijdstippen na lipofectie met fluorescent gemerkte plasmiden, gemeten in cellysaat. De 
resultaten toonden aan dat pDNA reeds 8 uur na de lipofectie significant afgebroken 
werd en zelfs bijna volledig afgebroken was na 24 uur. Dit resultaat toont aan dat SPT 
geschikt is om de afbraak van fluorescent gelabeld pDNA in een biologische omgeving 
te volgen. 
In zowel Hoofdstuk 3 als 4 werd de willekeurige covalente labeling van pDNA 
met fluorescente merkers gebruikt. In Hoofdstuk 5 werd een selectie gemaakt van 
alternatieve labelingstechnieken. ‘Cyanic dimeric nucleic acid stains’, 
hybridisatieprobes gebaseerd op fluorescente peptide nucleïnezuren (PNA), 
methyltransferase-gebaseerde enzymatische labeling en een niet-fluorescente ‘label-
free’ methode waren de technieken die geëvalueerd werden op basis van hun 
transfectie-efficiëntie (cf. Hoofdstuk 3). Aangezien deze parameter kan gezien 
worden als de lakmoesproef voor de invloed van de fluorescente labels op de 
intracellulaire verwerking van pDNA. Geen enkele fluorescente labelingstechniek 
beïnvloedde de transfectie-efficiëntie van pDNA ingrijpend. Wanneer de niet-
fluorescente “label-free” methode werd gebruikt was er echter geen transfectie meer 
te detecteren. De sequentiespecifieke technieken (PNA hybridisatie en enzymatische 
labeling) hebben als bijkomend voordeel dat plasmiden zo ontworpen kunnen worden 
dat ze afgelijnde regio’s bevatten met meerdere herkenningssequenties. Hierdoor 
wordt de invloed van de fluorescente merkers op de coderende pDNA sequentie 
geminimaliseerd. Bijkomend kunnen ook plasmiden worden ontworpen met de 
mogelijkheid voor een dubbele labeling met twee kleuren of het bevestigen van niet-
fluorescente moleculen die de aflevering positief beïnvloeden. Deze ontwerpen zijn 
echter zeer specifiek wat uitwisseling van de labelingsmethode over verschillende 
types plasmiden minder praktisch maakt. Wanneer de niet-fluorescente “label-free” 
techniek werd gebruikt, werd een alkyne-gemodificeerd nucleotide ingevoegd. Dit 
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alkyne maakt visualisatie met gestimuleerde Raman spectroscopie mogelijk. Onze 
resultaten met deze techniek toonden echter aan dat alle functionaliteit verdwijnt na 
de toevoeging van het gemodificeerd nucleotide aan pDNA. Met de voorgaande 
informatie in het achterhoofd, kunnen we besluiten dat Mirus nucleïnezuur labelingskit 
waarschijnlijk de beste keuze blijft, wanneer de juiste hoeveelheid fluorescente merker 
gebruikt wordt (cf. Hoofdstuk 3 en 4). 
In Hoofdstuk 6 werd het potentieel van drie nieuwe niet-virale dragers 
geëvalueerd. Deze drie polykationische amfifiele β-cyclodextrins (paCDs) werden 
gecomplexeerd met pDNA en mRNA waarna de stabiliteit en de transfectie-efficiëntie 
werden bestudeerd. De transfectie-experimenten in een geoptimaliseerd serumvrij 
transfectiemedium toonde aan dat de efficiëntie slechts marginaal lager lag dan bij de 
transfecties met Lipofectamine. Wanneer ze werden uitgevoerd in celcultuurmedium 
dat serum bevat, viel de efficiëntie terug voor alle complexen tot een verwaarloosbare 
hoeveelheid. De daaropvolgende experimenten toonden aan dat de interactie tussen 
cellulaire cholesterol en de paCDs een belangrijke rol zou kunnen spelen met 
betrekking tot de opname in de cel. Er werd namelijk gezien dat het toevoegen van vrij 
cholesterol aan de paCD complexen de opname in de cel verhinderde. Dit toont aan 
dat de saturatie van de hydrofobe holte van de paCDs de interacties met cellulair 
cholesterol bemoeilijken. Om deze reden luidde onze hypothese dat bij het uitvoeren 
van een transfectie in de aanwezigheid van serumproteïnen deze interacties eveneens 
verhinderd worden, wat leidt tot een verlaagde opname in de cel. 
Kortom, we kunnen concluderen dat het gebruik van microscopietechnieken 
zeer waardevol is in de studie en de evaluatie van niet-virale nanopartikels. SPT, dat 
wordt uitgevoerd op de beelden opgenomen met een snelle SFC microscoop, is een 
geschikte methode voor het bestuderen van afbraak van pDNA in een biologische 
omgeving. Naast de microscopietechniek en de biologische parameters van het 
experiment is het echter belangrijk dat aandacht wordt besteed aan de techniek 
waarmee fluorescente labels aan de nucleïnezuren worden bevestigd. De keuze voor 
een suboptimale techniek zou namelijk een invloed kunnen hebben op het cel proces 
dat bestudeerd wordt. Naast de enzymatische afbraak van pDNA, moet men ook altijd 
rekening houden met de vele andere extra-en intracellulaire barrières die aanwezig 
zijn tijdens een transfectie. Daarom zijn wij ervan overtuigd dat de transfectie-efficiëntie 
van nieuwe dragers altijd bestudeerd moet worden in een situatie die nauw aansluit bij 
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de in vivo situatie waarin de dragers gebruikt gaan worden. Al deze inspanningen om 
nieuwe afleveringsmethoden te optimaliseren en om de knelpunten te bestuderen die 
nucleïnezuren moeten overwinnen om een transfectie te veroorzaken, zullen in de 
nabije toekomst van het onderzoeksveld van de niet-virale dragers, de grootste 
uitdaging blijven vormen.
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Vier en een half jaar werken in het labo voor algemene biochemie en fysische 
farmacie (vanaf nu kortweg hét labo), maanden schrijven aan deze thesis, weken 
voorbereiden op de verdediging(en), dagen stressen om alle last-minute correcties 
uit te voeren…en dan rest me enkel nog het schrijven van het dankwoord. Het, zeer 
waarschijnlijk, vaakst gelezen stukje tekst uit de meeste doctoraatsthesissen. 
Ondanks de zware last op mijn schouders om er dan ook iets leuks van te maken, 
doet het ook ongelooflijk veel plezier om dit te mogen schrijven. Net zoals iedereen 
heb ik namelijk een hele waslijst aan mensen die ervoor hebben gezorgd dat ik sta 
waar ik nu sta en naar mijn gevoel is dat op alle vlak op een heel andere (en betere!) 
plaats dan waar ik gestart ben. Ik zou jullie dan ook graag snel willen meenemen in 
een beknopte “highlight reel” van de periode tussen aankomst op het labo en het 
heden. 
Voor ik daarmee van start ga wil ik eerst de mensen bedanken die mij hebben 
begeleid in elke stap van het wetenschappelijke parcours dat ik heb afgelegd. 
Katrien, als mijn principal investigator/begeleidster heb je veel tijd en moeite besteed 
aan mijn werk en veel geduld met mij gehad. Het zou een leugen zijn om te zeggen 
dat alles van een leien dakje liep, maar ik denk dat we er uiteindelijk in zijn geslaagd 
om dingen te creëren die de moeite waard zijn. Meer nog dan het wetenschappelijke 
zal ik echter vooral je eerlijkheid en directheid onthouden. In mijn ogen is dat een 
kwaliteit die zorgt voor een betere verstandhouding en samenwerking. Ik wil je dan 
ook bedanken voor alle ideeën, verbeteringen, discussies, vertrouwen en vooral voor 
de eerlijke gesprekken over waarom dingen soms niet vlot liepen! 
Naast Katrien kon ik ook rekenen op mijn tweede promotor Kevin. Ondanks 
dat we de laatste twee jaar iets minder samenzaten om de wetenschappelijke ideeën 
en resultaten te bespreken, slaagde je er altijd in om zeer snel de problemen te 
detecteren en oplossingen aan te reiken wanneer we elkaar spraken. Verder ben je 
onwaarschijnlijk sterk in het aanscherpen van een tekst. Met soms kleine, en vaak 
grote, ingrepen kan je een tekst meer dan één niveau hoger tillen. Dit vakmanschap 
(want hoe zou je dat anders kunnen benoemen?) heeft zonder twijfel enorm 
bijgedragen aan het welslagen van mijn doctoraat en daar wil ik je graag voor 
bedanken! 
Behalve mijn promotoren is het labo nog twee andere professoren rijk. In de 
eerste plaats Prof. (Emeritus) Demeester, kortweg Jo, die mij vooral zal bijblijven als 
de persoon die het labo deed “draaien” als director en de prof die zeer begaan was 
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met het goede verloop van de practica. Prof. De Smedt, kortweg Stefaan, is tenslotte 
de man die als geen ander de juiste vragen kan stellen. Deze wetenschappelijke, 
maar ook vaak filosofische, interpellaties zorgden vaak voor verwarring en soms tot 
hilariteit, maar mondden uiteindelijk altijd uit in een aha-erlebnis. Ook jullie wil ik dan 
ook graag bedanken voor de kansen die ik via het labo heb gekregen. 
Zoals eerder gezegd zou ik jullie als lezer even snel meenemen door een 
korte tocht door mijn periode op het labo. 
Op mijn eerste dag op het labo voor algemene biochemie en fysische farmacie 
kwam ik, met een bang hartje, onder de hoede van Prof. Braeckmans en -toen nog- 
Post-doc Katrien terecht. Zoals gebruikelijk begint die eerste dag met een rondleiding 
langs alle bureaus. Onmiddellijk werd ik voorgesteld aan waarschijnlijk de drie 
belangrijkste personen die het labo rijk is: onze secretaresses Katharine en Ilse en 
onze rots in de branding/manusje van alles/practicumgoeroe Bart L.. Katharine en 
Ilse, bij jullie kan je altijd terecht voor alle administratieve zorgen, organisatorische 
vragen, maar evengoed leven jullie mee met de stress die bijvoorbeeld het printen 
van een thesis met zich meebrengt of hebben jullie nog een motiverend woordje over 
vlak voor de interne verdediging. Dankjewel om er altijd voor te zorgen dat alles op 
wieltjes loopt! Voor eender welke andere vraag kan je altijd terecht bij Bart. Zo’n 
multi-getalenteerde kerel als jou heb ik nog niet vaak nooit ontmoet. Hoe jij er elke 
keer in slaagt om iets, al dan niet op de conventionele methode, te fixen daar doe ik 
mijn petje voor af. Daarnaast ben je een wandelende encyclopedie van het 
practicum, waar ik met veel plezier 5 keer aan heb mogen meewerken. Ik kan mij 
inbeelden dat je de woorden: “Ah Bart, ’t is Koen hier ee. Is er nog … ” wel kotsbeu 
bent gehoord. Ondanks al die straffe toeren die ik hier net heb opgesomd, ga ik je 
toch vooral missen als enorm wijze kerel (zowel in de Nederlandse als in de Gentse 
betekenis) die altijd wel zin heeft in een pintje en een feestje. Hopelijk mogen we nog 
vaak klinken! 
Op weg naar mijn nieuwe bureau werd ik voorgesteld aan allemaal nieuwe 
collega’s om uiteindelijk aan te belanden bij Dries. Dit Duracell-konijn was bezig aan 
zijn laatste maanden op het lab en wilde onmiddellijk alles weten over mijn 
toekomstige onderzoek. Een binnenkomer van jewelste! Naast zijn tomeloze 
enthousiasme verdient hij nog een eervolle vermelding als inspiratiebron voor de lay-
out van deze thesis. Merci! 
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Toen ik uiteindelijk plaatsnam aan mijn plekje voor de volgende 4.5 jaar, 
merkte ik al snel dat ik terecht kwam in een iets kalmere bureau. Met Bart Geers, 
Koen Ra. en Nathalie kwam ik terecht bij drie totaal verschillende karakters, waar ik 
graag de bureau mee deelde. Ik vond er ook snel gelijkgestemden over “de laatste 
kms” van de tour of de finale van de 100m op het wk atletiek snel meepikken. Bart 
G., ook wel gekend als den Barry kwam ik daarnaast, samen met Marie-luce ook 
tegen in het practicum. Tijdens dat eerste jaar kon ik dat geen onverdeeld succes 
noemen, maar ik pikte heel veel op van de geboren onderwijzer die Bart is. Dankzij 
dat stichtende voorbeeld, werd het practicum vanaf het tweede jaar iets om naar uit 
te kijken. Samen met Katrien F., Rein, Joke en Karen heb ik daar veel 
topmomenten (en ook veel oersaaie momenten) mogen beleven. 
Naarmate de tijd vorderde verminderde mijn initiële schuchterheid dankzij de 
altijd gezellige lunchpauzes, die toen collectief van 12u30 tot 13u30 werden 
gehouden, burgerevents onder de mannen en andere festiviteiten. Meer en meer 
dingen werden georganiseerd en wanneer er het volgende jaar enkele 
toptoevoegingen werden gedaan aan het labo, begon er een periode die ik tussen 
pot en pint de “golden years” durf te noemen. De perfecte mix tussen karakters, maar 
vooral het gedeelde enthousiasme voor TGIF-drinks, pizza en een pintje in het park 
en een ongepland stapje in het Gentse uitgaansleven zorgden voor een fantastische 
tijd. Het labweekend kreeg een nieuw leven, mede doordat er een cultureel 
verantwoord brouwerijbezoek werd ingevoerd en er vervolgens Gangnam Style-
gewijs moest worden aangetreden voor het filmpje voor de PhD verdediging van Bart 
G.. 
Meer en meer activiteiten werden de volgende tijd georganiseerd en volgens 
sommigen moest het “social committee” daardoor een nieuw leven worden 
ingeblazen. Er werd beslist dat ik mij vanaf dat moment tot die taak zou kwijten. Ik 
vond dat dit wel een titel verdiende, dus bedachten we de titel CPO (Chief Party 
Operations/Officer). Veel verder dan de permanentie verwittigen wanneer we bleven 
plakken na het werk, het vastleggen van de Sioux/Apache voor onze, ondertussen 
legendarische, labofeestjes en het organiseren van enkele lab events ging deze 
functie gelukkig niet. 
Door het afleggen van het doctoraat van Nathalie en door de “promotie” van 
Koen Ra naar de “Post-Doc bureau” werd mijn bureau ondertussen een beetje 
drukker. Het Italiaanse temperament en vrolijkheid (wat soms gepaard gaat met 
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gezang) van Elisa en de iets rustigere, gezellige babbeltjes met Freya vulden met 
glans het vertrek van hun voorgangers op en doordat ook Bart aflegde, kwam de plek 
recht tegenover mij vrij. Ondanks de diepe voetsporen die moesten gevuld worden 
vulde Lotte die met verve en af en toe met een tragikomische noot. Haar problemen 
met de SFC zorgden vaak voor hilarische (voor ons, minder voor jou) gesprekken. 
Zoals dat gaat met PhD’s verlieten er nog meer mensen het labo. Eerst gingen 
onze minzame SPT wizard Hendrik, en onze Limburgse practical joker Katrien F. 
andere oorden opzoeken. Daarna volgde Thomas -qui est-tu?- Mertens, euh, 
Martens. Naast een topwetenschapper – en gitarist ben jij ook gewoon een 
fantastische kerel! Een drukke periode met doctoraatsverdedigingen bood zich 
daarna aan met de flamboyante Poolse Mad Dog-queen Oliwia en de doctoraten 
van de twee toppers Heleen en Lynn die allebei op een compleet andere manier 
zorgden voor enorm veel humor tijdens de middagpauze. Heleen jouw scherpe 
opmerkingen en Lynn jouw gave om gênante opmerkingen enkel maar erger te 
maken ga ik ongetwijfeld missen. Het lab mag blij zijn met twee zo’n top-Post-Docs! 
De laatste die vertrok voor het mijn beurt is, was Ine D.C., die haar mannetje 
makkelijk stond wanneer er Keizer Karels van de tap te krijgen waren en daarbuiten 
altijd wel in was voor gezelligheid. Naast de verste zendeling is zij ook direct de 
eerste van “mijn” generatie PhD studenten die hebben afgelegd. De derde van deze 
topgeneratie die binnenkort zal afleggen is Laura. Waarschijnlijk ben jij de liefste en 
meest empathische persoon die ik ooit tegenkwam. Succes met jouw laatste loodjes 
en diegenen waarbij je hierna gaat werken, mogen hun pollekes kussen met zo’n 
topper! 
Zo’n verloop betekent dat er ook nieuwe mensen moeten bijkomen en op één 
of andere manier slaagden de proffen er telkens opnieuw in om mensen aan te 
trekken die perfect binnen het plaatje pasten. Not long after my arrival, the always 
thirst Ranhua arrived at the lab. I’ll never forget how you mistakenly thought that the 
bottle with vanilla jenever was milk during a short hike at the lab weekend. Your face 
was precious (and again sorry for not telling you clearly). Rond dezelfde tijd kwam 
ook George erbij. George, my man, naast de manier waarop jij het Nederlands zo 
snel hebt opgepikt, wil ik toch ook even zeggen dat ik respect heb en jaloers ben op 
jouw werkethiek. Ook jij binnenkort veel succes met het vervolg van je carrière! 
Nog zo’n knaller is Stephan. Het voorbije anderhalf jaar hebben wij ’s middags 
veel arbeid verricht op de 14e verdieping van het UZ of langs de Schelde om een 
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beetje aan die torso’s te werken en ik kan niet ontkennen dat ik je daardoor nog meer 
als een echte maat beschouw (en dat was daarvoor ook al niet lief ;-)). Ondanks een 
drukke planning in jouw volgende maanden, hoop ik dat we toch een paar keer met 
de boys ouderwets een receptie’ke kunnen doen op de verdediging van Laura, maar 
ook daarna. In dezelfde periode dat Stephan erbij kwam, kregen we er met Karen 
een sprankelende persoonlijkheid bij. Jouw weetjes over zeezoogdieren, jouw 
tomeloos (en ja, soms is dat een beetje vermoeiend) enthousiasme en jouw 
bereidheid om altijd iedereen te helpen, maken jou één uit de duizend. Ook Freya 
kwam er in die periode bij en kwam zoals reeds gezegd in dezelfde bureau als ik 
terecht. Al snel bleek dat we qua smaak in muziek, reizen en andere zaken best wel 
op één lijn zaten. Ik ben er zeker van dat ik onze korte gesprekjes ga missen, waar ik 
hierna ook terecht kom. Elisa, although you already spent some time at the lab 
during your master thesis, at your “real” start at the lab, you also became an office-
buddy. Thank you for making my messy desk looking “tidy” next to yours ;-), but 
foremost thank you for always being your happy self! 
De derde vrouw die ik office-buddy mocht noemen is Lotte. Het zou al te 
makkelijk zijn om jou enkel te beschrijven met jouw pech met de SFC, want jouw 
talent om een situatie met één nuchtere, droge én daarenboven grappige opmerking 
te fileren zijn ongetwijfeld wat ik zal onthouden. Die andere generatiegenoten Reintje 
en Joketje, zijn allebei opgeklommen van masterthesisstudent in het lab tot PhD 
student en hebben daar een speciale plek voor mij veroverd. Rein, zoals al eerder 
gezegd, door een droom mede-assistent te zijn. Jouw al dan niet aangebrande 
moppen maakten de saaie momenten véél aangenamer. Daarnaast ben je de auteur 
van legendarische uitspraken waarvan: “Omer obeter” één is waar ik zelf al mee heb 
gescoord bij maten op café. Joke, jij verdient een speciale plek in dit dankwoord 
omdat ik de eer had jouw peter te zijn. Daarnaast was je ook mijn vice-CPO en is het 
duidelijk dat je die fakkel met glans hebt overgenomen. Ik kan mezelf dus zeker een 
trotse peter noemen. Ik hoop dat je jezelf zonder mijn fantastische begeleiding kan 
behelpen ;-). 
Another ravishing lady in the lab is Rita, who joined us in two times. Looking 
back on things, I regret not running together sooner, since I have the feeling we only 
really got to know each other during those moments. Our last lunch run will be 
probably a sad one, since I will sincerely miss those 25-30 mins and already look 
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forward to be “running through barriers” with you, Stephan, PJ, Joke, and Rein if he 
feels like it ;-). 
Dat Stephan ook in goed gezelschap verkeert in zijn bureau laat geen twijfel, 
want naast Karen en Rita, heeft hij ook Eline naast zijn zijde. Jij bracht ons een hele 
nieuwe woordenschat bij van “hippe” jongerentaal en daarnaast heb ik nog nooit zo’n 
fantastische banaan het beste van zichzelf zien geven. Jammer dat er soms 
obstakels in de weg hingen! Sangram, you were always the definition of calm and 
friendliness. I wish you the best of luck in your new job in India. 
Dan resten mij enkel nog onze groentjes van de lichting 2015. Pieterjan, jij 
hebt nu al de harten veroverd van zowel de mannelijke als de vrouwelijke kant van 
het labo. Voor een man die de weetjes zo los uit zijn mouw schudt is dat niet 
verwonderlijk! Silke, jij hebt de zware opdracht gekregen om Ine D.C. te vervangen 
bij “the bubble girls from Ghent”, maar dat kan met jouw spontaniteit geen probleem 
zijn. Molood, Jing and Heyang, unfortunately I didn’t have the pleasure to really get 
to know you well, but I wish you all a great time at the lab. 
Naast de PhD studenten wil ik ook even de andere Post-Docs bedanken. Ine, 
jouw manier van werken vind ik heerlijk. In mijn ogen een beetje dwars op de 
gangbare methoden bij de rest van ons labo, probeer jij connecties te leggen met 
andere labs om vooruitgang te boeken. Volgens mij de enige goeie manier om 
wetenschappelijke vooruitgang te boeken! Koen, jou zal ik naast een vat vol 
wetenschappelijke ideeën toch vooral onthouden als de man die een gerecht kan 
beschrijven op een manier dat je het bijna kan ruiken en proeven. Last but not least, 
Toon, ik denk oprecht dat je op de korte tijd dat je nu op het labo werkt enorm veel 
mensen hebt geholpen. Daarnaast blijkt dat je bijdrage niet stopt bij het 
wetenschappelijke, want je hebt bewezen dat je ook op gezelligheid hoog scoort. 
Tot slot wil ik nog enkele mensen in het bijzonder extra bedanken: Rein, Joke, 
Karen, Bart L. en Hilde, jullie zijn in het bijzonder toppers aangezien ik mij dit jaar 
enkel kon toeleggen op schrijven van deze thesis en amper in het practicum moest 
staan, nog eens bedankt daarvoor. Daarbuiten heb ik ook het genoegen gehad om 
enkele thesisstudenten te begeleiden. Rui, Justin and Cristiana, I had a good time 
“supervising” you guys and I hope you felt the same way about your time in the lab! 
 
Naast de collega’s op het labo, wil ik ook mijn vrienden en familie bedanken. 
BuB ook wel de google 2.0 van Antwerpen of de boyz, jullie zorgen altijd voor de 
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ontspanning in het weekend wanneer die nodig is. Team Antwerp, ik zie jullie veel te 
weinig tegenwoordig, hopelijk kunnen we die schade binnenkort een beetje inhalen!  
 
Tot slot resten er mij nog drie heel belangrijke mensen om te bedanken. Eerst 
en vooral Suus. Schat, jij bent van onschatbare waarde geweest voor mij de laatste 
–bijna- drie jaar. Jouw spontaniteit, enthousiasme, drive en zin om op 
ontdekkingstochten te gaan, ga ik nooit beu geraken! Verder slaag je er ook als geen 
ander in om mijn cheerleader te zijn wanneer het nodig is. Een beetje tough love is je 
daarbij niet vreemd. De laatste weken waren vaak stressy en mijn humeur had daar 
zeker onder te lijden, dankjewel om op die momenten mijn rots in de branding te zijn. 
Ik kijk er nu al reikhalzend naar uit om met jou onze plannen voor volgende jaren 
waar te maken. (En ja, ik beloof plechtig dat ik vanaf nu volop tijd ga steken in de 
voorbereiding!) 
De twee andere enorm belangrijke mensen die ik nog absoluut moet 
bedanken zijn mijn geweldige ouders. Mama, papa, bedankt om al die jaren mee te 
leven, naar mijn gezaag te luisteren als ik in het weekend thuis kwam na een 
frustrerende week en mij al die jaren te steunen. Zonder jullie was dit zonder enige 
twijfel nooit gelukt. Dankjewel! 
 
Koen
  
 
